https://healthandpharma.net/ 2026-04-01T00:00:00+00:00 1.00 https://healthandpharma.net/posts 2026-04-01T00:00:00+00:00 0.80 https://healthandpharma.net/contact-us 2026-04-01T00:00:00+00:00 0.80 https://healthandpharma.net/about-us 2026-04-01T00:00:00+00:00 0.80 https://healthandpharma.net/terms-conditions 2026-04-01T00:00:00+00:00 0.80 https://healthandpharma.net/legal-warning 2026-04-01T00:00:00+00:00 0.80 https://healthandpharma.net/privacy-policy 2026-04-01T00:00:00+00:00 0.80 https://healthandpharma.net/posts?category=dermatology 2026-04-01T00:00:00+00:00 0.64 https://healthandpharma.net/posts?category=medicines 2026-04-01T00:00:00+00:00 0.64 https://healthandpharma.net/posts?category=infections 2024-05-15T00:00:00+00:00 0.64 https://healthandpharma.net/posts?category=blood-diseases 2026-04-01T00:00:00+00:00 0.64 https://healthandpharma.net/posts?category=cancer 2026-03-18T00:00:00+00:00 0.64 https://healthandpharma.net/posts?category=brain 2026-04-01T00:00:00+00:00 0.64 https://healthandpharma.net/posts?category=heart-diseases 2026-04-01T00:00:00+00:00 0.64 https://healthandpharma.net/posts?category=internal-diseases 2026-04-01T00:00:00+00:00 0.64 https://healthandpharma.net/posts?category=psychiatry 2024-07-16T00:00:00+00:00 0.64 https://healthandpharma.net/posts?category=important-tests 2026-04-01T00:00:00+00:00 0.64 https://healthandpharma.net/posts?category=neurology 2025-08-19T00:00:00+00:00 0.64 https://healthandpharma.net/posts?category=rheumatology 2023-11-11T00:00:00+00:00 0.64 https://healthandpharma.net/posts?category=biotech 2026-03-20T00:00:00+00:00 0.64 https://healthandpharma.net/posts?category=fda-ema 2026-04-01T00:00:00+00:00 0.64 https://healthandpharma.net/posts?category=clinical-trials 2026-03-30T00:00:00+00:00 0.64 https://healthandpharma.net/posts?category=pharma 2026-03-20T00:00:00+00:00 0.64 https://healthandpharma.net/posts?category=ai 2026-03-30T00:00:00+00:00 0.64 https://healthandpharma.net/posts?category=new-discovery 2024-01-12T00:00:00+00:00 0.64 https://healthandpharma.net/posts?category=pediatrics 2023-09-07T00:00:00+00:00 0.64 https://healthandpharma.net/posts?category=digital-health 2026-03-04T00:00:00+00:00 0.64 https://healthandpharma.net/posts?category=cardiology 2024-03-21T00:00:00+00:00 0.64 https://healthandpharma.net/posts?category=genetic 2025-04-28T00:00:00+00:00 0.64 https://healthandpharma.net/posts?category=gynecology 2026-04-01T00:00:00+00:00 0.64 https://healthandpharma.net/posts?category=health-tech 2026-04-01T00:00:00+00:00 0.64 https://healthandpharma.net/posts?category=medical-devices 2024-08-31T00:00:00+00:00 0.64 https://healthandpharma.net/posts?category=oncolife 2026-03-30T00:00:00+00:00 0.64 https://healthandpharma.net/posts?category=surgery 2025-08-18T00:00:00+00:00 0.64 https://healthandpharma.net/posts?category=opinion 2025-09-18T00:00:00+00:00 0.64 https://healthandpharma.net/posts?category=webinar 2025-09-17T00:00:00+00:00 0.64 https://healthandpharma.net/author/huseyin-kandemir 2026-03-30T00:00:00+00:00 0.64 https://healthandpharma.net/author/health-and-pharma 2026-04-01T00:00:00+00:00 0.64 https://healthandpharma.net/author/mithat-can-turan 2024-12-06T00:00:00+00:00 0.64 https://healthandpharma.net/author/martin-sandhu 2024-01-26T00:00:00+00:00 0.64 https://healthandpharma.net/author/jamie-kalafchi 2023-11-13T00:00:00+00:00 0.64 https://healthandpharma.net/author/tracy-mokwe 2024-12-11T00:00:00+00:00 0.64 https://healthandpharma.net/author/iffi-wahla 2024-05-10T00:00:00+00:00 0.64 https://healthandpharma.net/author/clifford-huntley 2024-08-09T00:00:00+00:00 0.64 https://healthandpharma.net/author/darron-antill 2025-01-13T00:00:00+00:00 0.64 https://healthandpharma.net/author/doron-sitbon 2025-02-21T00:00:00+00:00 0.64 https://healthandpharma.net/author/carine-cohen 2025-05-27T00:00:00+00:00 0.64 https://healthandpharma.net/fda-breakthrough-wu-cart-tcell-leukemias-lymphomas 2026-04-01T00:00:00+00:00 0.80 https://healthandpharma.net/1775256436CAR-T-cell-therapy-fda-1.webp FDA Grants Breakthrough Status to WU-CART-007 for Aggressive T-Cell Leukemias and Lymphomas https://healthandpharma.net/ai-predict-chemotherapy-breast-cancer-pathology 2026-03-30T00:00:00+00:00 0.80 https://healthandpharma.net/1774884072ai-detect-cancer-pathology-2.webp AI Predicts Who Benefits from Chemotherapy in Early Breast Cancer Using Routine Pathology Slides https://healthandpharma.net/immunotherapy-atezolizumab-boosts-chemotherapy-dmmr-colon-cancer 2026-03-30T00:00:00+00:00 0.80 https://healthandpharma.net/1753816348Immunotherapy-tcell-cancer-5.webp Immunotherapy Boosts Chemotherapy Cutting Recurrence Risk by 50% in St-3 dMMR Colon Cancer https://healthandpharma.net/nanoparticle-nonviral-gene-therapy-promise-cancer 2026-03-30T00:00:00+00:00 0.80 https://healthandpharma.net/1774911130dna-Nanoparticle-gene-transfer-21.webp Nonviral Gene Delivery Platform Offers Promise for Cancer Treatment and Cell Therapy https://healthandpharma.net/ihc-biomarker-test-predict-gastric-cancer-immunotherapy 2026-03-30T00:00:00+00:00 0.80 https://healthandpharma.net/1774911377dna-lab-gene-12..webp New IHC Biomarker Test Predicts Which Gastric Cancer Patients Benefit from Immunotherapy https://healthandpharma.net/fda-approves-agilent-pd-l1-test-keytruda-esophageal-gej-carcinoma 2026-03-28T00:00:00+00:00 0.80 https://healthandpharma.net/1774802158PD-L1IHC22C3-pharmDx-Test-2.webp FDA Approves Agilent’s PD-L1 Test to Guide KEYTRUDA Use in Esophageal and GEJ Carcinoma https://healthandpharma.net/photoresponsive-copper-nanoparticles-cuproptosis-cancer 2026-03-27T00:00:00+00:00 0.80 https://healthandpharma.net/1774740048copper-nanoparticles-cuproptosis-cancer-2.webp Light-Activated Copper Nanoparticles Trigger Cuproptosis in Drug-Resistant Cancer Cells https://healthandpharma.net/protein-modification-idh-mutant-cancers-therapeutic 2026-03-26T00:00:00+00:00 0.80 https://healthandpharma.net/1774564669IDH-Mutant-Cancer-1.webp New Protein Modification Linked to IDH-Mutant Cancers Opens Therapeutic Possibilities https://healthandpharma.net/biontech-bispecific-adc-lung-cancer-elcc2026 2026-03-25T00:00:00+00:00 0.80 https://healthandpharma.net/1774544760BioNTech-lung-cancer-2.webp BioNTech Showcases Promising Bispecific and ADC Data in Lung Cancer at ELCC 2026 https://healthandpharma.net/magnetic-nanoparticle-hyperthermia-cancer-solid-tumors 2026-03-23T00:00:00+00:00 0.80 https://healthandpharma.net/1774304471Mayo-Nanoparticle-cancer-2.webp Magnetic Nanoparticle-Guided Hyperthermia Opens a New Path for Advanced Solid Tumors https://healthandpharma.net/sunvozertinib-chemotherapy-egfr-nsclc-lung-cancer 2026-03-22T00:00:00+00:00 0.80 https://healthandpharma.net/1774317329Sunvozertinib-lung-cancer-11.webp Sunvozertinib Outperforms Chemo in First-Line EGFR Exon 20 Insertion NSC Lung Cancer https://healthandpharma.net/fda-approves-nivolumab-opdivo-immunotherapy-hodgkin-lymphoma 2026-03-20T00:00:00+00:00 0.80 https://healthandpharma.net/1774048488nivolumab-opdivo-fda-3.webp FDA Approves Nivolumab-AVD as First Immunotherapy Combination for Hodgkin Lymphoma https://healthandpharma.net/talazoparib-enzalutamide-prostate-cancer-mCSPC 2026-03-20T00:00:00+00:00 0.80 https://healthandpharma.net/1774114923Talazoparib-Prostate-Cancer-2.webp TALAPRO-3 Trial Supports Early Use of Talazoparib in HRR+ mCS Prostate Cancer https://healthandpharma.net/tg-therapeutics-briumvi-multiple-sclerosis 2026-03-20T00:00:00+00:00 0.80 https://healthandpharma.net/1774205154TG-Therapeutics-21.webp TG Therapeutics Secures $500M to Advance BRIUMVI in Relapsing Multiple Sclerosis https://healthandpharma.net/abenacianine-tumor-lung-cancer-surgery-vergent-bioscience 2026-03-19T00:00:00+00:00 0.80 https://healthandpharma.net/1716759963Vergent-surgery-6.jpg Abenacianine Enters Phase 3 to Enhance Real-Time Tumor Detection in Lung Surgery https://healthandpharma.net/cellcarta-biofidelity-aspyre-test-lung-cancer 2026-03-18T00:00:00+00:00 0.80 https://healthandpharma.net/1773963611Aspyre-Lung-cancer-test.webp CellCarta Secures Global Exclusivity for Aspyre Lung to Advance Lung Cancer Testing https://healthandpharma.net/atirmociclib-cdk4-metastatic-breast-cancer 2026-03-17T00:00:00+00:00 0.80 https://healthandpharma.net/1774124789Atirmociclib-mBCancer-2.webp Atirmociclib Reduces Progression Risk by 40% in CDK4/6 Metastatic Breast Cancer https://healthandpharma.net/car-tcell-longer-fight-against-cancer-hiv 2026-03-15T00:00:00+00:00 0.80 https://healthandpharma.net/1733854864cart-cell-cancer-4.jpg Reengineering CAR-T Cells to Last Longer in the Fight Against Cancer and HIV https://healthandpharma.net/bladder-cancer-erda-idrsr-response-rate-erdafitinib 2026-03-15T00:00:00+00:00 0.80 https://healthandpharma.net/1774192105Erda-iDRS-Bladder-Cancer.webp Targeted Bladder Cancer Therapy Erda-iDRS Achieves 89% Response Rate and PDC https://healthandpharma.net/recite-trial-romiplostim-chemotherapy-side-effects 2026-03-14T00:00:00+00:00 0.80 https://healthandpharma.net/1773454515Chemotherapy-cancer-41.webp Romiplostim Prevents Chemotherapy Side Effects and Preserves Treatment Intensity https://healthandpharma.net/vitamin-b2-cancer-survival-therapeutic-target 2026-03-14T00:00:00+00:00 0.80 https://healthandpharma.net/1773530876vitaminb2-cancer-1.webp Vitamin B2’s Hidden Role in Cancer Survival May Open a New Therapeutic Target https://healthandpharma.net/primary2-psma-petct-prostate-cancer-diagnosis-biopsies 2026-03-13T00:00:00+00:00 0.80 https://healthandpharma.net/1773438944pet-cancer-imaging-2.webp PSMA PET/CT May Transform Prostate Cancer Diagnosis and Reduce Biopsies by 50% https://healthandpharma.net/breast-cancer-patients-alternative-medicine-mortality 2026-03-09T00:00:00+00:00 0.80 https://healthandpharma.net/1773081886breast-cancer-cam-2.webp Breast Cancer Patients Choosing Alternative Medicine Face Four Times Higher Mortality https://healthandpharma.net/design-healthcare-system-patient-centered-care 2026-03-04T00:00:00+00:00 0.80 https://healthandpharma.net/1772654220ai-digital-data-21.webp Designing Digital Healthcare Systems for the Future of Patient-Centered Care https://healthandpharma.net/microbiome-gut-bacteria-nutrients-feed-tumors-immunity 2026-02-13T00:00:00+00:00 0.80 https://healthandpharma.net/gut-bacteria-stomach-3.jpg Gut Bacteria Decide Whether Nutrients Feed Tumors or Fuel Immunity https://healthandpharma.net/amivantamab-rybrevant-chemotherapy-colorectal-cancer 2026-01-11T00:00:00+00:00 0.80 https://healthandpharma.net/1768320043amivantamab-rybrevant-colorectal-cancer-2.webp Amivantamab Plus Chemotherapy Shows Promising Responses in Colorectal Cancer https://healthandpharma.net/novartis-radioligand-manufacturing-investment-florida 2026-01-09T00:00:00+00:00 0.80 https://healthandpharma.net/1767992359Novartis-Radioligand-3.webp Novartis Expands US Radioligand Manufacturing With $23 Billion Investment in Florida https://healthandpharma.net/oncogenic-rewiring-rna-therapy-pancreatic-cancer 2026-01-08T00:00:00+00:00 0.80 https://healthandpharma.net/1767919928PDAC-tumor-Cancer-5.webp Rewiring RNA: Antisense RNA Therapy Exposes a New Weakness in Pancreatic Cancer https://healthandpharma.net/adc-trbc2-antibody-tcell-cancer-lymphomas-leukemias 2025-12-24T00:00:00+00:00 0.80 https://healthandpharma.net/1766704951adc-antibody-tcell-cancer-3.webp TRBC2-Specific ADC Shows Robust Efficacy in T-Cell Lymphomas and Leukemias https://healthandpharma.net/glioblastoma-oncolytic-virus-immunity-brain-cancer 2025-12-20T00:00:00+00:00 0.80 https://healthandpharma.net/1766697534brain-cancer-oncolotic-2.webp Engineered Oncolytic Virus Reprograms Immunity and Extends Survival in Brain Cancer https://healthandpharma.net/padcev-keytruda-pembrolizumab-mi-bladder-cancer 2025-12-18T00:00:00+00:00 0.80 https://healthandpharma.net/1766097549Padcev-Pembrolizumab-Keytruda-mib-Cancer.webp Platinum-Free PADCEV Plus Pembrolizumab Improves Survival in MI Bladder Cancer https://healthandpharma.net/fda-subcutaneous-amivantamab-lazertinib-egfr-nsclc-lung-cancer 2025-12-18T00:00:00+00:00 0.80 https://healthandpharma.net/1766104509FDA-Amivantamab-Lazertinib-NSCLC.webp FDA Approves First Subcutaneous Amivantamab Plus Lazertinib for EGFR+ Lung Cancer https://healthandpharma.net/fda-approves-enhertu-tdxd-pertuzumab-breast-cancer 2025-12-16T00:00:00+00:00 0.80 https://healthandpharma.net/1765927022FDA-Enhertu-pertuzumab-mbc.webp FDA Approves T-DXd Plus Pertuzumab as a First-Line Standard in HER2+ Breast Cancer https://healthandpharma.net/ipilimumab-dose-melanoma-immunotherapy-less-toxic 2025-12-14T00:00:00+00:00 0.80 https://healthandpharma.net/1765908308cancer-immunotherapy-12.webp Less Toxic, More Effective: RW Evidence Supports Reduced Immunotherapy Dose in Melanoma https://healthandpharma.net/fda-approves-niraparib-abiraterone-brca-prostate-cancer 2025-12-12T00:00:00+00:00 0.80 https://healthandpharma.net/1765650734FDA-AKEEGA-Prostate-Cancer-2.webp FDA Approves AKEEGA for BRCA2+ Prostate Cancer as the First Precision Therapy https://healthandpharma.net/ai-artificial-intelligence-detects-pancreatic-cancer-radiologists 2025-12-12T00:00:00+00:00 0.80 https://healthandpharma.net/1765933297ai-artifical-cancer-31.webp Artificial Intelligence Detects Pancreatic Cancer More Accurately Than Radiologists https://healthandpharma.net/preoperative-radiation-antitumor-breast-cancer 2025-12-11T00:00:00+00:00 0.80 https://healthandpharma.net/1765470127radiation-brest-cancer-sabcs25.webp Preoperative Radiation May Improve Immune Response in HR+ HER2- Breast Cancer https://healthandpharma.net/serd-giredestrant-recurrence-er-breast-cancer-roche 2025-12-10T00:00:00+00:00 0.80 https://healthandpharma.net/1765410243Giredestrant-Breast-Cancer-roche.webp Giredestrant Cuts Risk of Invasive Recurrence by 30% in Early ER+ Breast Cancer https://healthandpharma.net/tukysa-tucatinib-combo-her2-breast-cancer 2025-12-10T00:00:00+00:00 0.80 https://healthandpharma.net/1765464277Tucatinib-Tukysa-Pfizer-BC.webp Tucatinib Combination Cuts Progression Risk by 36% in HER2+ Metastatic Breast Cancer https://healthandpharma.net/gsk-adc-risvutatug-rezetecan-fda-orphan-drug-sclc 2025-12-10T00:00:00+00:00 0.80 https://healthandpharma.net/1765487654FDA-Orphan-Drug-Risvutatug-Rezetecan.webp GSK’s ADC Risvutatug Rezetecan Earns FDA Orphan Drug Status for Small Cell Lung Cancer https://healthandpharma.net/teclistamab-daratumumab-multiple-myeloma-tecvayli 2025-12-10T00:00:00+00:00 0.80 https://healthandpharma.net/1765667344Teclistamab-Daratumumab-2.webp Teclistamab plus Daratumumab Achieves an 83% Risk Reduction in R/R Multiple Myeloma https://healthandpharma.net/cart-anito-cel-multiple-myeloma-arcellx 2025-12-09T00:00:00+00:00 0.80 https://healthandpharma.net/1765400293Arcellx-labratory-1.webp CAR T Anito cel Delivers Deep, Durable Responses in R&R Multiple Myeloma https://healthandpharma.net/kisqali-ribociclib-metastatic-breast-cancer-sabcs2025 2025-12-09T00:00:00+00:00 0.80 https://healthandpharma.net/1765477503Ribociclib-Kisqali-BC.webp Ribociclib Maintains Long-Term Disease Control in HR+ HER2 Metastatic Breast Cancer https://healthandpharma.net/lunsumio-mosunetuzumab-combo-follicular-lymphomas 2025-12-08T00:00:00+00:00 0.80 https://healthandpharma.net/1765322986Lunsumio-Cell-Lymphomas-3.webp Lunsumio Combo Deliver High Response Rates in Follicular and Large B-Cell Lymphomas https://healthandpharma.net/colibactin-gut-microbial-toxin-colorectal-cancer 2025-12-06T00:00:00+00:00 0.80 https://healthandpharma.net/1765065113dna-gene-43.webp Colibactin’s Molecular Blueprint Exposes How a Gut Microbial Toxin Triggers Colorectal Cancer https://healthandpharma.net/enozertinib-ergf-exon20-lung-cancer-nsclc 2025-12-06T00:00:00+00:00 0.80 https://healthandpharma.net/1765072344lung-cancer-nsclc-45.webp Enozertinib Shows Strong Systemic and CNS Activity in EGFR Exon 20+ NSC Lung Cancer https://healthandpharma.net/blood-cfdna-detecting-lung-cancer-nonsmokers 2025-12-05T00:00:00+00:00 0.80 https://healthandpharma.net/1765038888lung-cancer-gene-dna-24.webp Blood-Based cfDNA Test Demonstrates Potential for Detecting Lung Cancer in Nonsmokers https://healthandpharma.net/nanotherapy-glioblastoma-immunity-brain 2025-12-02T00:00:00+00:00 0.80 https://healthandpharma.net/1765147392Nanodrops-Glioblastoma-2.webp Nanotherapy Reprograms Glioblastoma Immunity Through Nose-to-Brain Delivery https://healthandpharma.net/lung-organoids-bioreactor-drug-testing-cancer-therapies 2025-12-02T00:00:00+00:00 0.80 https://healthandpharma.net/1765156148organoids-bioreactor-lab.webp Lung Organoids Offer a Revolutionary Path to Transform Drug Testing and Cancer Therapies https://healthandpharma.net/fda-durvalumab-imfinzi-gastric-gej-cancers 2025-11-26T00:00:00+00:00 0.80 https://healthandpharma.net/1764286030durvalumab-imfinzi-fda-32.webp FDA Approves Durvalumab as First Perioperative Immunotherapy for GEJ Cancers https://healthandpharma.net/fda-pembrolizumab-keytruda-padcev-bladder-cancer 2025-11-24T00:00:00+00:00 0.80 https://healthandpharma.net/1764268140Keytruda–Padcev-fda-3.webp FDA Approves Keytruda–Padcev Combo as First Perioperative Treatment for Bladder Cancer https://healthandpharma.net/fda-sevabertinib-hyrnuo-her2-lung-cancer-nsclc 2025-11-20T00:00:00+00:00 0.80 https://healthandpharma.net/1763772916sevabertinib-hyrnuo-fda-2.webp Sevabertinib Wins FDA Approval with Strong Responses in HER2+ NSC Lung Cancer https://healthandpharma.net/fda-epcoritamab-bysp-epkinly-follicular-lymphoma 2025-11-19T00:00:00+00:00 0.80 https://healthandpharma.net/1763577083Epkinly-Epcoritamab-3.webp FDA Approves Epcoritamab-bysp as the First Bispecific Antibody for Follicular Lymphoma https://healthandpharma.net/fda-approves-ziftomenib-npm1-aml-acute-myeloid-leukemia 2025-11-14T00:00:00+00:00 0.80 https://healthandpharma.net/1763481283fda-headquarter-55.webp FDA Approves Ziftomenib as a New Targeted Option for NPM1+ Acute Myeloid Leukemia https://healthandpharma.net/novartis-invests-23-billion-radioligand-manufacturing-carlsbad 2025-11-11T00:00:00+00:00 0.80 https://healthandpharma.net/pharma-drug-radioligand-2.webp Novartis Invests $23 Billion to Boost Radioligand Manufacturing Capacity in Carlsbad https://healthandpharma.net/lenvatinib-everolimus-rcc-kidney-cancer-immunotherapy 2025-11-06T00:00:00+00:00 0.80 https://healthandpharma.net/1762993990Kidney-rcc-Lenvatinib-everolimus-1.webp Lenvatinib Plus Everolimus Improves Outcomes After PD-1 Failure in Kidney Cancer https://healthandpharma.net/psmaddition-radioligand-therapy-pluvicto-prostate-cancer 2025-11-05T00:00:00+00:00 0.80 https://healthandpharma.net/1763160560PSMAddition-Pluvicto-1.webp Radioligand Therapy Pluvicto Reduces Progression Risk by 28% in mHS Prostate Cancer https://healthandpharma.net/ctdna-blood-test-guides-chemotherapy-colon-cancer-treatment 2025-11-04T00:00:00+00:00 0.80 https://healthandpharma.net/1754817255dna-test-genetic-66.webp ctDNA Blood Test Guides Chemotherapy Decisions for Tailored Colon Cancer Treatment https://healthandpharma.net/imdelltra-deLLphi-tarlatamab-chemo-essc-lung-cancer 2025-11-04T00:00:00+00:00 0.80 https://healthandpharma.net/1762876523Imdelltra-Tarlatamab-Lung-Cancer-12.webp DeLLphi-303: Tarlatamab Plus Chemo Achieves 71% Response in ES Small-Cell Lung Cancer https://healthandpharma.net/esmo-ai-llm-guide-roadmap-oncology-cancer-care 2025-11-03T00:00:00+00:00 0.80 https://healthandpharma.net/1762381753esmo-ai-llm-guide-2.webp ESMO’s Road Map for Safe and Effective Use of AI-LLMs in Cancer Care: 23 Rules from 20 Experts https://healthandpharma.net/natalee-kisqali-ribociclib-early-breast-cancer-esmo2025 2025-11-03T00:00:00+00:00 0.80 https://healthandpharma.net/1762899836Kisqali-NATALEE.webp Ribociclib Extends Disease-Free Survival Beyond Treatment in HR+/HER2– Early Breast Cancer https://healthandpharma.net/trodelvy-mtn-breast-cancer-sacituzumab-govitecan-gilead 2025-10-24T00:00:00+00:00 0.80 https://healthandpharma.net/1762469050Trodelvy-Gilead-breast-cancer-61.webp Trodelvy Emerges as Potential New Standard for First-Line Metastatic TN Breast Cancer https://healthandpharma.net/datroway-datopotamab-deruxtecan-mtn-breast-cancer 2025-10-21T00:00:00+00:00 0.80 https://healthandpharma.net/1762268414Datroway-esmo25.webp Datroway Extends Survival by 5 Months in Metastatic Triple-Negative Breast Cancer https://healthandpharma.net/esmo25-lenvatinib-pembrolizumab-endometrial-carcinoma 2025-10-20T00:00:00+00:00 0.80 https://healthandpharma.net/1760972148Esmo25-Lenvatinib-Pembrolizumab-1.webp Lenvatinib Plus Pembrolizumab Delivers Durable 5-Year Survival in Endometrial Carcinoma https://healthandpharma.net/esmo25-ai-thymic-health-immunotherapy-cancer 2025-10-18T00:00:00+00:00 0.80 https://healthandpharma.net/1760990576esmo25-ai-thymic-cancer.webp AI Analysis of Thymic Health Predicts Immunotherapy Success, Cutting Death Risk by 44% https://healthandpharma.net/prostate-cancer-enzyme-blockade-tumor-enzalutamide 2025-10-14T00:00:00+00:00 0.80 https://healthandpharma.net/1760462700prostate-cancer-pdi-2.webp Disarming Prostate Cancer: Dual Enzyme Blockade Weakens Tumors and Boosts Drug Response https://healthandpharma.net/trojan-horse-cancer-peptide-nanotubes-drug-resistant-tumor 2025-10-13T00:00:00+00:00 0.80 https://healthandpharma.net/1760397554peptide-nanotubes-cancer-2.webp Molecular Trojan Horse: Peptide Nanotubes Offer a Path to Defeat Drug-Resistant Tumors https://healthandpharma.net/reprogramming-cancer-cell-death-leukemia 2025-10-12T00:00:00+00:00 0.80 https://healthandpharma.net/1760307056cancer-cell-3.webp Reprogramming Cancer Cell Death: A New Immune-Based Strategy for Blood Cancers https://healthandpharma.net/astrazeneca-deal-trump-admin-cut-drug-prices 2025-10-11T00:00:00+00:00 0.80 https://healthandpharma.net/1760196102WhiteHouse-US-AstraZeneca.webp AstraZeneca makes deal with Trump Admin to Cut Drug Prices 80% and Invest $50B in US https://healthandpharma.net/led-snox-nanoflake-therapy-tumor-cells-cancer 2025-10-11T00:00:00+00:00 0.80 https://healthandpharma.net/1760293224cancer-led-SnOx-Nanoflake-2.webp LED-Activated SnOx Nanoflake Therapy Destroy Tumor Cells with Precision https://healthandpharma.net/bms-acquires-orbital-therapeutics-vivo-cart-cell 2025-10-10T00:00:00+00:00 0.80 https://healthandpharma.net/1760216915BMS-Orbital-Acquisition.webp In Vivo CAR T on the Horizon: BMS Acquires Orbital to Expand Cell Therapy Reach https://healthandpharma.net/fda-approves-libtayo-cemiplimab-cell-carcinoma-skin-cancer 2025-10-09T00:00:00+00:00 0.80 https://healthandpharma.net/1760097689Libtayo-cemiplimab-23.webp FDA Approves Libtayo as First Adjuvant Immunotherapy for High-Risk CS Cell Carcinoma https://healthandpharma.net/datroway-datopotamab-deruxtecan-triple-breast-cancer 2025-10-06T00:00:00+00:00 0.80 https://healthandpharma.net/1759844362Datroway-datopotamab-deruxtecan-ADC-3.webp Datroway Improves Survival in First-Line Treatment of Metastatic Triple- Breast Cancer https://healthandpharma.net/fda-tecentriq-zepzelca-lung-cancer-atezolizumab-lurbinectedin 2025-10-03T00:00:00+00:00 0.80 https://healthandpharma.net/1759786592Fda-Tecentriq–Zepzelca-2.webp FDA Approves Tecentriq–Zepzelca Combo as FL Maintenance Therapy for ES-SC Lung Cancer https://healthandpharma.net/water-vapor-ablation-prostate-cancer-michael-kujak 2025-10-02T00:00:00+00:00 0.80 https://healthandpharma.net/1759445957water-vapor-23.webp The VAPOR 2 Trial and the Potential of Water Vapor Ablation in Prostate Cancer Treatment https://healthandpharma.net/destiny-deruxtecan-enhertu-her2-breast-cancer 2025-10-01T00:00:00+00:00 0.80 https://healthandpharma.net/1759358553Enhertu-trastuzumab-deruxtecan-1.webp DESTINY-Breast05: Enhertu Outperforms T-DM1 in High-Risk HER2+ Early Breast Cancer https://healthandpharma.net/eleni-lagkadinou-abbvie-targeted-innovation-treat-cancers 2025-10-01T00:00:00+00:00 0.80 https://healthandpharma.net/1759533446Eleni-Headshot-32.webp Dr. Eleni Lagkadinou Discusses How AbbVie Is Advancing Targeted Innovation for HT Cancers https://healthandpharma.net/fda-approves-inluriyo-imlunestrant-breast-cancer 2025-09-27T00:00:00+00:00 0.80 https://healthandpharma.net/1759415090imlunestrant-Inluriyo-2.webp FDA Approves Imlunestrant for ESR1-Mutated Metastatic Breast Cancer https://healthandpharma.net/giredestrant-everolimus-er-breast-cancer 2025-09-26T00:00:00+00:00 0.80 https://healthandpharma.net/1759247348Giredestrant-Breast-Cancer.webp Giredestrant Plus Everolimus Improves PF Survival in ER+ Advanced Breast Cancer https://healthandpharma.net/sugary-drinks-drive-colorectal-cancer-metastasis-sord 2025-09-20T00:00:00+00:00 0.80 https://healthandpharma.net/1758405658cancer-cell-focus-32.webp Sugary Drinks Drive Colorectal Cancer Metastasis via SORD Pathway, Study Finds https://healthandpharma.net/low-dose-aspirin-halves-recurrence-colorectal-cancer 2025-09-20T00:00:00+00:00 0.80 https://healthandpharma.net/1758495565aspirin-drug-cancer-3.webp NEJM Study Confirms Low-Dose Aspirin Halves Recurrence in Colorectal Cancer https://healthandpharma.net/ema-chmp-keytruda-subcutaneous-pembrolizumab-head-neck-cancer 2025-09-19T00:00:00+00:00 0.80 https://healthandpharma.net/1758317143Ema-Cmph-Keytruda-2.webp EMA’s CHMP Backs Subcutaneous Pembrolizumab in Head and Neck Cancer https://healthandpharma.net/climate-change-health-risks-cost 2025-09-18T00:00:00+00:00 0.80 https://healthandpharma.net/1758184500Climate-Change-3.webp Climate-Driven Health Risks to Put $1.5 Trillion in Productivity at Stake by 2050 https://healthandpharma.net/gsk-invest-30-billion-inrd-manufacturing-us 2025-09-18T00:00:00+00:00 0.80 https://healthandpharma.net/1758200417GSK-pharma-3.webp GSK to invest $30 billion in R&D and Manufacturing in the US over next 5 years https://healthandpharma.net/dajun-yang-tyrosine-kinase-inhibitors-myeloid-leukemia-olverembatinib 2025-09-17T00:00:00+00:00 0.80 https://healthandpharma.net/1758137617Dajun-Yang-Ascentage-3.webp The Role of Third-Generation TKIs in Overcoming Chronic Myeloid Leukemia Resistance https://healthandpharma.net/fda-grant-breakthrough-raludotatug-deruxtecan-ovarian-cancer 2025-09-17T00:00:00+00:00 0.80 https://healthandpharma.net/1758285404FDA-Raludotatug-Deruxtecan.webp FDA Grants Breakthrough Status to Raludotatug Deruxtecan for Refractory Ovarian Cancer https://healthandpharma.net/jason-westin-sunmo-trail-largeb-cell-lymphoma-treatment 2025-09-15T00:00:00+00:00 0.80 https://healthandpharma.net/1757958765Jason-Westin-sunmo-33.webp SUNMO Trial: A New Chapter for Transplant-Ineligible Large B-Cell Lymphoma https://healthandpharma.net/vfoundation-cvc-collaborate-breast-cancer-vaccine-research 2025-09-12T00:00:00+00:00 0.80 https://healthandpharma.net/1758665267V-Foundation-CVC-3.webp The V Foundation and CVC Collaborate to Advance Breast Cancer Vaccine Research https://healthandpharma.net/cvc-vfoundation-grant-breast-cancer-vaccine-research 2025-09-10T00:00:00+00:00 0.80 https://healthandpharma.net/1757869164Cancer-CVC-VFoundation-3.webp CVC and V Foundation Fuel $500K Grant for Next Phase of Breast Cancer Vaccine Research https://healthandpharma.net/susanna-greer-vfoundation-cancer-research 2025-08-29T00:00:00+00:00 0.80 https://healthandpharma.net/1756479442Susanna-V-Foundation-4.webp The V Foundation for Cancer Research and CVC Partner to Accelerate Breast Cancer Vaccines https://healthandpharma.net/new-issue-oncolife-edition-live-cancer 2025-08-26T00:00:00+00:00 0.80 https://healthandpharma.net/1756360902oncolife8-cover-2.webp ONCOLife’s New Edition Is Live with Breakthroughs in Cancer Research https://healthandpharma.net/fda-breakthrough-izalontamab-brengitecan-egfr-lung-cancer 2025-08-20T00:00:00+00:00 0.80 https://healthandpharma.net/1756041853fda-Izalontamab-Brengitecan.webp FDA Grants Breakthrough Status to Izalontamab Brengitecan for EGF+ Lung Cancer https://healthandpharma.net/fda-cleared-blood-test-alzheimer-diagnosis-available 2025-08-19T00:00:00+00:00 0.80 https://healthandpharma.net/1756035676Lumipulse-Blood-Test-Alzheimer-2.webp The First FDA-Cleared Blood Test for Alzheimer’s Diagnosis Now Available on the Market https://healthandpharma.net/aliya-pef-tumor-ablation-lung-liver-cancer-lesions 2025-08-18T00:00:00+00:00 0.80 https://healthandpharma.net/1755512256galvanize-tumor-ablasyon-2.webp First Patient Enrolled for Aliya® PEF Tumor Ablation of Lung/Liver Soft-Tissue Lesions https://healthandpharma.net/ferroptosis-iron-driven-death-cancer-stem-cells 2025-08-17T00:00:00+00:00 0.80 https://healthandpharma.net/1755462288Cancer-stem-cells-2.webp Ferroptosis as a New Strategy: Iron-Driven Cell Death Targets Cancer Stem Cells https://healthandpharma.net/bacteria-cloak-oncolytic-virus-cancer-solid-tumors 2025-08-16T00:00:00+00:00 0.80 https://healthandpharma.net/1755355637bacteria-oncolytic-virus-cancer.webp Bacteria Cloak Viruses to Safely Deliver Cancer-Killing Payloads into Solid Tumors https://healthandpharma.net/fda-semaglutide-wegovy-mash-liver-fibrosis 2025-08-16T00:00:00+00:00 0.80 https://healthandpharma.net/1755365094fda-Wegovy-semaglutide-3.webp FDA Grants Accelerated Approval to Semaglutide for MASH with Liver Fibrosis https://healthandpharma.net/rna-isoform-runx1c-molecular-switch-chemoresistance-blood-cancer 2025-08-16T00:00:00+00:00 0.80 https://healthandpharma.net/1746157294test-labratory-diagnos-2.webp RNA Isoform RUNX1C Identified as Molecular 'Switch' Behind Chemoresistance in Blood Cancer https://healthandpharma.net/fda-viral-immunotherapy-papzimeos-recurrent-respiratory-papillomatosis 2025-08-15T00:00:00+00:00 0.80 https://healthandpharma.net/1755265528Fda-papzimeos-rrp.webp FDA Approves Papzimeos, First Immunotherapy for Recurrent Respiratory Papillomatosis https://healthandpharma.net/mrna-vaccines-checkpoint-inhibitors-metastatic-gastric-cancer 2025-08-15T00:00:00+00:00 0.80 https://healthandpharma.net/1753484011cell-cancer-immunotherapy-2.webp mRNA Vaccines Plus Checkpoint Inhibitors Shows Curative Potential in Gastric Cancer https://healthandpharma.net/cd40-antibody-tumor-regression-cancer-immunotherapy 2025-08-15T00:00:00+00:00 0.80 https://healthandpharma.net/1755450262CD40-Agonist-Antibody-2141-V11.webp Redesigned CD40 Antibody Triggers Systemic Tumor Regression and Complete Remission https://healthandpharma.net/alcohol-pancreatic-cancer-targeting-creb 2025-08-13T00:00:00+00:00 0.80 https://healthandpharma.net/1755187168alcol-drink-3.webp Breaking the Molecular Link Between Alcohol and Pancreatic Cancer by Targeting CREB https://healthandpharma.net/padcev-keytruda-survival-gains-bladder-cancer 2025-08-12T00:00:00+00:00 0.80 https://healthandpharma.net/1755027675keytruda-padcev-bladder-cancer-2.webp PADCEV–KEYTRUDA Combination Delivers Survival Gains in High-Risk Bladder Cancer https://healthandpharma.net/genetic-testing-safety-cut-chemotherapy-toxicity-gastrointestinal-cancer 2025-08-09T00:00:00+00:00 0.80 https://healthandpharma.net/1754817255dna-test-genetic-66.webp Genetic Testing Boosts Safety, Reduces Chemotherapy Side Effects in GI Cancer https://healthandpharma.net/fda-fast-track-birelentinib-cll-sll-leukemia-lymphoma 2025-08-09T00:00:00+00:00 0.80 https://healthandpharma.net/1754901657fda-birelentinib-41.webp FDA Grants Fast Track Designation to Birelentinib for Relapsed/Refractory CLL and SLL https://healthandpharma.net/fda-zongertinib-approval-her2-nsclc-lung-cancer-hernexeos 2025-08-08T00:00:00+00:00 0.80 https://healthandpharma.net/1754684441zongertinib-Hernexeo-1.webp Zongertinib Gains FDA Accelerated Approval for HER2+ NSCLC with 75% ORR https://healthandpharma.net/fda-epcoritamab-epkinly-follicular-lymphoma 2025-08-08T00:00:00+00:00 0.80 https://healthandpharma.net/1754744428epcoritamab-Epkinly.webp Epcoritamab + R2 Achieves 95.7% ORR, Cuts Risk by 79% in R/R Follicular Lymphoma https://healthandpharma.net/fda-jazz-modeyso-dordaviprone-pediatric-brain-tumor-glioma 2025-08-06T00:00:00+00:00 0.80 https://healthandpharma.net/1754566924fda-Modeyso-dordaviprone-jazz.webp FDA Approves Modeyso as First-Ever Therapy for Pediatric Brain Tumor, H3 K27M+ Glioma https://healthandpharma.net/fda-breyanzi-car-tcell-therapy-marginal-zone-lymphoma 2025-08-05T00:00:00+00:00 0.80 https://healthandpharma.net/1710700949BMS-breyanzi-2.jpg FDA Fast-Tracks Breyanzi as First CAR T Cell Therapy for Marginal Zone Lymphoma https://healthandpharma.net/fda-oncolytic-immunotherapy-supernova-sarcoma-tumor 2025-08-04T00:00:00+00:00 0.80 https://healthandpharma.net/1754594701FDA-CLD201-SuperNova-2.webp Novel Viral Immunotherapy SuperNova Gains FDA Fast Track Designation for Sarcoma https://healthandpharma.net/pan-mass-challenge-2025-cyclists-cancer-research-donations 2025-08-03T00:00:00+00:00 0.80 https://healthandpharma.net/1754207773Pan-Mass-Challenge-DFI.webp 2025 Pan-Mass Challenge Draws Thousands of Cyclists to Fuel Next Era of Cancer Research https://healthandpharma.net/metastasis-eif2a-melanoma-driver-cancer-cell-migration 2025-08-02T00:00:00+00:00 0.80 https://healthandpharma.net/1754175670Melanoma-cancer-cell.webp Targeting eIF2A to Halt Melanoma: Study Reveals Key Driver of Cancer Cell Migration https://healthandpharma.net/hidden-disease-ovarian-cancer-patients-remission 2025-08-02T00:00:00+00:00 0.80 https://healthandpharma.net/1700491749ovarian-cancer-2.jpg New Study Uncovers Hidden Disease in 42% of Ovarian Cancer Patients in Remission https://healthandpharma.net/iris-kuss-aranote-trial-prostate-cancer-treatment 2025-08-01T00:00:00+00:00 0.80 https://healthandpharma.net/1754148861Aranote-Prostate-cancer-2.webp Dr. Iris Kuss: ARANOTE Trial Results Signal a New Era in Prostate Cancer Treatment https://healthandpharma.net/radio-immunotherapy-cancer-stem-cells-ovarian 2025-08-01T00:00:00+00:00 0.80 https://healthandpharma.net/1754160777radio-immunotherapy-owerian-cancer-2.webp New Radioimmunotherapy Strategy Eradicates Cancer Stem Cells in Ovarian Cancer https://healthandpharma.net/edendx-noninvasive-endometrial-cancer-detection-test 2025-07-31T00:00:00+00:00 0.80 https://healthandpharma.net/1705460565genetic-dna-biotech-32.jpg First Non-Invasive Endometrial Cancer Detection Test, EdenDx, Launched by Gnosis https://healthandpharma.net/sucralose-cancer-immunotherapy-sugar 2025-07-31T00:00:00+00:00 0.80 https://healthandpharma.net/1754023588Sucralose-Cancer-Immunotherapy.webp Artificial Sweetener Sucralose May Undermine Cancer Immunotherapy, Study Finds https://healthandpharma.net/cart-therapy-secondary-cancers-lifelong-monitoring 2025-07-31T00:00:00+00:00 0.80 https://healthandpharma.net/1709596869Cart-cell-12.jpg Global Data Warns of Secondary Cancers Linked to CAR-T Therapy, Urging Monitoring https://healthandpharma.net/tumor-microenvironment-pancreatic-cancer-treatment 2025-07-30T00:00:00+00:00 0.80 https://healthandpharma.net/1747176468cancer-cell-tumor-adc-2.webp Rewiring Tumor Microenvironment Improved Pancreatic Cancer Treatment https://healthandpharma.net/ema-orphan-drug-designation-nuvisertib-blood-cancer-myelofibrosis 2025-07-30T00:00:00+00:00 0.80 https://healthandpharma.net/1753898705ema- Nuvisertib-2.webp EMA Grants Orphan Drug Designation to Nuvisertib for Rare Blood Cancer Myelofibrosis https://healthandpharma.net/chemotherapy-mitochondrial-lung-cancer-treatment 2025-07-30T00:00:00+00:00 0.80 https://healthandpharma.net/1753908106Mitochondrial-cancer-2.webp Supercharging Chemotherapy with a Mitochondrial Strategy for Lung Cancer Treatment https://healthandpharma.net/jaypirca-pirtobrutinib-lilly-imbruvica-cll-sll 2025-07-30T00:00:00+00:00 0.80 https://healthandpharma.net/1754046519Jaypirca-pirtobrutinib-2.webp Promising Results: Jaypirca Outperforms Imbruvica in Landmark Phase 3 CLL/SLL Trial https://healthandpharma.net/adcs-rafael-amadong-bispecifics-oncology-immunology-zailab 2025-07-29T00:00:00+00:00 0.80 https://healthandpharma.net/1753800671Rafael-Amado-ZaiLab-25.webp Advancing ADCs and Bispecifics Across Oncology and Immunology https://healthandpharma.net/tcell-mitochondria-cancer-immunotherapy 2025-07-29T00:00:00+00:00 0.80 https://healthandpharma.net/1747177012cancer-cell-tumor-adc-33.webp A Mitochondrial Makeover: Rewiring T Cells to Supercharge Cancer Immunotherapy https://healthandpharma.net/ai-cure-protein-tcell-cancer 2025-07-28T00:00:00+00:00 0.80 https://healthandpharma.net/1753703878ai-protein-cancer-immunotherapy.webp From Code to Cure: AI-Designed Proteins Arm T Cells to Precisely Target Cancer https://healthandpharma.net/fda-imfinzi-durvalumab-immunotherapy-gastric-gej-cancer 2025-07-28T00:00:00+00:00 0.80 https://healthandpharma.net/1753728122fda-Imfinzi-durvalumab-31.webp Imfinzi Receives FDA Priority Review as First Immunotherapy for Gastric and GEJ Cancers https://healthandpharma.net/obesity-related-cancer-deaths-us-endo 2025-07-28T00:00:00+00:00 0.80 https://healthandpharma.net/1753790738endo-ebesity-cancer.webp Obesity-Related Cancer Deaths Triple in the U.S., Raising Alarming Concern https://healthandpharma.net/start-cancer-advarra-oncology-trials-precision 2025-07-25T00:00:00+00:00 0.80 https://healthandpharma.net/1753452705START-Advarra-2.webp START and Advarra Unite to Streamline Early-Phase Oncology Trials with Speed https://healthandpharma.net/raphael-rousseau-dont-eat-me-signal-macrophage-checkpoint-inhibitors-oncology 2025-07-25T00:00:00+00:00 0.80 https://healthandpharma.net/1753465253Pheast-Lab-6208-2.webp Targeting the ‘Don’t Eat Me’ Signal: The Future of Macrophage Checkpoint Inhibitors https://healthandpharma.net/targeted-immunotherapy-hpv16-head-neck-cervical-cancers 2025-07-24T00:00:00+00:00 0.80 https://healthandpharma.net/1753484011cell-cancer-immunotherapy-2.webp Promising Targeted Immunotherapy Improves Survival in HPV16+ Cancers https://healthandpharma.net/shane-jacobson-ceo-american-cancer-society-acs 2025-07-23T00:00:00+00:00 0.80 https://healthandpharma.net/1753393080ACS-Shane-Jacobson.webp Shane Jacobson Appointed CEO of the American Cancer Society https://healthandpharma.net/vfoundation-shane-jacobson-acs-clark-kinlin-ceo-leadership 2025-07-22T00:00:00+00:00 0.80 https://healthandpharma.net/1753376627VFoundation-Clark-Kinlin.webp Leadership Change at V Foundation, Clark Kinlin Appointed Interim CEO https://healthandpharma.net/john-gribben-access-cart-cell-therapy-policy-innovation 2025-07-16T00:00:00+00:00 0.80 https://healthandpharma.net/1752671757John-Gribben-3.webp How to Improve Access to CAR T-cell Therapy: The Role of Policy and Innovation https://healthandpharma.net/abenacianine-john-santini-lung-cancer-surgery 2025-07-16T00:00:00+00:00 0.80 https://healthandpharma.net/1752690458John-Santini-Vergent-3.webp Shining a Light on Lung Cancer: The Promise of Abenacianine https://healthandpharma.net/access-cart-cell-therapy-cancer-miguel-perales 2025-07-02T00:00:00+00:00 0.80 https://healthandpharma.net/1751469712Car-T-Dr-Angel-Perales-32.webp Overcoming Challenges and Expanding Access to CAR T-Cell Therapy https://healthandpharma.net/skinject-medicus-microneedle-patch-technology-cancer 2025-07-02T00:00:00+00:00 0.80 https://healthandpharma.net/1753722017medicus-skinject-micronidle-72 kopya.webp How SkinJect’s Microneedle-Patch Could Improve Skin Cancer Treatment Outcomes https://healthandpharma.net/lorna-warick-patient-advocacy-access-cart-cell-therapy 2025-06-27T00:00:00+00:00 0.80 https://healthandpharma.net/1752613644Lorna-Warwick-Cart-4.webp A Patient Advocacy Perspective on Expanding Access to CAR T-cell Therapy https://healthandpharma.net/start-curc-neal-shore-clinical-trials 2025-06-20T00:00:00+00:00 0.80 https://healthandpharma.net/1756507349labaratuvar-test-32.webp The Integration of START and CURC Could Play a Pivotal Role in Advancing Clinical Trials https://healthandpharma.net/elvina-almuradova-tropion-breast01-metastatic-breast-cancer 2025-06-18T00:00:00+00:00 0.80 https://healthandpharma.net/1756501931Elvina-Almuradova-33.webp TROPION-Breast01: Redefining Treatment for HR+/HER2– Metastatic Breast Cancer https://healthandpharma.net/start-hope-hub-cancer-care-clinical-trial 2025-06-18T00:00:00+00:00 0.80 https://healthandpharma.net/1748361568start-sanantonio-4.webp START Hope Hub Connect Patients and Physicians with Faster, Smarter Trial Access https://healthandpharma.net/ai-drug-discovery-innovation-chris-foley 2025-06-10T00:00:00+00:00 0.80 https://healthandpharma.net/1756640087ai-lab-drug-42.webp Overcoming Drug Discovery Challenges Through AI-Driven Innovation https://healthandpharma.net/ai-biox-genetics-variant-detection-drug-discovery 2025-06-05T00:00:00+00:00 0.80 https://healthandpharma.net/1749246564AI-data-drug.webp AI-Driven bioX Genetics Platform Slashes Genetic Variant Detection Time https://healthandpharma.net/darzalex-faspro-multiple-myeloma-treatment-asco25 2025-06-05T00:00:00+00:00 0.80 https://healthandpharma.net/1749253803asco-perseus-4.webp Darzalex Faspro Achieves Outstanding Results in Multiple Myeloma with 95% 4-Year PFS https://healthandpharma.net/adc-zl1310-lung-cancer-sclc-asco25 2025-06-05T00:00:00+00:00 0.80 https://healthandpharma.net/1749393011lung-cancer-zl1310.webp Targeted ADC ZL-1310 Shows Promising 67% ORR in Heavily Pretreated ES-SC Lung Cancer https://healthandpharma.net/imforte-tecentriq-lurbinectedin-essc-lung-cancer 2025-06-04T00:00:00+00:00 0.80 https://healthandpharma.net/1749081106asco-tecentriq-Lurbinectedin-3.webp IMforte Study: Tecentriq Plus Lurbinectedin Extends Survival in ES-SC Lung Cancer https://healthandpharma.net/vividion-bayer-wrn-vvd214-cancer-solid-tumors 2025-06-04T00:00:00+00:00 0.80 https://healthandpharma.net/1749141021Bayer-Vividion-3.webp Vividion and Bayer Advance First-in-Class WRN Inhibitor VVD-214 for Solid Tumors https://healthandpharma.net/amplitude-niraparib-hrr-mcs-prostate-cancer 2025-06-04T00:00:00+00:00 0.80 https://healthandpharma.net/1749159367Amplitude-Niraparib-Akeega-12.webp AMPLITUDE: Niraparib Combo Improves rPFS in HRR-Altered mCS Prostate Cancer https://healthandpharma.net/aranote-darolutamide-quality-life-mcspc-prostate-cancer 2025-06-04T00:00:00+00:00 0.80 https://healthandpharma.net/1749494530asco-Darolutamide-arnold-2.webp Darolutamide Shows Significant Quality-of-Life Improvements in mCS Prostate Cancer https://healthandpharma.net/fda-approves-darolutamide-nubeqa-msc-prostate-cancer 2025-06-03T00:00:00+00:00 0.80 https://healthandpharma.net/1748991088FDA-Nubeqa-darolutamide-bayer.webp FDA Approves Darolutamide Plus ADT for mCS Prostate Cancer https://healthandpharma.net/destiny-enhertu-pertuzumab-breast-cancer-pertuzumab 2025-06-03T00:00:00+00:00 0.80 https://healthandpharma.net/1749028973Destiny-Breast09-Enhertu-trastuzumab-1.webp Enhertu-pertuzumab Combo Shows 44% Risk Reduction in HER2+ Breast Cancer https://healthandpharma.net/atomic-atezolizumab-dmmr-colon-cancer-asco25 2025-06-03T00:00:00+00:00 0.80 https://healthandpharma.net/1749417477Atomic-Atezolizumab-Colon-Cancer-62.webp ATOMIC Trial: Atezolizumab Combo Halves Recurrence in Stage III dMMR Colon Cancer https://healthandpharma.net/asco-imdelltra-tarlatamab-sc-lung-cancer 2025-06-02T00:00:00+00:00 0.80 https://healthandpharma.net/1748883381Imdelltra-asco-43.webp Imdelltra Extends Survival in Small Cell Lung Cancer, Cutting Death Risk by 40% https://healthandpharma.net/biontech-bms-partnership-bnt327-bispecific-tumors 2025-06-02T00:00:00+00:00 0.80 https://healthandpharma.net/1748909974BMS-BioNTech-bnt-327.webp BioNTech and BMS Forge Partnership to Advance BNT327 for Solid Tumors https://healthandpharma.net/asco25-oasis4-elinzanetant-vms-breast-cancer-treatment 2025-06-02T00:00:00+00:00 0.80 https://healthandpharma.net/1748963613asco-Elinzanetant-oasis-12.webp OASIS-4 Trial: Elinzanetant Reduces Hot Flashes in Breast Cancer Treatment https://healthandpharma.net/exercise-boosts-survival-colon-cancer 2025-06-01T00:00:00+00:00 0.80 https://healthandpharma.net/1748797501exercise-colon cancer.webp World-First Clinical Trial Confirms Exercise Boosts Survival in Colon Cancer https://healthandpharma.net/serena6-trail-ctdna-camizestrant-breast-cancer-treatment 2025-06-01T00:00:00+00:00 0.80 https://healthandpharma.net/1748821216serena-trail-65.webp ctDNA-Guided Camizestrant Switch Redefines 1st-Line Breast Cancer Treatment https://healthandpharma.net/pasritamig-prostate-cancer-asco25-mcrpc 2025-06-01T00:00:00+00:00 0.80 https://healthandpharma.net/1748896181Johnson-Pasritamig-prostat-2.webp Pasritamig’s Favorable Safety and Efficacy in Advanced Prostate Cancer https://healthandpharma.net/asco25-inavolisib-combination-pik3ca-breast-cancer 2025-05-31T00:00:00+00:00 0.80 https://healthandpharma.net/1748703178Itovebi-inavolisib-asco--25.webp Inavolisib Combination Doubles PFS in PIK3CA Mutated Advanced Breast Cancer https://healthandpharma.net/asco25-cemiplimab-libtayo-cs-cell-carcinoma 2025-05-31T00:00:00+00:00 0.80 https://healthandpharma.net/1748792396cemiplimab-libtayo-22.webp Libtayo Demonstrates 68% Risk Reduction in High-Risk CS Cell Carcinoma https://healthandpharma.net/start-oneoncology-partnership-clinical-trials 2025-05-27T00:00:00+00:00 0.80 https://healthandpharma.net/1748361568start-sanantonio-4.webp START and OneOncology Partnership Expands Clinical Trials from Academia to Community https://healthandpharma.net/everolimus-afinitor-safety-oncology-risk 2025-05-27T00:00:00+00:00 0.80 https://healthandpharma.net/1748374375drug-pil-medicine-4.webp Improving Everolimus Safety in Oncology: Missed Opportunities in Risk Minimization https://healthandpharma.net/dna-immunotherapy-immn001-imunon-ovarian-cancer 2025-05-23T00:00:00+00:00 0.80 https://healthandpharma.net/1731002775imunon-cancer-2.jpg DNA-Based Immunotherapy IMNN-001 Shows Survival Gains in Advanced Ovarian Cancer https://healthandpharma.net/nick-sluck-start-curch-cancer-research-clinical-trials 2025-05-22T00:00:00+00:00 0.80 https://healthandpharma.net/1747917369Nick-Slack-start-3.jpg How the Integration of START and CURC Is Advancing Cancer Research and Clinical Trials https://healthandpharma.net/sarah-hein-mb105-cart-therapy-tcell-lymphoma 2025-05-22T00:00:00+00:00 0.80 https://healthandpharma.net/1748013905Sarah-Hein-March-Bio-9.webp MB-105 CAR-T Therapy: Advancing Precision Treatment for CD5+ T-Cell Lymphoma https://healthandpharma.net/fda-approves-first-blood-test-alzheimer-diagnosis 2025-05-16T00:00:00+00:00 0.80 https://healthandpharma.net/1747429405FDA-Alzheimer-test-33.webp FDA Approves First Blood Test for Alzheimer’s, Marking a Historic Shift in Early Detection https://healthandpharma.net/eu-approves-opdivo-nivolumab-resectable-lung-cancer-nsclc 2025-05-16T00:00:00+00:00 0.80 https://healthandpharma.net/1747520440opdivo-nivolumab-bms-eu-logo-2.webp EU Commission Approves Opdivo Regimen for High-Risk Resectable NSCLC https://healthandpharma.net/ilkiz-er-dag-oncolife-project-director-training-programs 2025-05-15T00:00:00+00:00 0.80 https://healthandpharma.net/1747269068ilkiz-er-dag-23.webp ONCOLife Warmly Welcomes Dr İlkiz Er Dağ as ONCOLife Project Director https://healthandpharma.net/fda-approves-emrelis-telisotuzumab-adc-cmte-lung-cancer 2025-05-15T00:00:00+00:00 0.80 https://healthandpharma.net/1747322195Emrelis-telisotuzumab-adc-4.webp FDA Approves Emrelis as the First Targeted ADC for High c-Met Expressing Lung Cancer https://healthandpharma.net/start-doses-patient-mrna-pan-therapy-solid-tumors 2025-05-15T00:00:00+00:00 0.80 https://healthandpharma.net/1747343492start-cancer-adc-2.webp START Doses First Patient in Trial of mRNA-4106, a Pan-Tumor Therapy for Solid Tumors https://healthandpharma.net/oncolife-new-issue-oncology-cancer-7 2025-05-15T00:00:00+00:00 0.80 https://healthandpharma.net/1748537942oncolife-issue-7.webp The Latest Issue of ONCOLife Is Now Live – Follow the Cutting Edge of Oncology Innovation https://healthandpharma.net/pertuzumab-trastuzumab-survival-her2-breast-cancer 2025-05-14T00:00:00+00:00 0.80 https://healthandpharma.net/1747260547pertuzumab-trastuzumab-4.webp 10-Year Results Confirm Pertuzumab Combo Extends Survival in HER2+ Breast Cancer https://healthandpharma.net/v-foundation-cancer-vaccine-coalition-partner 2025-05-14T00:00:00+00:00 0.80 https://healthandpharma.net/1747265871VFoundation-Cancer-Vaccine-Coalition.webp V Foundation and Cancer Vaccine Coalition Partner to Accelerate Breast Cancer Vaccine https://healthandpharma.net/cytomx-epcam-adc-cx2051-colorectal-cancer 2025-05-13T00:00:00+00:00 0.80 https://healthandpharma.net/1747177012cancer-cell-tumor-adc-33.webp EpCAM-Targeting ADC CX-2051 Shows Promising Efficacy in Advanced Colorectal Cancer https://healthandpharma.net/leucid-bio-first-patient-aerial-trial-leuo11-cart-solid-tumors 2025-05-12T00:00:00+00:00 0.80 https://healthandpharma.net/1740762204adc-cell-dna-33.webp Leucid Bio Doses First Patient in Trial of LEU011, a CAR-T Therapy for Solid Tumors https://healthandpharma.net/oncology-care-index-innovation-overload-cancer-care 2025-05-10T00:00:00+00:00 0.80 https://healthandpharma.net/1746885288doctors-oncologist-innovation-44.webp Oncologists Struggle with Innovation Overload: 'The Growing Chasm in Cancer Care' https://healthandpharma.net/fda-avmapki-fakznja-avutometinib-defactinib-ovarian-cancer 2025-05-09T00:00:00+00:00 0.80 https://healthandpharma.net/1746809735avutometinib-defactinib-2.webp Avutometinib Earn Accelerated FDA Approval for Ovarian Cancer https://healthandpharma.net/durvalumab-imfinzi-bcg-early-stage-bladder-cancer 2025-05-09T00:00:00+00:00 0.80 https://healthandpharma.net/1746858010durvalumab-iImfinzi-1.webp Durvalumab Plus BCG Boosts Outcomes in Early-Stage Bladder Cancer https://healthandpharma.net/fda-ai-strategy-pilot-drug-review 2025-05-08T00:00:00+00:00 0.80 https://healthandpharma.net/1746747248FDA-ai-artifi-drug.webp FDA Announces AI Strategy with First AI-Assisted Scientific Pilot for Drug Review https://healthandpharma.net/enhertu-trastuzumab-chemotherapy-breast-cancer 2025-05-07T00:00:00+00:00 0.80 https://healthandpharma.net/1745793329Enhertu-Astra-3.webp Enhertu Outperforms Chemotherapy in Early-Stage HER2+ Breast Cancer https://healthandpharma.net/elraglusib-survival-pancreatic-cancer-actuate 2025-05-07T00:00:00+00:00 0.80 https://healthandpharma.net/1746984107Pancreatic-Cancer-34.webp Elraglusib Shows Survival Benefit in First-Line Metastatic Pancreatic Cancer Trial https://healthandpharma.net/adcentrx-nectin-adc-adrx-fda-cervical-cancer 2025-05-07T00:00:00+00:00 0.80 https://healthandpharma.net/1747179722Adcentrx-adc-cancer-32.webp Adcentrx’s Nectin-4 ADC, ADRX-0706, Earns FDA Fast Track for Cervical Cancer https://healthandpharma.net/ai-urine-test-detect-prostate-cancer-psa 2025-05-02T00:00:00+00:00 0.80 https://healthandpharma.net/1746157077Prostate-Cancer-test-4.webp New AI-Powered Urine Test Detects Prostate Cancer with Higher Precision than PSA https://healthandpharma.net/zongertinib-her2-mutant-lung-cancer-treatment 2025-05-02T00:00:00+00:00 0.80 https://healthandpharma.net/1747004235lung-cancer-44.webp Zongertinib Demonstrates 71% Response Rate in HER2-Mutant Lung Cancer Treatment https://healthandpharma.net/briaimt-briacell-biomarkers-personalized-therapy-breast-cancer 2025-05-02T00:00:00+00:00 0.80 https://healthandpharma.net/1709596869Cart-cell-12.jpg Bria-IMT’s Early Promise: Biomarkers Signal Path to Personalized Therapy in Breast Cancer https://healthandpharma.net/aacr-rome-tissue-liquid-biopsies-solid-tumors 2025-05-01T00:00:00+00:00 0.80 https://healthandpharma.net/1746378914cancer-test-biopsy-2.webp Combined Tissue and Liquid Biopsies Improve Survival in Advanced Solid Tumors https://healthandpharma.net/bayer-human-trial-targeted-alpha-therapy-liver-cancer-bay3547926 2025-04-30T00:00:00+00:00 0.80 https://healthandpharma.net/1728514888Bayer-logo-3.jpg Bayer Launches First-in-Human Trial of Targeted Alpha Therapy for Advanced Liver Cancer https://healthandpharma.net/fda-ai-driven-diagnostic-device-designation-lung-cancer 2025-04-30T00:00:00+00:00 0.80 https://healthandpharma.net/1746150789FDA-AI-Roche-4.webp First AI-Driven Diagnostic Tool Wins FDA Breakthrough Designation for Lung Cancer https://healthandpharma.net/zoldonrasib-krasg12d-inhibitor-lung-cancer-nsclc 2025-04-30T00:00:00+00:00 0.80 https://healthandpharma.net/1746893801lung-cancer-43.webp First-Ever KRAS G12D Inhibitor Zoldonrasib Shows 61% Response Rate in Lung Cancer https://healthandpharma.net/gut-microbiom-mb097-immunotherapy-melanoma 2025-04-29T00:00:00+00:00 0.80 https://healthandpharma.net/1745959894Microbiotica-drug-gut-2.webp Gut Bacteria as Co-Therapy: MB097’s Role in Overcoming Resistance in Melanoma https://healthandpharma.net/merck-expands-us-biologics-manufacturing-wilmington-keytruda 2025-04-29T00:00:00+00:00 0.80 https://healthandpharma.net/1745968281merck-pharma-drug-factory.webp Merck Expands US Bio Manufacturing with $1B Wilmington Facility for KEYTRUDA https://healthandpharma.net/fda-ind-spg47-blackfinbio-bfb101-gene-therapy 2025-04-28T00:00:00+00:00 0.80 https://healthandpharma.net/1745882313fda-ind-gen-dna-2.webp New Hope for SPG47: BlackfinBio’s BFB-101 Gene Therapy Advances with FDA Approval https://healthandpharma.net/pembrolizumab-keytruda-survival-head-neck-cancer 2025-04-28T00:00:00+00:00 0.80 https://healthandpharma.net/1746061757Pembrolizumab-Keytruda-merck-2.webp Pembrolizumab Improves Event-Free Survival in Resectable Head and Neck Cancer https://healthandpharma.net/sasanlimab-bladder-cancer-bcg-pfizer-antibody 2025-04-26T00:00:00+00:00 0.80 https://healthandpharma.net/1745888849Bladder-Cancer-pd-1.webp Sasanlimab Plus BCG Shows Significant Survival Benefit for NMI Bladder Cancer https://healthandpharma.net/nimbus-therapeutics-wrn-inhibitor-msih-cancer 2025-04-25T00:00:00+00:00 0.80 https://healthandpharma.net/1745611702nimbus-wrn-inhibitor-2.webp Nimbus Launches First Human Trial of Promising WRN Inhibitor for MSI-H Cancers https://healthandpharma.net/boehringer-ingelheim-tessellate-bio-partner-cancer 2025-04-23T00:00:00+00:00 0.80 https://healthandpharma.net/1745429381Boehringer-Ingelh-Tessellate-2.webp Boehringer and Tessellate Partner to Develop Treatments for Hard-to-Treat Cancers https://healthandpharma.net/ivonescimab-lung-cancer-advanced-squamous-nsclc 2025-04-23T00:00:00+00:00 0.80 https://healthandpharma.net/1732755990Lung-Cancer-34.jpg Ivonescimab Shows Significant Improvement in First-Line Treatment of NSCLC https://healthandpharma.net/enhertu-pertuzumab-metastatic-breast-cancer 2025-04-23T00:00:00+00:00 0.80 https://healthandpharma.net/1745793329Enhertu-Astra-3.webp Enhertu Redefines First-Line Treatment for HER2+ Metastatic Breast Cancer https://healthandpharma.net/patient-dosed-mb105-cart-therapy-lymphoma 2025-04-22T00:00:00+00:00 0.80 https://healthandpharma.net/1745446151march-bio-Lymphoma.webp First Patient Dosed in Phase 2 Trial of MB-105, CD5 CAR-T Therapy for T-Cell Lymphoma https://healthandpharma.net/trodelvy-keytruda-combination-breast-cancer-mtnbc 2025-04-22T00:00:00+00:00 0.80 https://healthandpharma.net/1731100939cancer-cell-Cytokine2.jpg Trodelvy and Keytruda Combination Marks Breakthrough in mTN-Breast Cancer https://healthandpharma.net/skinject-patch-carcinoma-cancer-medicus 2025-04-21T00:00:00+00:00 0.80 https://healthandpharma.net/1745455968skinject-patch-bbc.webp SkinJect Patch Shows Early Success in Phase 2 Study for Basal Cell Carcinoma https://healthandpharma.net/bayer-pharma-mediaday-landmark-treatment-diseases 2025-04-04T00:00:00+00:00 0.80 https://healthandpharma.net/1744935360Bayer-mediaday-2.webp Bayer Poised for Landmark Year with Blockbuster Treatment Advances Across Key Diseases https://healthandpharma.net/ai-breast-cancer-detection-diagnoses-dana-brown 2025-03-27T00:00:00+00:00 0.80 https://healthandpharma.net/1743114831Dana-Brawn-2A.webp How AI Transforms Early Breast Cancer Detection, and Improves Outcomes https://healthandpharma.net/imfinzi-durvalumab-gastric-gej-cancer 2025-03-07T00:00:00+00:00 0.80 https://healthandpharma.net/1741376448imfinzi-durvalumab-AZ.webp Durvalumab Shows Significant Survival Benefit in Gastric and GEJ Cancer Treatment https://healthandpharma.net/skinject-microneedle-skin-cancer-raza-bokhari 2025-03-05T00:00:00+00:00 0.80 https://healthandpharma.net/1741200844Raza-Bokhari-12.webp How SkinJect's Microneedle Technology Could Transform the Treatment of Skin Cancer https://healthandpharma.net/fda-tislelizumab-tevimbra-esophageal-cancer 2025-03-04T00:00:00+00:00 0.80 https://healthandpharma.net/1741129072Tevimbra-tislelizumab-BeiGene.webp FDA Approves Tislelizumab Plus Chemotherapy for PD-L1+ Metastatic Esophageal Cancer https://healthandpharma.net/g0-chip-lung-cancer-therapy-tumor-monitoring 2025-03-04T00:00:00+00:00 0.80 https://healthandpharma.net/1741136232go-chip-42.webp A Breakthrough in Personalizing Lung Cancer Therapy with the GO Chip for Tumor Monitoring https://healthandpharma.net/durvalumab-imfinzi-ema-chmp-eu-approval-nsclc 2025-03-04T00:00:00+00:00 0.80 https://healthandpharma.net/1741305800durvalumab-imfinzi-ema-chmp.webp CHMP Recommends Durvalumab Combination for EU Approval in Resectable NSCLC https://healthandpharma.net/enhertu-ema-chmp-her2-breast-cancer-treatment 2025-02-28T00:00:00+00:00 0.80 https://healthandpharma.net/1740873308Enhertu-EMA-2.webp Enhertu Gains EMA’s CHMP Support for HER2-Low Metastatic Breast Cancer Treatment https://healthandpharma.net/oral-serd-camizestrant-cdk-breast-cancer 2025-02-26T00:00:00+00:00 0.80 https://healthandpharma.net/1740628415dna-cell-gen-31.webp Camizestrant Plus CDK4/6 Inhibition Boosts PFS in ESR1+, HR+/HER2– Breast Cancer https://healthandpharma.net/odronextamab-fda-bla-review-follicular-lymphoma 2025-02-26T00:00:00+00:00 0.80 https://healthandpharma.net/1740964379Odronextamab-fda-regeneron.webp Odronextamab Gains FDA Review for Hard-to-Treat R/R Follicular Lymphoma https://healthandpharma.net/fda-keytruda-pembrolizumab-head-neck-cancer 2025-02-26T00:00:00+00:00 0.80 https://healthandpharma.net/1741050961fda-keytruda-pembrolizumab.webp KEYTRUDA Receives Priority FDA Review for Perioperative Use in ES Head and Neck Cancer https://healthandpharma.net/francis-patient-vapor-vanquish-prostate-cancer-therapy 2025-02-25T00:00:00+00:00 0.80 https://healthandpharma.net/1740529706Francis-Vanquish-Device.webp Patient Enrollment Completed in VAPOR 2 Trial for Vanquish Prostate Cancer Therapy https://healthandpharma.net/maria-de-miguel-adcs-potential-nsclc-lung-cancer 2025-02-24T00:00:00+00:00 0.80 https://healthandpharma.net/1740630710Maria-Miguel-23.webp The Next Generation of ADCs and Their Potential for Non-Small Cell Lung Cancer https://healthandpharma.net/opdivo-nivolumab-chemotherapy-lung-cancer-nsclc 2025-02-22T00:00:00+00:00 0.80 https://healthandpharma.net/1741296032nivolumab-Opdivo-bms.webp Nivolumab Plus Chemotherapy Demonstrates Survival Benefit in Resectable NSCLC https://healthandpharma.net/ai-life-sciences-trends-predictions-2025 2025-02-21T00:00:00+00:00 0.80 https://healthandpharma.net/1711233923drug-ai-robot-23.jpg AI in Life Sciences: Trends and Predictions for 2025 - By Doron Sitbon https://healthandpharma.net/bayer-strategic-partnerships-cancer-interview-juergen-eckhardt 2025-02-20T00:00:00+00:00 0.80 https://healthandpharma.net/1740356786Bayer-Juergen-Eckhardt-3.webp How Bayer Shapes Strategic Partnerships for the Next Generation of Cancer Therapies https://healthandpharma.net/cdk4-inhibitor-et-first-line-hr-mbc-breast-cancer 2025-02-20T00:00:00+00:00 0.80 https://healthandpharma.net/1740609719Elvina-Almuradova-23.webp No More Doubts: CDK 4/6 inhibitor + ET as First-Line Standard for HR+ mBC https://healthandpharma.net/imnn1-dna-immunotherapy-survival-ovarian-cancer 2025-02-19T00:00:00+00:00 0.80 https://healthandpharma.net/1733854864cart-cell-cancer-4.jpg DNA-Based Immunotherapy IMNN-001 Promises to Improve Survival in Ovarian Cancer https://healthandpharma.net/darolutamide-bayer-mhspc-prostate-cancer 2025-02-14T00:00:00+00:00 0.80 https://healthandpharma.net/1722012779Nubeqa-darolutamide-bayer.jpg New Data Confirms Darolutamide’s Safety and Efficacy in mHS Prostate Cancer https://healthandpharma.net/ai-dense-breast-cancer-diagnosis-screening-bayer 2025-01-30T00:00:00+00:00 0.80 https://healthandpharma.net/1738264707Bayer-Joana-Reis-2.jpg How AI Innovations Are Transforming Breast Cancer Screening https://healthandpharma.net/fda-sotorasib-panitumumab-krasg12c-colorectal-cancer 2025-01-17T00:00:00+00:00 0.80 https://healthandpharma.net/1737159878Lumokras-sotorasib-Vectibix.jpg FDA Approves Sotorasib and Panitumumab Combo for KRAS G12C+ Colorectal Cancer https://healthandpharma.net/fda-adc-metastatic-hr-her2-breast-cancer 2025-01-17T00:00:00+00:00 0.80 https://healthandpharma.net/1737237883FDA-Datroway-23.webp FDA Approves Innovative ADC Datroway for Metastatic HR+, HER2- Breast Cancer https://healthandpharma.net/approval-pelareorep-oncolytic-virus-pancreatic-cancer 2025-01-15T00:00:00+00:00 0.80 https://healthandpharma.net/1737066206Pelareorep-Oncolytic-Virus-1.webp Regulatory Approval Advances Pelareorep’s Virus Therapy for Pancreatic Cancer https://healthandpharma.net/fda-225ac-ss0110-satoreotide-radiopharmaceutical-lung-cancer 2025-01-14T00:00:00+00:00 0.80 https://healthandpharma.net/1736905397Ariceum-satoreotide-225Ac-SSO110-fda.webp FDA Approves 225Ac-SSO110 Radiopharmaceutical Trial for Small Cell Lung Cancer https://healthandpharma.net/fda-datopotamab-deruxtecan-egfr-lung-cancer-nsclc 2025-01-14T00:00:00+00:00 0.80 https://healthandpharma.net/1737300003fda-datopotamab-Deruxtecan-1.webp FDA Grants Priority Review to Datopotamab Deruxtecan for EGFR+ Lung Cancer https://healthandpharma.net/internet-medical-things-iomt-security 2025-01-13T00:00:00+00:00 0.80 https://healthandpharma.net/1736809800iomt-internet-medical-things-2.jpg The Internet of Medical Things needs a new security model to fulfil its potential https://healthandpharma.net/ai-overcome-data-scarcity-transform-medicine-drug 2025-01-10T00:00:00+00:00 0.80 https://healthandpharma.net/1736818860AI-robot-Drug-95.webp How AI Could Overcome Data Scarcity to Transform Medicine https://healthandpharma.net/fda-tirzepatide-zepbound-osa-sleep-apnea-obesity 2024-12-21T00:00:00+00:00 0.80 https://healthandpharma.net/1734973297tirzepatide-Zepbound-Lilly-2.jpg First-Ever Obstructive Sleep Apnea Drug, Zepbound, Approved by FDA for Obesity https://healthandpharma.net/fda-approves-braftovi-encorafenib-brafv6ooe-colorectal-cancer 2024-12-20T00:00:00+00:00 0.80 https://healthandpharma.net/1734831831BRAFTOVI-Pfizer.jpg FDA Approves BRAFTOVI Combo as First-Line Treatment for Colorectal Cancer https://healthandpharma.net/hbv-recombinant-polyclonal-drug-hepatitisb-treatment 2024-12-19T00:00:00+00:00 0.80 https://healthandpharma.net/1734715446Giga-Hepatit-Caeter-5.jpg The Recombinant Polyclonal Drug Candidate GIGA-2339 for Hepatitis B Treatment https://healthandpharma.net/quvin-qpad-women-health-menstrual-blood-test-webinar 2024-12-16T00:00:00+00:00 0.80 https://healthandpharma.net/1734360520Qvin-Pad-Sara-Naseri-5.jpg How Qvin's Q-Pad Could Transform Women’s Health Through Menstrual Blood Testing https://healthandpharma.net/palbociclib-ibrance-patina-her2-breast-cancer 2024-12-14T00:00:00+00:00 0.80 https://healthandpharma.net/1734361236Patina-Trail-4.jpg Palbociclib Combination Yields PFS Improvement in HR+, HER2+ Breast Cancer https://healthandpharma.net/abbvie-acquires-nimble-therapeutics-immunology 2024-12-13T00:00:00+00:00 0.80 https://healthandpharma.net/1734128202Abbvie-nimble-2.jpg AbbVie Acquires Nimble in $200 Million Deal to Strengthen Immunology Pipeline https://healthandpharma.net/olympia-trial-olaparib-survival-brca-her2-breast-cancer 2024-12-13T00:00:00+00:00 0.80 https://healthandpharma.net/1734223697OlympiA-trial-1b.jpg Olaparib Shows Long-term Survival Benefits in BRCA+ and HER2- Breast Cancer https://healthandpharma.net/imlunestrant-serd-verzenio-er-her2-breast-cancer 2024-12-12T00:00:00+00:00 0.80 https://healthandpharma.net/1734133766cancer-Imlunestrant-Lilly-3.jpg Imlunestrant Shows Promising Results Alone and with Verzenio in ER+, HER2- Breast Cancer https://healthandpharma.net/elevation-oncology-partners-synaffix-deal-adc 2024-12-12T00:00:00+00:00 0.80 https://healthandpharma.net/1734053649Elevation-Synaffix.jpg Elevation Partners with Synaffix in $368M Deal to Advance HER3 ADC Development https://healthandpharma.net/general-inception-acquires-enable-medicine-ai-drug-discovery 2024-12-12T00:00:00+00:00 0.80 https://healthandpharma.net/1734056153general-incepttion-enable-med.jpg General Inception Acquires Enable Medicine to Drive AI-Led Drug Discovery https://healthandpharma.net/natali-kisqali-ribociclib-erly-breast-cancer-treatment-sabcs24 2024-12-12T00:00:00+00:00 0.80 https://healthandpharma.net/1734476948Kisqali-Ribociclib-5.jpg Ribociclib Shows Promising Long-Term Benefits in Early Breast Cancer Treatment https://healthandpharma.net/nektar-drug-nktr255-cart-therapy-bcell-lymphoma 2024-12-11T00:00:00+00:00 0.80 https://healthandpharma.net/1734133266NKTR-255-1.jpg IL-15 Agonist NKTR-255 Enhances CAR-T Therapy Effectiveness in LB-Cell Lymphoma https://healthandpharma.net/fda-breakthrough-datopotamab-deruxtecan-egfr-lung-cancer 2024-12-10T00:00:00+00:00 0.80 https://healthandpharma.net/1733794925Datopotamab-Deruxtecan.jpg FDA Grants Breakthrough Status to Datopotamab Deruxtecan for EGFR+ Lung Cancer https://healthandpharma.net/merck-ovarian-cancer-treatment-keytruda-lynparza 2024-12-10T00:00:00+00:00 0.80 https://healthandpharma.net/1733913388KEYTRUDA-LYNPARZA-1.jpg Breakthrough in First-Line Ovarian Cancer Treatment: KEYTRUDA and LYNPARZA https://healthandpharma.net/blenrep-belantamab-mafodotin-multiple-myeloma 2024-12-10T00:00:00+00:00 0.80 https://healthandpharma.net/1734031900GSK-Blenrep-belantamab-mafodotin-2.jpg Blenrep Combination Reduces Death Risk by 42% in Relapsed Multiple Myeloma https://healthandpharma.net/acalabrutinib-venetoclax-cll-lymphocytic-leukemia 2024-12-09T00:00:00+00:00 0.80 https://healthandpharma.net/1733712214acalabrutinib-venetoclax-2.jpg Fixed-Duration Acalabrutinib Plus Venetoclax Achieves Superior 77% PFS in Untreated CLL https://healthandpharma.net/blinatumomab-chemotherapy-blincyto-pediatric-leukemia 2024-12-08T00:00:00+00:00 0.80 https://healthandpharma.net/1733699907BLINCYTO-blinatumomab-3.jpg Adding Blinatumomab to Chemotherapy Extends 96% DF Survival in Pediatric Leukemia https://healthandpharma.net/fda-durvalumab-priority-review-bladder-cancer 2024-12-07T00:00:00+00:00 0.80 https://healthandpharma.net/1733503958FDA-Durvalumab-PReview.jpg Durvalumab Granted FDA Priority Review for Muscle-Invasive Bladder Cancer Patients https://healthandpharma.net/adc-sac-tmt-fda-breakthrough-therapy-lung-cancer 2024-12-07T00:00:00+00:00 0.80 https://healthandpharma.net/1733521984Sacituzumab-tirumotecan-sac-TMT.jpg Promising Sac-TMT Receives FDA Breakthrough Therapy Designation for Lung Cancer https://healthandpharma.net/ai-driven-cancer-therapy-recursion-rec1245-solid-tumors 2024-12-06T00:00:00+00:00 0.80 https://healthandpharma.net/1733617999Recursion-ai-rec-1245.jpg AI-Driven Cancer Therapy: Recursion Doses First Patient in REC-1245 Trial for Solid Tumors https://healthandpharma.net/fda-approve-durvalumab-imfinzi-immunotherapy-lung-cancer 2024-12-05T00:00:00+00:00 0.80 https://healthandpharma.net/1733496922Durvalumab-Imfinzi-AstraZeneca.jpg FDA Approves Durvalumab as the First and Only Immunotherapy for LSSC Lung Cancer https://healthandpharma.net/fda-approval-bizengri-pancreatic-cancer-nsclc 2024-12-05T00:00:00+00:00 0.80 https://healthandpharma.net/1733854643Bizengri-zenocutuzumab-zbco-2.jpg FDA Grants Accelerated Approval to Bizengri for NRG1+ Pancreatic Cancer and NSCLC https://healthandpharma.net/ai-pet-ct-analysis-side-effects-immunotherapy-lung-cancer 2024-11-29T00:00:00+00:00 0.80 https://healthandpharma.net/1733004065ai-lung-pet-3.jpg AI-Powered PET/CT Analysis May Predict Side Effects of Immunotherapy in Lung Cancer https://healthandpharma.net/roche-acquires-poseida-deal-cell-therapy 2024-11-28T00:00:00+00:00 0.80 https://healthandpharma.net/1732834790roche-headquarter-23.jpg Roche Acquires Poseida in $1.5 Billion Deal to Advance Cell Therapy Innovation https://healthandpharma.net/ai-drug-discovery-lp300-lung-cancer-treatment 2024-11-27T00:00:00+00:00 0.80 https://healthandpharma.net/1732755014AI-robot-Drug-42.jpg How AI is Shaping Drug Discovery: LP-300 in Lung Cancer Treatment https://healthandpharma.net/fda-imkeldi-oral-imatinib-leukemia-cancer 2024-11-27T00:00:00+00:00 0.80 https://healthandpharma.net/1732902854 imatinib-imkeldi.jpg The FDA Approves IMKELDI, the First Oral Liquid Form of Imatinib, for Leukemia https://healthandpharma.net/skyscraper-trail-tiragolumab-atezolizumab-lung-cancer 2024-11-26T00:00:00+00:00 0.80 https://healthandpharma.net/1732831490Tiragolumab-tecentriq-2.jpg SKYSCRAPER-01 Trial Shows Safety of Tiragolumab Plus Atezolizumab in Lung Cancer https://healthandpharma.net/imunon-immunotherapy-imnn-ovarian-cancer 2024-11-25T00:00:00+00:00 0.80 https://healthandpharma.net/1732543381immuno-therapy-cell-2.jpg How Novel Immunotherapy IMNN-001 Could Change Ovarian Cancer Outcomes https://healthandpharma.net/fda-revumenib-cancer-leukemia-treatment 2024-11-23T00:00:00+00:00 0.80 https://healthandpharma.net/1732457904fda-Revumenib-FCS-1.jpg FDA Greenlights Revumenib for Relapsed Leukemia Treatment https://healthandpharma.net/fda-approves-ziihera-her2-biliary-tract-cancer 2024-11-22T00:00:00+00:00 0.80 https://healthandpharma.net/1732379794Jazz-pharma-Ziihera-2.jpg FDA Approves Ziihera as First Dual HER2-Targeted Therapy for Biliary Tract Cancer https://healthandpharma.net/bayer-aranote-trial-prostate-cancer-treatment 2024-11-21T00:00:00+00:00 0.80 https://healthandpharma.net/1732208631Bayer-webinar-Iris-22.jpg How the ARANOTE Trial Results Could Advance Prostate Cancer Treatment https://healthandpharma.net/oncolytic-viruses-cancer-treatment-thomas-heineman 2024-11-20T00:00:00+00:00 0.80 https://healthandpharma.net/1732152813Oncolitic-virus-2.jpg How Oncolytic Viruses Could Be a New Frontier in Transforming Cancer Treatment https://healthandpharma.net/researcher-uncover-cancer-survival-secrets 2024-11-19T00:00:00+00:00 0.80 https://healthandpharma.net/1732143624laboratory-research-44.jpg UK Researchers Launch Groundbreaking Study to Uncover Cancer Survival Secrets https://healthandpharma.net/fda-approves-mi-cancer-seek-test 2024-11-09T00:00:00+00:00 0.80 https://healthandpharma.net/1731793237fda-gene-dna-test-4.jpg FDA Approves MI Cancer Seek Test for Targeted Cancer Therapy https://healthandpharma.net/cancer-treatment-cytokine-therapies-nemvaleukin 2024-11-08T00:00:00+00:00 0.80 https://healthandpharma.net/1731100939cancer-cell-Cytokine2.jpg Overcoming Resistance in Cancer Treatment with Cytokine Therapies https://healthandpharma.net/imunon-immunotherapy-imnn001-ovarian-cancer 2024-11-07T00:00:00+00:00 0.80 https://healthandpharma.net/1731002775imunon-cancer-2.jpg IMUNON’s Novel Immunotherapy IMNN-001 Enhances Survival in Ovarian Cancer https://healthandpharma.net/biomarker-driven-lung-cancer-treatments-adc-nsclc 2024-11-05T00:00:00+00:00 0.80 https://healthandpharma.net/1730915202ADC-cell-bio-cancer-1.jpg Novel Biomarker-Driven Treatments with ADCs in NSC Lung Cancer Management https://healthandpharma.net/cgp-gene-test-dna-cancer-treatment-personalized-care 2024-11-04T00:00:00+00:00 0.80 https://healthandpharma.net/1730835149illumina-Cgp-test.jpg Role of CGP Testing in the Management of Cancer Treatment and Personalized Care https://healthandpharma.net/spglobal-ai-drug-discovery 2024-10-31T00:00:00+00:00 0.80 https://healthandpharma.net/1730394409SP-AI-Pharma.jpg Exploring the Transformative Power of AI in Drug Discovery: A report by S&P Global https://healthandpharma.net/scib1-melanoma-treatment-dna-plasmid-vaccine 2024-10-28T00:00:00+00:00 0.80 https://healthandpharma.net/1730585201DNA-Gene-labar-1.jpg Transforming Melanoma Treatment with DNA Plasmid Vaccine https://healthandpharma.net/fda-oncomine-dx-target-testherapy-glioma-cancer 2024-10-21T00:00:00+00:00 0.80 https://healthandpharma.net/1729521635Oncomine-Dx-Target-Test-4.jpg FDA Approves First Targeted Therapy for IDH-Mutant Glioma with Companion Diagnostic https://healthandpharma.net/biomarker-predict-immunotherapy-liver-cancer 2024-10-20T00:00:00+00:00 0.80 https://healthandpharma.net/1729512502Liver-cancer-biomarker-2.jpg Targeting NBR1: New Biomarker Could Predict Immunotherapy Success in Liver Cancer https://healthandpharma.net/fda-approves-vyloy-zolbetuximab-gastric-gej-cancer 2024-10-19T00:00:00+00:00 0.80 https://healthandpharma.net/1729441315vyloy-zolbetuximab-fda-2.jpg FDA Approves VYLOY™ as a New Targeted Therapy for Advanced Gastric and GEJ Cancer https://healthandpharma.net/sanofi-orano-partner-radioligand-therapy-cancer 2024-10-18T00:00:00+00:00 0.80 https://healthandpharma.net/1729427851Sanofi-oranomed-3.jpg Sanofi and Orano Join Forces to Develop Novel Radioligand Therapies for Rare Cancers https://healthandpharma.net/lantern-ai-cancer-drug-lp184-fda-ftd-glioblastoma 2024-10-17T00:00:00+00:00 0.80 https://healthandpharma.net/1729461075ai-robot-artifical-lantern-4.jpg AI-Powered Cancer Drug LP-184 Receives FDA Fast-Track Designation for Glioblastoma https://healthandpharma.net/tilt-engineered-oncolytic-adenoviruses-cancer-treatment 2024-10-15T00:00:00+00:00 0.80 https://healthandpharma.net/1729470322tilt-bio-22.jpg How Engineered Oncolytic Adenoviruses Could Transform Cancer Treatment https://healthandpharma.net/fda-itovebi-pik3ca-mutated-breast-cancer 2024-10-12T00:00:00+00:00 0.80 https://healthandpharma.net/1728854708Genentech-Itovebi-inavolisib-2.jpg FDA Approves Itovebi as First-Line Therapy for PIK3CA-Mutated Breast Cancer https://healthandpharma.net/merlin-test-melanoma-unnecessary-surgeries 2024-10-11T00:00:00+00:00 0.80 https://healthandpharma.net/1728662549Merlin-test-melonoma.jpg Merlin Molecular Test Offers Hope for Melanoma by Reducing Unnecessary Surgeries https://healthandpharma.net/adc-abbv400-lung-cancer-treatment 2024-10-09T00:00:00+00:00 0.80 https://healthandpharma.net/1728489908Abbvie-Maria-Miguel-7.jpg The Next Generation of ADCs and the Potential of ABBV-400 in Lung Cancer Treatment https://healthandpharma.net/bayer-oncology-portfolio-moma-therapeutics 2024-10-09T00:00:00+00:00 0.80 https://healthandpharma.net/1728514888Bayer-logo-3.jpg Bayer Expands Precision Oncology Portfolio with MOMA Therapeutics' KNOMATIC Platform https://healthandpharma.net/luminosity-trail-cmet-adc-lung-cancer-nsclc 2024-10-07T00:00:00+00:00 0.80 https://healthandpharma.net/1728489215Abbvie-Nicolas-Girard-6.jpg The LUMINOSITY Trial And Novel Biomarker Targets in the Future of ADCs for NSCLC https://healthandpharma.net/oncolytic-viruses-breast-cancer-treatment 2024-10-03T00:00:00+00:00 0.80 https://healthandpharma.net/1728491781Thoms-Heinemn-Oncolytic-4.jpg The Future of Oncolytic Viruses and Their Role in Cancer Treatment https://healthandpharma.net/ai-drug-discovery-sparse-data-verseon 2024-10-02T00:00:00+00:00 0.80 https://healthandpharma.net/1728492317Adityo-VersAI-Verseon.jpg The Role of AI in the Future of Drug Discovery: Redefining Accuracy... https://healthandpharma.net/verseon-ai-versai-accuracy-drug-discovery 2024-09-18T00:00:00+00:00 0.80 https://healthandpharma.net/1726817871ai-robot-artifical-drug-52.jpg New AI Model VersAI™ Elevates AI Accuracy in Drug Discovery with Sparse Data https://healthandpharma.net/esmo24-braftovi-mektovi-lung-cancer-treatment 2024-09-17T00:00:00+00:00 0.80 https://healthandpharma.net/1726562492ESMO-24-Pfizer-Braftovi-mektovi.jpg ESMO 2024: BRAFTOVI and MEKTOVI Extend Survival in Rare Mutant Lung Cancer https://healthandpharma.net/esmo24-novartis-kisqali-breast-cancer-recurrence 2024-09-16T00:00:00+00:00 0.80 https://healthandpharma.net/1726498973ESMO-24-Kisqali-ribociclib.jpg ESMO 2024: Novartis's Kisqali Reduces Breast Cancer Recurrence Risk by 28.5% https://healthandpharma.net/ovation-study-immunotherapy-imnn-ovarian-cancer 2024-09-12T00:00:00+00:00 0.80 https://healthandpharma.net/1728493720Ovation-immuno-overian.jpg The OVATION 2 Study and the Novel Immunotherapy IMNN-001 for Ovarian Cancer https://healthandpharma.net/eu-approves-braftovi-mektovi-lung-cancer 2024-09-04T00:00:00+00:00 0.80 https://healthandpharma.net/1726149861Pierre-Fabre-Logo-12.jpg European Commission Approves BRAFTOVI and MEKTOVI for Lung Cancer https://healthandpharma.net/fda-illumina-trusight-cancer-test-targeted-therapies 2024-09-02T00:00:00+00:00 0.80 https://healthandpharma.net/1725126125illumina-fda-test.jpg FDA Approves TruSight Cancer Test for Matching Patients with Targeted Therapies https://healthandpharma.net/fda-approves-altius-system-chronic-amputation-pain 2024-08-31T00:00:00+00:00 0.80 https://healthandpharma.net/1725206812Neuros-Altius-2.jpg FDA Approves Breakthrough Device: Altius System to Tackle Chronic Amputation Pain https://healthandpharma.net/fda-nipocalimab-treatment-myasthenia-gravis 2024-08-30T00:00:00+00:00 0.80 https://healthandpharma.net/1725141179Nipocalimab-fda.jpg Nipocalimab Submitted to FDA for Treatment of Generalized Myasthenia Gravis https://healthandpharma.net/cytokine-therapies-cancer-treatment-caroline-loew-murol 2024-08-29T00:00:00+00:00 0.80 https://healthandpharma.net/1728491137Caroline-Loew-Murol-5.jpg Exploring The Potential of Cytokine Therapies to Transform Cancer Treatment https://healthandpharma.net/nimacimab-obesity-weight-loss-drug-cbeyond-trial 2024-08-22T00:00:00+00:00 0.80 https://healthandpharma.net/1724414579obesty-CBeyond-skye.jpg Next-Generation Weight Loss Therapeutic Nimacimab Enters Phase 2 Clinical Trial https://healthandpharma.net/cancer-drug-pt217-fda-orphan-neuroendocrine-carcinoma 2024-08-20T00:00:00+00:00 0.80 https://healthandpharma.net/1724274812FDA-odd-PT217.jpg Novel Cancer Drug PT217 Wins FDA Orphan Drug Status for Neuroendocrine Carcinoma https://healthandpharma.net/lung-cancer-treatment-never-smokers-harmonic-lp300 2024-08-19T00:00:00+00:00 0.80 https://healthandpharma.net/1728504951Harmonic-Reggie-3.jpg Lung Cancer Treatment for Never Smokers: The HARMONIC Phase 2 Trial and LP-300 https://healthandpharma.net/fda-mixed-reality-system-hipinsight-hip-surgery 2024-08-13T00:00:00+00:00 0.80 https://healthandpharma.net/1723569560HipInsight-Animation-fda-2.jpg Mixed-Reality System, HipInsight, Receives FDA Approval for Hip Surgery https://healthandpharma.net/ai-treatment-lp300-lung-cancer-nonsmoker-lantern 2024-08-12T00:00:00+00:00 0.80 https://healthandpharma.net/1723896121AI-lung-cancer-lattern.jpg AI-Powered Treatment Success: LP-300 Shows Promise for Non-Smoker Lung Cancer https://healthandpharma.net/fda-approves-neffy-nasal-epinephrine-spray-allergy-anaphylaxis 2024-08-10T00:00:00+00:00 0.80 https://healthandpharma.net/1723582030Neffy-fda-alergy-2.jpg FDA Approves Neffy: First Nasal Spray for Emergency Allergic Reactions https://healthandpharma.net/role-pharmacists-fight-against-liver-disease 2024-08-09T00:00:00+00:00 0.80 https://healthandpharma.net/1725082770CatherineDuggan-Liver-disease.jpg The Role of Pharmacists in the Fight Against Liver Disease / Interview with Dr. Duggan https://healthandpharma.net/climate-emissions-health-pharmaceutical-industry-emission 2024-08-09T00:00:00+00:00 0.80 https://healthandpharma.net/1700345757satalite-ai-world-2.jpg Healthy Planet: How The Pharmaceutical Industry Can Reduce Its Emissions https://healthandpharma.net/merck-end-keyvibe-trial-lung-cancer-treatment 2024-08-09T00:00:00+00:00 0.80 https://healthandpharma.net/1723326703Merck-msd-head.jpg Merck Ends KeyVibe-008 Trial Over Safety Concerns: A Setback in Lung Cancer https://healthandpharma.net/fda-approve-fabhalta-Iptacopan-iga-nephropathy 2024-08-08T00:00:00+00:00 0.80 https://healthandpharma.net/1723103360fabhalta-iptacopan-1.jpg Iptacopan, the First CI, Wins FDA Accelerated Approval for IgA Nephropathy https://healthandpharma.net/fda-voranigo-vorasidenib-brain-cancer-therapy-glioma 2024-08-07T00:00:00+00:00 0.80 https://healthandpharma.net/1723057020Voranigo-vorasidenip-Servier.jpg FDA Approves Vorasidenib as First Targeted Therapy for G2 IDH-Mutant Glioma https://healthandpharma.net/cart-cell-therapy-brain-cancer-pathways-glioblastoma 2024-08-06T00:00:00+00:00 0.80 https://healthandpharma.net/1723032222Brain-Cancer.jpg Novel CAR T Cell Therapy Targets Brain Cancer's Hidden Pathways, Doubling Survival https://healthandpharma.net/rafael-rosell-krasg12c-inhibitor-lung-cancer-treatment 2024-08-05T00:00:00+00:00 0.80 https://healthandpharma.net/1737164048Rafael-Rosell-2.webp Dr. Rafael Rosell Discusses the Efficacy of KRAS G12C Inhibitor in Lung Cancer Treatment https://healthandpharma.net/immunotherapy-imnn001-ovarian-cancer-treatment 2024-08-03T00:00:00+00:00 0.80 https://healthandpharma.net/1722704572Immunotherapy IMNN-001.jpg Novel Immunotherapy IMNN-001 Shows Extended Survival Rates for Ovarian Cancer https://healthandpharma.net/fda-approves-cell-therapy-tecelra-synovial-sarcoma-tumor 2024-08-02T00:00:00+00:00 0.80 https://healthandpharma.net/1722614607Tecelra-fda-cell-Therapy.jpg Novel Cell Therapy Tecelra Receives FDA Accelerated Approval for Synovial Sarcoma https://healthandpharma.net/fda-approve-expand-dostarlimab-jemperli-endometrial-cancer 2024-08-02T00:00:00+00:00 0.80 https://healthandpharma.net/1722690922jemperli-dostarlimab-1.jpg FDA Approves Expanded Use of Dostarlimab for Treatment of Endometrial Cancers https://healthandpharma.net/ai-tumor-lung-cancer-diagnostic-indica 2024-08-01T00:00:00+00:00 0.80 https://healthandpharma.net/1722600453AI-Lung-Macrodissect-Indica-Labs-3.jpg Transforming Tumor Analysis: LM AI Tool Enhances Lung Cancer Diagnostic Workflows https://healthandpharma.net/fda-approves-dna-blood-test-colorectal-cancer 2024-07-31T00:00:00+00:00 0.80 https://healthandpharma.net/1722380269Guardant-Shield-cancer-blood-test.jpg FDA Approves First Blood Test for Early Detection and Screening of Colorectal Cancer https://healthandpharma.net/biontech-mrna-therapy-bnt111-melanoma-p2-trial 2024-07-30T00:00:00+00:00 0.80 https://healthandpharma.net/1722357445BioNTech-bnt111-melanoma.jpg BioNTech's mRNA Therapy BNT111 Shows Promise for Advanced Melanoma https://healthandpharma.net/fda-approves-johnson-darzalex-faspro-multiple-myeloma 2024-07-30T00:00:00+00:00 0.80 https://healthandpharma.net/1722453997Darzalex-Faspro-Johnson.jpg FDA Approves Johnson's Daratumumab Plus VRd for Newly Diagnosed Multiple Myeloma https://healthandpharma.net/aps2-blood-test-alzheimer-diagnosis-treatment-primary-care 2024-07-29T00:00:00+00:00 0.80 https://healthandpharma.net/1707101982blood-test-tube-4.jpg APS2 Blood Test for Alzheimer's Could Revolutionize Early Diagnosis in Primary Care https://healthandpharma.net/fda-approves-expanded-xembify-immunodeficiency 2024-07-29T00:00:00+00:00 0.80 https://healthandpharma.net/1722493500FDA-Grifols-Xembify.jpg FDA Approves Expanded Use of Xembify for Immunodeficiency Treatment https://healthandpharma.net/senovax-fda-ind-tumor-lung-cancer 2024-07-26T00:00:00+00:00 0.80 https://healthandpharma.net/1722106604FDA-IND-SenoVax-2.jpg SenoVax: Targeting "Zombie Cells" to Destroy Tumor Barriers and Combat Lung Cancer https://healthandpharma.net/bayer-prostate-cancer-personalized-medicine-asco 2024-07-26T00:00:00+00:00 0.80 https://healthandpharma.net/1723652407Bayer-Tara-Asco-125.jpg New Developments in Prostate Cancer: The Road to More Personalized Medicine https://healthandpharma.net/fda-ind-anixa-cart-therapy-ovarian-cancer 2024-07-25T00:00:00+00:00 0.80 https://healthandpharma.net/1722443382FDA-ind-cart-terapy.jpg Anixa's CAR-T Therapy for Ovarian Cancer Earns FDA IND Approval https://healthandpharma.net/fda-zymeworks-zw191-cancer-drug-ovarian 2024-07-24T00:00:00+00:00 0.80 https://healthandpharma.net/1722091752ZW191-FDA-IND-Zyme.jpg FDA Clears ZW191 for Clinical Trials: Novel Drug Targets NSCLC and Ovarian Cancer https://healthandpharma.net/emerson-monteris-nb3-laser-probe-brain-tumor-treatmenth 2024-07-23T00:00:00+00:00 0.80 https://healthandpharma.net/1723307610Monteris-laser-probe-2.jpg Elevating Safety and Efficacy in Brain Tumor Treatment with the NB3 Laser Probe https://healthandpharma.net/beyond-chemotherapy-medicine-adc-solid-tumors-abbvie 2024-07-22T00:00:00+00:00 0.80 https://healthandpharma.net/1722192108abbvie-asco-21.jpg Beyond Chemotherapy: The Rise of Precision Medicine and Targeted Therapy with ADCs https://healthandpharma.net/nubeqa-darolutamide-metastatic-prostate-cancer 2024-07-19T00:00:00+00:00 0.80 https://healthandpharma.net/1722012779Nubeqa-darolutamide-bayer.jpg Darolutamide Shows Promise in Phase III ARANOTE Trial for Treating Prostate Cancer https://healthandpharma.net/cgp-illumina-gene-test-genomic-profiling-cancer 2024-07-17T00:00:00+00:00 0.80 https://healthandpharma.net/1722871025asco-illumina-23.jpg The Impact of Comprehensive Genomic Profiling on Personalized Cancer Care https://healthandpharma.net/alto-100-trail-depression-treatment-biomarkers 2024-07-16T00:00:00+00:00 0.80 https://healthandpharma.net/1721923885brain-depression-2.jpg ALTO-100 Trial: Using Cognitive Biomarkers to Personalize Depression Treatment https://healthandpharma.net/predict-disease-machine-learning-detection 2024-07-15T00:00:00+00:00 0.80 https://healthandpharma.net/1700866845microbes-bacterium-ai-5.jpg Machine Learning Could Detect Disease from Proteins 15 Years Before It Strikes https://healthandpharma.net/ionctura-gsk-nsclc-cancer-therapy-roginolisib 2024-07-10T00:00:00+00:00 0.80 https://healthandpharma.net/1720522707iOnctura-Roginolisib-NSCLC.jpg iOnctura and GSK Collaborate to Advance NSCLC Therapy with Roginolisib Trials https://healthandpharma.net/lung-cancer-research-foundation-board-chair 2024-07-10T00:00:00+00:00 0.80 https://healthandpharma.net/1720549625LCRF-Politi_ODonnell.jpg Lung Cancer Research Foundation Names New Scientific Advisory Board Chair https://healthandpharma.net/vision-trial-ai-digital-twins-breast-cancer-treatment 2024-07-10T00:00:00+00:00 0.80 https://healthandpharma.net/1720635850ai-digital-twin-robot-12.jpg VISION Trial Employs AI and Digital Twins to Tailor Breast Cancer Treatment https://healthandpharma.net/fda-kisunla-alzheimer-therapy-donanemab-amyloid-lilly 2024-07-03T00:00:00+00:00 0.80 https://healthandpharma.net/1720366446Kisunla-Lilly-5.jpg FDA Approves Kisunla, a Novel Alzheimer's Therapy Targeting Amyloid Plaques https://healthandpharma.net/fda-fast-track-sync-sv102-prostate-cancer 2024-07-02T00:00:00+00:00 0.80 https://healthandpharma.net/1720269350fda-Cancer-tumor-3.jpg FDA Grants Fast-Track Designation to SYNC-T SV-102 for Prostate Cancer https://healthandpharma.net/schizophrenia-treatment-phase2-alto-101 2024-06-25T00:00:00+00:00 0.80 https://healthandpharma.net/1720248211Brain-Schizophrenia-2.jpg New Horizons in Schizophrenia Treatment: ALTO-101 Targets Cognitive Dysfunction https://healthandpharma.net/fda-approves-zw171-bispecific-antibody-cancer 2024-06-21T00:00:00+00:00 0.80 https://healthandpharma.net/1719159859ZW171-cancer-cell-antibody-1.jpg FDA Approves Trials for ZW171: A Novel Bispecific Antibody for Hard-to-Treat Cancers https://healthandpharma.net/fda-approves-grifols-yimmugo-immunodeficiency 2024-06-18T00:00:00+00:00 0.80 https://healthandpharma.net/1718900644grifols-biotest-yimmugo-2.jpg FDA Approves Grifols' Yimmugo® for Primary Immunodeficiency, Marking a Milestone https://healthandpharma.net/potential-neutrophil-cell-therapies-oncology 2024-06-10T00:00:00+00:00 0.80 https://healthandpharma.net/1720097840Neutrophil-cell-32.jpg Unleashing the Potential of Neutrophil Cell Therapies in Oncology https://healthandpharma.net/asco-opdivo-yervoy-liver-cancer-hepatocellular-carcinoma 2024-06-07T00:00:00+00:00 0.80 https://healthandpharma.net/1717965017bms-opdivo-yervoy-2.jpg ASCO24: Opdivo Plus Yervoy Significantly Improves Overall Survival in Liver Cancer https://healthandpharma.net/abbvie-adc-data-solid-tumor-cancer-treatments-asco24 2024-06-03T00:00:00+00:00 0.80 https://healthandpharma.net/1717719488asco-abbvie-24.jpg AbbVie Reveals Promising ADC Data for Advanced Cancer Treatments at ASCO 2024 https://healthandpharma.net/asco24-genfleet-fulzerasib-lung-cancer-treatment 2024-06-02T00:00:00+00:00 0.80 https://healthandpharma.net/1717344914Fulzerasib-Genfleet-34.jpg GenFleet's Fulzerasib Combo Achieves High Response Rate in Lung Cancer Treatment https://healthandpharma.net/asco24-tagrisso-osimertinib-egfrm-lung-cancer-treatment 2024-06-02T00:00:00+00:00 0.80 https://healthandpharma.net/1717376770Tagrisso-osimertinib-4.jpg Tagrisso Extends Survival in Stage III EGFR-Mutated Lung Cancer Treatment https://healthandpharma.net/asco24-scemblix-asciminib-chronic-myeloid-leukemia-treatments 2024-05-31T00:00:00+00:00 0.80 https://healthandpharma.net/1717193766Novartis-Logo-2.jpg Scemblix® Outperforms Standard Treatments in Phase III Myeloid Leukemia Trial https://healthandpharma.net/fda-ind-spg302-als-treatment-spinogenix 2024-05-29T00:00:00+00:00 0.80 https://healthandpharma.net/1716996250Spinogenix-ALS-2.jpg Spinogenix's Daily Pill SPG302 Receives FDA IND Nod for ALS Treatment https://healthandpharma.net/focused-ultrasound-treatment-brain-cancer 2024-05-28T00:00:00+00:00 0.80 https://healthandpharma.net/1717114606Focused-Ultrasound-33.jpg How Focused Ultrasound Could Change Treatment Options for Brain Cancers https://healthandpharma.net/agendia-genomic-testing-breast-cancer-treatment 2024-05-27T00:00:00+00:00 0.80 https://healthandpharma.net/1716931326Agendia-Gene-test-1.jpg Genomic Testing Transforms Breast Cancer Care and Treatment Success https://healthandpharma.net/zailab-psoriasis-treatment-zl1102-topical-therapy-trial 2024-05-25T00:00:00+00:00 0.80 https://healthandpharma.net/1716768447zl1102-humabody-psoriasis.jpg Zai Lab Advances Psoriasis Treatment with ZL-1102 Topical Therapy in Phase 2 Trial https://healthandpharma.net/fda-alcohol-hepatitis-larsucosterol-treatment-breakthrough 2024-05-24T00:00:00+00:00 0.80 https://healthandpharma.net/1716681425DURECT-Larsucosterol.jpg New Treatment for AA Hepatitis: Larsucosterol Earns FDA Breakthrough Designation https://healthandpharma.net/majzner-cart-cell-pediatric-cancert-therapies 2024-05-24T00:00:00+00:00 0.80 https://healthandpharma.net/1716688017Cart-cell-cancer-4.jpg The Impact of CAR-T Cell Therapies on the Future of Pediatric Cancer Care https://healthandpharma.net/nimbus-treating-tumor-ndi101150-hpk1-inhibitor 2024-05-24T00:00:00+00:00 0.80 https://healthandpharma.net/1716512390Nimbus-Therapeutics.jpg Nimbus Reports Early Success in Treating Solid Tumors with NDI-101150, an HPK1 Inhibitor https://healthandpharma.net/non-opioid-pain-relief-srp001-trial-rampart-pharma 2024-05-23T00:00:00+00:00 0.80 https://healthandpharma.net/1716500508drug-pill-medicine-4.jpg Safer Non-Opioid Pain Relief on the Horizon: SRP-001 Shows Promise in Phase 1 Trials https://healthandpharma.net/vergent-lung-cancer-surgery-visualization-vgt309ung 2024-05-22T00:00:00+00:00 0.80 https://healthandpharma.net/1716759963Vergent-surgery-6.jpg Beyond Visualization: The Promise of VGT-309 in Minimally Invasive Lung Cancer Surgery https://healthandpharma.net/fda-imdelltra-tarlatamab-lung-cancer-amgen 2024-05-17T00:00:00+00:00 0.80 https://healthandpharma.net/1715976400Imdelltra-tarlatamab-2.jpg FDA Approves IMDELLTRA for Lung Cancer After a 40% Response Rate https://healthandpharma.net/arvinas-pfizer-vepdegestrant-trial-breast-cancer 2024-05-16T00:00:00+00:00 0.80 https://healthandpharma.net/1715881291Arvinas-Pfizer-Vepdegestrant-3.jpg Pfizer Reports Promising Survival Benefits in Vepdegestrant Trial for Breast Cancer https://healthandpharma.net/hepatitis-b-cure-barinthus-vtp300-nadege-pelletier 2024-05-15T00:00:00+00:00 0.80 https://healthandpharma.net/1715730788Nadege-Pelletier-32.jpg Advancing Hepatitis B Cure: A Closer Look at Barinthus Bio's VTP-300 Project https://healthandpharma.net/fda-approves-mrna-cancer-vaccine-oncology-wgc043 2024-05-10T00:00:00+00:00 0.80 https://healthandpharma.net/1715358031WestGene-fda-mrna-2.jpg A New Horizon in Oncology: FDA Approves the First-Ever mRNA Cancer Vaccine https://healthandpharma.net/ai-help-bridge-gap-healthcare-tech-skills 2024-05-10T00:00:00+00:00 0.80 https://healthandpharma.net/1715728215Example-21.jpg Can Artificial Intelligence Help Bridge the Gap in Healthcare Tech Skills? https://healthandpharma.net/ring-therapeutics-anellovectors-treatment-genetic-diseases 2024-05-07T00:00:00+00:00 0.80 https://healthandpharma.net/1711990408ring-Anellovirus-2.jpg How Ring's Anellovectors Could Change the Treatment of Genetic Diseases https://healthandpharma.net/oregon-lantern-pharma-ai-collaboration-cancer-drug 2024-05-06T00:00:00+00:00 0.80 https://healthandpharma.net/1715002768ai-robot-artifical-22.jpg Oregon & Lantern Pharma's Strategic AI Collaboration to Enhance Cancer Drug https://healthandpharma.net/erdafitinib-balversa-study-bladder-cancer-treatment 2024-05-05T00:00:00+00:00 0.80 https://healthandpharma.net/1714946767Erdafitinib-Balversa-4.jpg TAR-210 Study Shows Promise in Bladder Cancer Treatment with 90% RF Survival Rate https://healthandpharma.net/novartis-radioligand-therapy-acquisition-mariana-oncology 2024-05-03T00:00:00+00:00 0.80 https://healthandpharma.net/1714921695Novartis-Mariana-onco.jpg Novartis Expands Radioligand Therapy Portfolio with $1B Acquisition of Mariana https://healthandpharma.net/keytruda-survival-gastric-cancer-keynote-trial 2024-05-02T00:00:00+00:00 0.80 https://healthandpharma.net/1715393450Keytruda-merck-pembrolizumab-2.jpg KEYTRUDA Shows Promising Survival Benefits in Gastric Cancer: Phase 3 Trial https://healthandpharma.net/monteris-nb3-laser-probe-brain-tumor-surgery 2024-05-01T00:00:00+00:00 0.80 https://healthandpharma.net/1714583824Monteris-NB3-Probe-lazer-2.jpg Monteris Introduces Smallest NB3 Laser Probe for Brain Tumor Surgery https://healthandpharma.net/fda-approve-tivdak-metastatic-cervical-cancer 2024-05-01T00:00:00+00:00 0.80 https://healthandpharma.net/1714695039Pfizer-tivdak-genmab-2.jpg FDA Grants Full Approval for Tivdak® to Treat Recurrent or Metastatic Cervical Cancer https://healthandpharma.net/genfleet-fda-approval-gfh925-colorectal-cancer-treatment 2024-04-29T00:00:00+00:00 0.80 https://healthandpharma.net/1714575020GenFleet-Therapeutics-2.jpg GenFleet Receives FDA Approval for P3 Trial of GFH925 in Colorectal Cancer Treatment https://healthandpharma.net/fda-gene-therapy-pfizer-beqvez-hemophilia-b 2024-04-26T00:00:00+00:00 0.80 https://healthandpharma.net/1714209056Pfizer-beqvez.jpg Transformative One-Time Gene Therapy: FDA Approves Pfizer's BEQVEZ, for Hemophilia B https://healthandpharma.net/fda-approve-novartis-lutathera-pediatric-neuroendocrine-tumors 2024-04-24T00:00:00+00:00 0.80 https://healthandpharma.net/1713977850FDA-Lutathera-23.jpg FDA Approves Lutathera as First Treatment for Pediatric Neuroendocrine Tumors https://healthandpharma.net/ai-driven-drug-discovery-xaira-therapeutics 2024-04-24T00:00:00+00:00 0.80 https://healthandpharma.net/1714144433ai-robot-drug-23.jpg A New AI-Driven Drug Discovery Company, Xaira Therapeutics, Launches with $1 Billion https://healthandpharma.net/flindr-receive-precision-cancer-treatment 2024-04-23T00:00:00+00:00 0.80 https://healthandpharma.net/1713989204flindr-logo.jpg Flindr Receives €20 Million to Advance Precision Cancer Treatments with RNF31 Inhibitor https://healthandpharma.net/fda-anktiva-immunotherapy-bladder-cancer-treatment 2024-04-23T00:00:00+00:00 0.80 https://healthandpharma.net/1714005182FDA-Anktiva-4.jpg First-of-Its-Kind Immunotherapy Anktiva Receives FDA Approval for Bladder Cancer https://healthandpharma.net/fda-approves-imaging-tumor-detection-breast-cancer-surgeries 2024-04-21T00:00:00+00:00 0.80 https://healthandpharma.net/1713716112LumiSystem-fda-2.jpg FDA Approves New Imaging System to Enhance Tumor Detection in Cancer Surgery https://healthandpharma.net/fda-approves-alecensa-alectinib-alk-lung-cancer 2024-04-19T00:00:00+00:00 0.80 https://healthandpharma.net/1713630369FDA-Alecensa-2.jpg FDA Approves Alecensa for ALK+ Lung Cancer Following 76% Drop in Risk of Death https://healthandpharma.net/panna-sharma-ai-cancer-care-medicine-artificial-intelligence 2024-04-19T00:00:00+00:00 0.80 https://healthandpharma.net/1713836466Ai-robot-882.jpg Panna Sharma: AI to Transform Cancer Care and Usher in a New Era of Medicine https://healthandpharma.net/lilly-obesity-drug-zepbound-tirzepatide-reduces-sleep-apnea 2024-04-18T00:00:00+00:00 0.80 https://healthandpharma.net/1713442910Lilly-headquarter-2.jpg P3 Study Shows Obesity Drug Tirzepatide Reduces Sleep Apnea Severity by Up to 63% https://healthandpharma.net/roche-blood-test-alzheimer-fda-bdd 2024-04-18T00:00:00+00:00 0.80 https://healthandpharma.net/1713650437Alzheimer-test-fda.jpg Roche's Blood Test for Alzheimer's Earns FDA Breakthrough Device Designation https://healthandpharma.net/roche-ocrevus-injection-ms-multiple-sclerosis-treatment 2024-04-17T00:00:00+00:00 0.80 https://healthandpharma.net/1713388325Roche-Ocrevus-MS.jpg Roche's Phase III Study Promises Effective Ocrevus Injection for Multiple Sclerosis https://healthandpharma.net/tris-pharma-digital-health-ai-adhd-diagnostic-tool 2024-04-16T00:00:00+00:00 0.80 https://healthandpharma.net/1713313522Tris-ADHD-ai.jpg Tris Pharma Takes Bold Step into Digital Health with AI-Driven ADHD Diagnostic Tool https://healthandpharma.net/fda-spinogenix-fragile-x-syndrome-treatment 2024-04-15T00:00:00+00:00 0.80 https://healthandpharma.net/1713213138spinogenix-lfragile.jpg FDA Clears Spinogenix's Phase 2a Trial for Innovative Fragile X Syndrome Treatment https://healthandpharma.net/fda-lsta1-certepetide-orphan-drug-osteosarcoma-bone-cancer 2024-04-15T00:00:00+00:00 0.80 https://healthandpharma.net/1713284712Lisata-bone-cancer-2.png LSTA1 (Certepetide) Wins FDA Orphan Drug Status for Osteosarcoma Treatment https://healthandpharma.net/tilt-123-kyeruda-ovarian-cancer-treatment 2024-04-11T00:00:00+00:00 0.80 https://healthandpharma.net/1712967485tilt-bio-2.jpg Oncolytic TILT-123 and KEYTRUDA Combination Shows Promise for Ovarian Cancer https://healthandpharma.net/sunvozertinib-fda-breakthrough-lung-cancer-treatment 2024-04-07T00:00:00+00:00 0.80 https://healthandpharma.net/1712505107Sunvozertinib-FDA.jpg FDA Endorses Sunvozertinib for First-Line Treatment of Lung Cancer with EGFR-E20i https://healthandpharma.net/fda-approves-cart-cell-therapy-abecma-multiple-myeloma 2024-04-06T00:00:00+00:00 0.80 https://healthandpharma.net/1712356823BMS-Abecma-Myeloma-3.jpg FDA Approves Groundbreaking CAR T Cell Therapy, Abecma, for Multiple Myeloma https://healthandpharma.net/fda-approves-carvykti-bcma-cart-cell-therapy-multiple-myeloma 2024-04-06T00:00:00+00:00 0.80 https://healthandpharma.net/1712433575Carvykti-legend-2.jpg FDA Approves Carvykti as Targeted CAR-T Cell Therapy for Multiple Myeloma https://healthandpharma.net/fda-approval-enhertut-her2-solid-tumors-treatment 2024-04-05T00:00:00+00:00 0.80 https://healthandpharma.net/1712423896ENHERTU-fda.jpg FDA Grants Fast-Track Approval to Enhertu for Treatment of HER2+ Solid Tumors https://healthandpharma.net/psychedelic-assisted-therapy-cancer-care-sunstone 2024-04-05T00:00:00+00:00 0.80 https://healthandpharma.net/1713318602psychotherapy-cancer-sunstone.jpg The Role of Psychedelic-Assisted Therapy in Transforming Cancer Care https://healthandpharma.net/apollomics-sanjeev-redkar-oncolife-histology-agnostic-cancer-treatment 2024-04-05T00:00:00+00:00 0.80 https://healthandpharma.net/1713450511Apollomics-Sanjeev-Redkar-533.jpg Dr. Redkar Unveils the Role of Targeted and Histology-Agnostic Therapies in Cancer https://healthandpharma.net/spatial-biology-immunotherapy-cancer-treatment 2024-04-05T00:00:00+00:00 0.80 https://healthandpharma.net/1714154136Spatial-Biology-4.jpg The Role of Spatial Biology in Immunotherapy and Cancer Treatment https://healthandpharma.net/abcellera-antibody-discovery-cancer-therapeutics 2024-04-05T00:00:00+00:00 0.80 https://healthandpharma.net/1715266885AbCellera-tcell-12.jpg AbCellera’s Breakthroughs in Antibody Discovery for Advanced Cancer Therapeutics https://healthandpharma.net/oncology-programmable-mrna-therapies-cancer 2024-04-04T00:00:00+00:00 0.80 https://healthandpharma.net/1712253346mrna-gene-cancer-1.jpg A New Era in Oncology: Programmable mRNA Therapies in the Battle Against Cancer https://healthandpharma.net/gender-melanoma-vaccine-cancer-treatment 2024-04-03T00:00:00+00:00 0.80 https://healthandpharma.net/1712189345immunotherapy-cell-cancer-2.jpg Novel Gender-Specific Melanoma Vaccine Marks a Milestone in Cancer Treatment https://healthandpharma.net/gene-therapy-anellovirus-vectors 2024-04-01T00:00:00+00:00 0.80 https://healthandpharma.net/1711989681Anello-virus-32.jpg The Next Frontier: Revolutionizing Gene Therapy with Anellovirus-Based Vectors https://healthandpharma.net/kristal-trial-krazati-adagrasib-lung-cancer 2024-03-29T00:00:00+00:00 0.80 https://healthandpharma.net/1711748510BMS-Krazati-12.jpg KRAZATI Success in Treating Advanced KRASG12C-Mutated Lung Cancer https://healthandpharma.net/ai-pleiograph-drug-discovery 2024-03-22T00:00:00+00:00 0.80 https://healthandpharma.net/1711233923drug-ai-robot-23.jpg Revolutionizing Drug Discovery with AI-Powered PleioGraph: 100 Times Faster https://healthandpharma.net/auxilius-aux001-chronic-angina 2024-03-21T00:00:00+00:00 0.80 https://healthandpharma.net/1711209987heart-kalp-22.jpg Auxilius's Clinical Trial Results for AUX-001 Show Promise in Combatting Chronic Angina https://healthandpharma.net/fda-approve-gene-therapy-children-rare 2024-03-20T00:00:00+00:00 0.80 https://healthandpharma.net/1711109793fda-gene-dna-aprove-2.jpg FDA Approves Groundbreaking Gene Therapy for Children with Rare Genetic Disorder https://healthandpharma.net/astrazeneca-acquiring-fusion-radiopharmaceutical 2024-03-19T00:00:00+00:00 0.80 https://healthandpharma.net/1710930671Astrazeneca-Fusion-4.jpg AstraZeneca's $2.4 Billion Strategic Move: Acquiring Fusion for Radiopharmaceutical https://healthandpharma.net/fda-leukemia-breyanzi-cart-therapy-cll-sll 2024-03-17T00:00:00+00:00 0.80 https://healthandpharma.net/1710700949BMS-breyanzi-2.jpg New Hope for Leukemia: FDA Approves Breyanzi, the First CAR T Therapy for CLL and SLL https://healthandpharma.net/fda-rezdiffra-resmetirom-liver-disease-nash 2024-03-15T00:00:00+00:00 0.80 https://healthandpharma.net/1710591405fda-liver-rezaiffra-3.jpg A New Era in Liver Disease: FDA Approves First Medication 'Rezdiffra' for NASH https://healthandpharma.net/fda-approves-beigene-tevimbra-esophageal-carcinoma-cancer 2024-03-15T00:00:00+00:00 0.80 https://healthandpharma.net/1710758890Tevimbra-BeiGene-22.jpg FDA Approves Tevimbra for Advanced Esophageal Squamous Cell Carcinoma Treatment https://healthandpharma.net/pfizer-adcetris-brentuximab-dlbcl-lymphoma-cancer 2024-03-12T00:00:00+00:00 0.80 https://healthandpharma.net/1710302554Pfizer-Adcetris-1.jpg Pfizer Announces Promising Results from Adcetris® Trial for DLBCL Lymphoma Patients https://healthandpharma.net/fda-pancreatic-cancer-therapy-cambritaxestat-orphan-drug 2024-03-09T00:00:00+00:00 0.80 https://healthandpharma.net/1710000098Cambritaxestat-fda.jpg Pancreatic Cancer Therapy Cambritaxestat Receives FDA Orphan Drug Designation https://healthandpharma.net/gilead-merck-historic-data-hiv-treatment-weekly-pill 2024-03-08T00:00:00+00:00 0.80 https://healthandpharma.net/1709854209hiv-aids-treatment-16.jpg Gilead and Merck Announce Historic Data for HIV Treatment: A Weekly Pill Shows Promise https://healthandpharma.net/brukinsa-fda-approval-follicular-lymphoma-zanubrutinib 2024-03-08T00:00:00+00:00 0.80 https://healthandpharma.net/1709865952BeiGene-Brukinsa-2.jpg New Hope for Follicular Lymphoma: FDA Grants Accelerated Approval to Brukinsa https://healthandpharma.net/fda-approves-wegovy-risk-heart-problems-obesity-semaglutide 2024-03-08T00:00:00+00:00 0.80 https://healthandpharma.net/1699887056Wegovy-drug-heart-2.jpg FDA Approves Wegovy to Reduce Risk of Heart Problems in Obese Adults https://healthandpharma.net/gilead-merus-oncology-alliance-cancer 2024-03-08T00:00:00+00:00 0.80 https://healthandpharma.net/1710119801gilead-merus-logo.jpg Gilead and Merus Forge $1.5 Billion Oncology Alliance to Novel Cancer Treatments https://healthandpharma.net/fda-inotuzumab-besponsa-lymphoblastic-leukemia 2024-03-07T00:00:00+00:00 0.80 https://healthandpharma.net/1709780592Besponsa-inotuzumab-Pfizer.jpg FDA Approves Besponsa for Pediatric Acute Lymphoblastic Leukemia https://healthandpharma.net/fda-bladder-cancer-treatment-opdivo-nivolumab 2024-03-07T00:00:00+00:00 0.80 https://healthandpharma.net/1709953153BMS-opdivo-nivolumap-23.jpg A New Phase in Bladder Cancer Treatment: Nivolumab Combination Wins FDA Approval https://healthandpharma.net/gsk-dreamm-trial-blenrep-multiple-myeloma-treatment 2024-03-07T00:00:00+00:00 0.80 https://healthandpharma.net/1710018539Blenrep-pomdex-gsk.jpg DREAMM-8 Trial: Blenrep Reshapes Treatment of Multiple Myeloma https://healthandpharma.net/diabet-ozempic-semaglutide-kidney-cardiac-deaths 2024-03-05T00:00:00+00:00 0.80 https://healthandpharma.net/1701134096ozempic-Semaglutide-2.jpg Ozempic Reduces Kidney Disease Risk and Cardiac Deaths by 24% in Diabetics https://healthandpharma.net/cart-cell-therapy-multiple-sclerosis 2024-03-04T00:00:00+00:00 0.80 https://healthandpharma.net/1709597362Cell-Therapy-645.jpg CAR-T Therapy and Multiple Sclerosis: A New Horizon for Disease Management https://healthandpharma.net/fda-rybrevant-lung-cancer-therapy-egfr 2024-03-02T00:00:00+00:00 0.80 https://healthandpharma.net/1709518073FDA-drug-approve-1.jpg A New Horizon for Lung Cancer: FDA Approves Rybrevant as First-line Therapy https://healthandpharma.net/personalized-immunotherapy-cancer-treatment 2024-03-01T00:00:00+00:00 0.80 https://healthandpharma.net/1709492568immunotherapy-cancer-cell-3.jpg New Research Offers Hope with Personalized Immunotherapy for Cancer Patients https://healthandpharma.net/bayer-lung-cancer-drug-fda-breakthrough 2024-03-01T00:00:00+00:00 0.80 https://healthandpharma.net/1709608383Bayer-baykomm-3.jpg Bayer's New Lung Cancer Drug Receives Critical FDA Breakthrough Designation https://healthandpharma.net/alzheimers-diagnosis-sunbird-bio-apex-platform 2024-02-26T00:00:00+00:00 0.80 https://healthandpharma.net/1709070924Sunbird-Bio-APEX-Platform-2.jpg Breakthrough in Alzheimer's Diagnosis: APEX Platform Shows Promising Results https://healthandpharma.net/fda-artiva-allonk-nk-cell-therapy-ftd-lupus-nephritis 2024-02-22T00:00:00+00:00 0.80 https://healthandpharma.net/1708614973AlloNK-Artiva-FDA-cell.jpg FDA Grants Fast Track Designation to NK Cell Therapy AlloNK® for Lupus Nephritis https://healthandpharma.net/fda-approves-cellular-therapy-amtagvi-melanoma 2024-02-17T00:00:00+00:00 0.80 https://healthandpharma.net/fda-drug-23.jpg FDA Approves First Cellular Therapy, Amtagvi, for Treatment of Metastatic Melanoma https://healthandpharma.net/xolair-fda-approve-food-allergy-treatment 2024-02-16T00:00:00+00:00 0.80 https://healthandpharma.net/1703033976xolair-omalizumab-allergy.jpg New Horizon in Food Allergy Treatment: FDA Approves Xolair for All Ages https://healthandpharma.net/v-foundation-role-cancer-research-scientists 2024-02-15T00:00:00+00:00 0.80 https://healthandpharma.net/1713050938Susanna-Greer-VFound.jpg The V Foundation’s Role in Advancing Cancer Research and Supporting Women Scientists https://healthandpharma.net/christine-roth-bayer-oncology-plan 2024-02-15T00:00:00+00:00 0.80 https://healthandpharma.net/1713146952Christine-Roth-Bayer-1.jpg Christine Roth Unveils Bayer Oncology’s Plan for the Next Ten Years https://healthandpharma.net/johan-baeck-paradigms-oncology-cancer-pt112 2024-02-15T00:00:00+00:00 0.80 https://healthandpharma.net/1713232416Cell-threapy-cancer-8.jpg Dr. Johan Baeck Discusses PT-112: A New Frontier in Immuno-Oncology https://healthandpharma.net/digital-therapeutics-virtual-reality-masks-ptsd 2024-02-13T00:00:00+00:00 0.80 https://healthandpharma.net/1707939736Virtual-VR-digital-34.jpg Digital Therapeutics: The Promise of Virtual Reality Masks in Treating PTSD Symptoms https://healthandpharma.net/novartis-oncology-acquisition-morphosys 2024-02-07T00:00:00+00:00 0.80 https://healthandpharma.net/1707267039Novartis-Morphosys-logo-2.jpg Novartis Strengthens Its Oncology Pipeline with the Acquisition of MorphoSys https://healthandpharma.net/cancer-inequities-pfizer-acs-asco-disparities 2024-02-05T00:00:00+00:00 0.80 https://healthandpharma.net/1707158361Pfizer-asco-logo-33.jpg Fighting Against Cancer Inequities: Pfizer and ACS's Bold Plan to Tackle Cancer Disparities https://healthandpharma.net/natera-blood-test-signatera-dna-lung-cancer 2024-02-03T00:00:00+00:00 0.80 https://healthandpharma.net/1707102288blood-test-natera-3.jpg Natera's Novel Blood Test Signatera Offers New Hope for Early Lung Cancer Detection https://healthandpharma.net/fda-biosyngen-liver-cancer-therapy-ftd 2024-02-02T00:00:00+00:00 0.80 https://healthandpharma.net/1706895502FDA-FTD-Biosyngen-logo.jpg FDA Grants Biosyngen's Innovative Liver Cancer Therapy Fast Track Designation https://healthandpharma.net/rznomics-rna-therapy-fda-orphan-drug-liver-cancer 2024-02-02T00:00:00+00:00 0.80 https://healthandpharma.net/1706930578RNA-therapy-liver-cancer.jpg Rznomics' RNA-Based Therapy Receives FDA Orphan Drug Status for Liver Cancer https://healthandpharma.net/vergent-vgt-visualization-lung-tumors-surgery 2024-02-01T00:00:00+00:00 0.80 https://healthandpharma.net/1706830871Vergent-bio-3.jpg Vergent's VGT-309 Shows Promise in Real-Time Visualization of Tumors During Surgery https://healthandpharma.net/fda-fast-track-biontech-ovarian-cancer-therapy 2024-01-31T00:00:00+00:00 0.80 https://healthandpharma.net/1706712965BioNTech-DualityBio-BNT325-over.jpg FDA Grants Fast Track Status to BioNTech and DualityBio's Ovarian Cancer Therapy https://healthandpharma.net/revolo-eoe-therapy-fda-orphan-drug-esophageal 2024-01-30T00:00:00+00:00 0.80 https://healthandpharma.net/1706664422Revolo-Bio-odd-EoE-2.jpg Revolo's 1104 EoE Therapy Earns FDA Orphan Drug Status for Rare Esophageal Disorder https://healthandpharma.net/fda-orphan-drug-neoImmunetech-pancreatic-cancer 2024-01-30T00:00:00+00:00 0.80 https://healthandpharma.net/1706668865NeoImmuneTech-nt17.jpg FDA Grants Orphan Drug Status to NeoImmuneTech's NT-I7 for Pancreatic Cancer https://healthandpharma.net/fda-bdd-amadix-blood-test-prevecol-colorectal-cancer 2024-01-27T00:00:00+00:00 0.80 https://healthandpharma.net/1706410084Amadix-blood-test-2.jpg FDA Grants Breakthrough Device Designation to Amadix's Blood Test PreveCol for CRC https://healthandpharma.net/global-cart-cell-therapy-market-cancer 2024-01-26T00:00:00+00:00 0.80 https://healthandpharma.net/1706235908graphic-arrow-32.jpg The Global CAR T-Cell Therapy Market's Ascent: From $8.2 B in 2022 to $11.2 B by 2030 https://healthandpharma.net/ai-vr-acronyms-healthcare-digital-twins 2024-01-26T00:00:00+00:00 0.80 https://healthandpharma.net/1706292277Martin-digital-helath-2.jpg AI and VR – two little acronyms that will change the healthcare world this year https://healthandpharma.net/elicio-therapeutics-amp-combination-therapy-kras-tumor 2024-01-25T00:00:00+00:00 0.80 https://healthandpharma.net/1706204986Elicio-Therapeutics2.jpg Elicio Therapeutics' Novel Therapy Successfully Targets KRAS-Mutated Tumors https://healthandpharma.net/colorectal-cancer-treatment-bold100-results-asco 2024-01-23T00:00:00+00:00 0.80 https://healthandpharma.net/1706063306Bold-Therapeutics.jpg New Treatment for Colorectal Cancer: BOLD-100 Shows Positive Results at ASCO GI 2024 https://healthandpharma.net/bms-colorectal-cancer-treatment-opdivo-yervoy 2024-01-22T00:00:00+00:00 0.80 https://healthandpharma.net/1705887488Bristol-BMS-Opdivo-Yervoy.jpg A Milestone in Colorectal Cancer Treatment: Opdivo and Yervoy Show Remarkable Efficacy https://healthandpharma.net/biontech-dualitybio-phase3-trial-breast-cancer-drug-bnt323 2024-01-22T00:00:00+00:00 0.80 https://healthandpharma.net/1705934757BioNTech-DualityBio-BNT323-DB-1303.jpg BioNTech and DualityBio Announce Phase 3 Trial for Promising Breast Cancer Drug, BNT323 https://healthandpharma.net/novartis-lutathera-neuroendocrine-tumor-cancer 2024-01-19T00:00:00+00:00 0.80 https://healthandpharma.net/1705697158novartis-lutathera-2.jpg NETTER-2 Trial: Lutathera Cuts Risk of Death by 72% in Neuroendocrine Tumor Treatment https://healthandpharma.net/fda-johnson-balversa-metastatic-bladder-cancer 2024-01-19T00:00:00+00:00 0.80 https://healthandpharma.net/1705709114Johnson-Balversa-fda.jpg FDA Grants Full Approval for Balversa to Treat Advanced or Metastatic Bladder Cancer https://healthandpharma.net/tarsier-pharma-fda-ophthalmic-solution-uveitis 2024-01-18T00:00:00+00:00 0.80 https://healthandpharma.net/1705629186Tarsier-Pharma-logo2.jpg Tarsier Pharma Secures FDA Agreement for Phase 3 Trial of Ophthalmic Solution for Uveitis https://healthandpharma.net/bioengineering-treatment-ulcerative-colitis-cancer 2024-01-17T00:00:00+00:00 0.80 https://healthandpharma.net/1705460565genetic-dna-biotech-32.jpg New Bioengineering Strategy Promises Treatment for Ulcerative Colitis and Cancer https://healthandpharma.net/fda-approval-vertex-gene-therapy-casgevy-beta-thalassemia 2024-01-17T00:00:00+00:00 0.80 https://healthandpharma.net/dna-repair-gen.jpg FDA Expands Approval of Vertex's CRISPR Therapy, Casgevy, for Beta Thalassemia https://healthandpharma.net/castle-biosciences-gene-expression-tests-skin-cancer 2024-01-16T00:00:00+00:00 0.80 https://healthandpharma.net/1706142501Castle-bio-4.jpg Castle's Innovative Gene Expression Tests Transform Clinical Decisions for Skin Cancer https://healthandpharma.net/deloitte-survey-optimism-generative-ai-adoption 2024-01-15T00:00:00+00:00 0.80 https://healthandpharma.net/1705372892Deloitte-ai-report.jpg Deloitte's Survey Uncovers Optimism and Concerns in Generative AI Adoption https://healthandpharma.net/fda-approves-keytruda-chemoradiotherapy-cervical-cancer 2024-01-13T00:00:00+00:00 0.80 https://healthandpharma.net/1705274233keytruda-merck-fda-2.jpg FDA Approves Keytruda in Combination with Chemo-radiotherapy for Cervical Cancer https://healthandpharma.net/ai-study-identifies-new-drug-targets-cancer 2024-01-12T00:00:00+00:00 0.80 https://healthandpharma.net/1705440684ai-artificial-intelligence-3.jpg AI-Assisted Study Identifies 370 Key Drug Targets for 27 Cancer Types https://healthandpharma.net/fda-first-ai-powered-alzheimers-diagnostic-test-brainsee 2024-01-12T00:00:00+00:00 0.80 https://healthandpharma.net/1705083286BrainSee-fda-3.jpg FDA Approves First AI-Powered Alzheimer's Prediction and Diagnostic Test: BrainSee https://healthandpharma.net/epfl-develop-new-class-oral-peptide-drugs 2024-01-12T00:00:00+00:00 0.80 https://healthandpharma.net/1705114188drug-labaratory-sciencist-2.jpg EPFL Scientists Develop New Class of Oral Peptide Drugs for Complex Diseases https://healthandpharma.net/bayer-askbio-gene-therapy-genephit-trial-heart-failure 2024-01-12T00:00:00+00:00 0.80 https://healthandpharma.net/1705367731Bayer-askbio-hf-1.jpg GenePHIT: Bayer and AskBio Launch Pioneering Gene Therapy Trial for Heart Failure https://healthandpharma.net/fda-no-evidence-link-glp-weight-loss-drugs-suicidal-thoughts 2024-01-11T00:00:00+00:00 0.80 https://healthandpharma.net/fda-drug-23.jpg FDA Finds No Evidence Linking GLP-1 Weight-Loss Drugs to Suicidal Thoughts https://healthandpharma.net/techsomed-biotrace-fda-denovo-clearance-ultrasound-software 2024-01-10T00:00:00+00:00 0.80 https://healthandpharma.net/1704929849Techsomed-BTIOsimulation.jpg BioTrace: First FDA-Cleared Ultrasound Software for Liver Tumor Response Prediction https://healthandpharma.net/abbvie-concertai-caris-oncology-partnership-ai 2024-01-10T00:00:00+00:00 0.80 https://healthandpharma.net/1704935386Abbvie-caris-concert-2.jpg AbbVie Joins Forces with ConcertAI and Caris in Landmark Oncology Partnership https://healthandpharma.net/fda-review-cervical-cancer-drug-tivdak-pfizer 2024-01-10T00:00:00+00:00 0.80 https://healthandpharma.net/1704940750Pfizer-Tivdak-2.jpg FDA Prioritizes Review of Cervical Cancer Drug TIVDAK Following Promising Trial Results https://healthandpharma.net/johnson-jj-acquisition-ambrx-biopharma-oncology 2024-01-09T00:00:00+00:00 0.80 https://healthandpharma.net/1704839915Johnson-jj-ambrx-logo.jpg J&J's $2 Billion Strategic Acquisition of Ambrx Biopharma: Leading in ADC Oncology https://healthandpharma.net/evolutionary-uturn-antibiotic-resistance 2024-01-08T00:00:00+00:00 0.80 https://healthandpharma.net/1704755499Evolution-Antibiotic-Resistance-3.jpg New Study Reveals Evolutionary 'U-turn' in the Fight Against Antibiotic Resistance https://healthandpharma.net/novartis-scemblix-chronic-myeloid-leukemia-treatment 2024-01-08T00:00:00+00:00 0.80 https://healthandpharma.net/1704765020Novartis-Scemblix-clm.jpg Scemblix Outperforms Standard TKIs in Phase III Chronic Myeloid Leukemia Trial https://healthandpharma.net/women-health-qvin-qpad-fda-menstrual-blood-test 2024-01-08T00:00:00+00:00 0.80 https://healthandpharma.net/1704771648Qvin-qpad.jpg Milestone in Women's Health: Qvin's QPad Gains FDA Approval for Menstrual Blood Testing https://healthandpharma.net/merck-oncology-pipeline-harpoon-therapeutics-acquisition 2024-01-08T00:00:00+00:00 0.80 https://healthandpharma.net/1704827278Merck-Harpoon-therap-4.jpg Merck's $680 Million Strategic Move to Boost Oncology Pipeline with Harpoon Acquisition https://healthandpharma.net/cancer-therapy-myc-protein 2024-01-06T00:00:00+00:00 0.80 https://healthandpharma.net/1704640858cancer-MYC-protein-5.jpg Transforming Cancer Therapy by Taming the Chaotic MYC Protein Fueling 75% of Cases https://healthandpharma.net/opening-blood-brain-barrier-ultrasound-alzheimers-drug 2024-01-06T00:00:00+00:00 0.80 https://healthandpharma.net/1704680841Ultrasound-Alzheimer-treatment-1.jpg Opening Blood-Brain Barrier with Ultrasound to Deliver Alzheimer's Drug https://healthandpharma.net/gene-therapy-results-parkinsons-disease 2024-01-05T00:00:00+00:00 0.80 https://healthandpharma.net/1704423686gene-dna-therapy-PD.jpg Pioneering Gene Therapy Shows Promising Results in Parkinson’s Disease Trial https://healthandpharma.net/schizophrenia-treatment-lyndra-weekly-oral-risperdal-pill 2024-01-05T00:00:00+00:00 0.80 https://healthandpharma.net/1704481895drug-pill-medicine-4.jpg New Era in Schizophrenia Treatment: Lyndra's Weekly Oral Pill Shows Promising Results https://healthandpharma.net/fda-ai-assisted-capsule-endoscopy-anxrobotica-proscan 2024-01-05T00:00:00+00:00 0.80 https://healthandpharma.net/1704564153AnX-Robotica-ProScan.jpg The First AI-Assisted Video Capsule Endoscopy: FDA Approves AnX Robotica's ProScan https://healthandpharma.net/novartis-largest-rlt-facility-indianapolis-pluvicto 2024-01-05T00:00:00+00:00 0.80 https://healthandpharma.net/1704573139novartis-facility-factory.jpg Novartis Launches Its Largest RLT Facility in Indianapolis, Enhancing Pluvicto Production https://healthandpharma.net/rna-puzzle-als-paradigm-neurodegenerative-disease 2024-01-04T00:00:00+00:00 0.80 https://healthandpharma.net/1704643881rnna-dna-als-7.jpg Unraveling the RNA Puzzle in ALS: A Paradigm Shift in Neurodegenerative Research https://healthandpharma.net/boehringer-ingelheim-3t-biosciences-cancer-immunotherapies 2024-01-04T00:00:00+00:00 0.80 https://healthandpharma.net/1704378550Boehringer-Ingelheim-3t.jpg Boehringer Ingelheim and 3T Forge Alliance to Advance Cancer Immunotherapies https://healthandpharma.net/abbvie-umoja-collaborate-cart-cell-therapy 2024-01-04T00:00:00+00:00 0.80 https://healthandpharma.net/1704387303AbbVie-Umoja-3.jpg AbbVie and Umoja Collaborate to Advance CAR-T Cell Therapy https://healthandpharma.net/novo-nordisk-omega-cellarity-obesity-mash-treatment 2024-01-04T00:00:00+00:00 0.80 https://healthandpharma.net/1704404479Novo-Nordisk-cellarity-omega.jpg Novo Nordisk, Omega and Cellarity Collaborate to Reshape Future of Obesity and MASH https://healthandpharma.net/boehringer-ingelheim-partners-ribo-liver-disease 2024-01-04T00:00:00+00:00 0.80 https://healthandpharma.net/1704414485Boehringer-Ingelheim-ribo-2.jpg Boehringer Ingelheim Partners with Ribo for Liver Disease Therapies in $2 Billion Deal https://healthandpharma.net/roche-medilink-therapeutics-collaborate-cancer-drug-yl211 2024-01-03T00:00:00+00:00 0.80 https://healthandpharma.net/1704248925Roche-Medilink-terapeutic-2.jpg Roche and MediLink Collaborate to Develop Next-Generation Cancer Drug YL211 https://healthandpharma.net/genetic-mitochondrial-discovery-parkinsons-disease-treatment 2024-01-03T00:00:00+00:00 0.80 https://healthandpharma.net/1704645345parkinson-dna-genetic-1.jpg Mitochondrial Discovery: A New Era in Parkinson's Prevention and Treatment https://healthandpharma.net/bloodstream-iInfection-treatment-citius-mino-lok 2024-01-03T00:00:00+00:00 0.80 https://healthandpharma.net/1704331591Citius-Mino-Lok.jpg Bloodstream Infection Treatment: Phase 3 Trial of Mino-Lok Completed https://healthandpharma.net/fda-ind-approval-remegen-rc88-ovarian-cancer-treatment 2024-01-02T00:00:00+00:00 0.80 https://healthandpharma.net/1704231671RemeGen-fda-2.jpg FDA Grants IND Approval to RemeGen's RC88 for Phase II Ovarian Cancer Treatment Trials https://healthandpharma.net/novartis-voyager-collaboration-gene-therapies 2024-01-02T00:00:00+00:00 0.80 https://healthandpharma.net/1704240182Novartis-Voyager-Therapeutic.jpg Novartis and Voyager Enter Strategic Collaboration to Advance Novel Gene Therapies https://healthandpharma.net/neurobo-submits-fda-ind-obesity-drug 2024-01-01T00:00:00+00:00 0.80 https://healthandpharma.net/1704143872NeuroBo-Pharma-FDA.jpg NeuroBo Pharmaceuticals Submits FDA IND Application for Novel Obesity Drug DA-1726 https://healthandpharma.net/astellas-elpiscience-collaborate-macrophage-cancer 2023-12-30T00:00:00+00:00 0.80 https://healthandpharma.net/1703961679Astellas-Elpiscience-logo.jpg Astellas and Elpiscience Collaborate on Bispecific Macrophage Engager for Cancer Research https://healthandpharma.net/molecular-jackhammers-eradicating-cancer-cells 2023-12-29T00:00:00+00:00 0.80 https://healthandpharma.net/1703897185Molecular-Jackhammers-cancer-cell-1.jpg Revolutionary Molecular Jackhammers: A 99% Success Rate in Eradicating Cancer Cells https://healthandpharma.net/bms-bristol-myers-ncology-rayzebio-acquisition 2023-12-27T00:00:00+00:00 0.80 https://healthandpharma.net/1703784392Bristol-BMS-RayzeBio-4.jpg Bristol Myers Squibb Expands Oncology Line with $4.1 Billion RayzeBio Acquisition https://healthandpharma.net/neuropharma-bristol-myers-squibba-acquisition-karuna 2023-12-24T00:00:00+00:00 0.80 https://healthandpharma.net/1703447627Bristol-Myers-BMS-Karuna.jpg Strategic Leap in Neuropharma: Bristol Myers' $14 Billion Acquisition of Karuna https://healthandpharma.net/fda-rare-disease-treatment-wainua-attr-pn 2023-12-23T00:00:00+00:00 0.80 https://healthandpharma.net/1703358979fda-Wainua-2.jpg A New Horizon in Rare Disease Treatment: FDA Approves Wainua for ATTR-PN https://healthandpharma.net/biontech-endometrial-cancer-drug-fda-therapy 2023-12-22T00:00:00+00:00 0.80 https://healthandpharma.net/1703294988BioNTech-FDA-3.jpg BioNTech's Endometrial Cancer Drug Receives FDA Breakthrough Therapy Designation https://healthandpharma.net/kidney-fda-approves-nefecon-nephropathy-treatment 2023-12-22T00:00:00+00:00 0.80 https://healthandpharma.net/1703303847Nefecon-FDA-everest-23.jpg FDA Approves Everest's Nefecon for IgA Nephropathy Treatment https://healthandpharma.net/johnson-fda-approval-rybrevant-lazertinib-lung-cancer 2023-12-21T00:00:00+00:00 0.80 https://healthandpharma.net/1703209357Johnson-Rybrevant-Lazertinib.jpg J&J Seeks FDA Approval for Rybrevant and Lazertinib Duo in Advanced Lung Cancer https://healthandpharma.net/thermo-fisher-corevidence-pharmacovigilance-clinical-research 2023-12-20T00:00:00+00:00 0.80 https://healthandpharma.net/1703084659Thermo-Fisher-corevidence.jpg Thermo Fisher Launches CorEvidence for Advanced Clinical Research https://healthandpharma.net/gilead-compugen-agreement-cancer-immunotherapy-licensing 2023-12-20T00:00:00+00:00 0.80 https://healthandpharma.net/1703110954Gilead-Compugen-logo-2.jpg Gilead and Compugen Collaborate on Cancer Immunotherapy in New Licensing Deal https://healthandpharma.net/mit-drug-discovery-ai-superbugs-antibiotic-resistance 2023-12-20T00:00:00+00:00 0.80 https://healthandpharma.net/1703121028ai-robot-artifical-drug-4.jpg AI Against Superbugs: MIT's Discovery of a Revolutionary New Class of Antibiotics https://healthandpharma.net/chronic-migraine-therapy-implant-device-shiratronics 2023-12-20T00:00:00+00:00 0.80 https://healthandpharma.net/1703128574ShiraTronics-Neuromodulation-Device.jpg World's First Chronic Migraine Therapy System Successfully Implanted in Six Patients https://healthandpharma.net/fda-grant-review-merck-pneumococcal-vaccine 2023-12-19T00:00:00+00:00 0.80 https://healthandpharma.net/1702994687Merck-Pneumonia-vaccine-V116-5.jpg FDA Grants Priority Review to Merck's 21-Valent Pneumococcal Vaccine V116 for Adults https://healthandpharma.net/fda-review-xolair-omalizumab-allergy-drug-approval 2023-12-19T00:00:00+00:00 0.80 https://healthandpharma.net/1703033976xolair-omalizumab-allergy.jpg FDA Prioritizes Review of Xolair: First-of-its-Kind Allergy Drug on the Brink of Approval https://healthandpharma.net/ec-european-aprove-keytruda-gastric-biliary-cancers 2023-12-18T00:00:00+00:00 0.80 https://healthandpharma.net/1702917934EU-European-C-Keytruda.jpg European Commission Greenlights KEYTRUDA for Gastric and Biliary Cancers https://healthandpharma.net/neuexcell-aav-gene-therapy-fda-orphan-drug-glioma 2023-12-18T00:00:00+00:00 0.80 https://healthandpharma.net/1702946056FDA-NeuExcell-gen-1.jpg NeuExcell's AAV Gene Therapy Granted FDA Orphan Drug Designation for Glioma https://healthandpharma.net/medtronic-pulseselect-pfa-system-fda-atrial-fibrillation 2023-12-15T00:00:00+00:00 0.80 https://healthandpharma.net/1702654406Medtronic-PulseSelect-PFA-System.jpg Medtronic's PulseSelect PFA System Earns FDA Approval for Atrial Fibrillation Treatment https://healthandpharma.net/neurosense-primec-als-progression-treatment 2023-12-15T00:00:00+00:00 0.80 https://healthandpharma.net/1702681638als-drug-discovery-1.jpg PARADIGM Trial: PrimeC Demonstrates 37.4% Reduction in ALS Progression https://healthandpharma.net/plant-based-diets-kidney-health-mortality-reduction 2023-12-15T00:00:00+00:00 0.80 https://healthandpharma.net/1702694233Plant-kidney-Diets-5.jpg Plant-Based Diets for Kidney Health: Lead to 26% Mortality Risk Reduction in CKD https://healthandpharma.net/depixus-daiichi-sankyo-collaborate-rna-drug-discovery 2023-12-14T00:00:00+00:00 0.80 https://healthandpharma.net/1702568963depixus-daiichi-2.jpg Depixus and Daiichi Sankyo Collaborate to Accelerate RNA-targeted Drug Discovery https://healthandpharma.net/merck-moderna-keytruda-mrna-combo-melanoma-treatment 2023-12-14T00:00:00+00:00 0.80 https://healthandpharma.net/1702604837Merck-Keytruda-moderna-mrna.jpg KEYTRUDA Combo Show Promise in Melanoma Treatment, Reducing Death Risks by 49% https://healthandpharma.net/novartis-kisqali-reduction-breast-cancer-treatment-recurrence 2023-12-13T00:00:00+00:00 0.80 https://healthandpharma.net/1702480929kisqali-ribociclib-novartis-2.jpg NATALEE Trial: Novartis' Kisqali Achieves 25% Reduction in Breast Cancer Recurrence Risk https://healthandpharma.net/kyverna-drug-fda-myasthenia-gravis-reatment 2023-12-13T00:00:00+00:00 0.80 https://healthandpharma.net/1702502548Kyverna-KYV101.jpg Kyverna's New Drug KYV-101 Granted FDA Fast Track Designation for Myasthenia Gravis https://healthandpharma.net/fda-amgen-tarlatamab-small-cell-lung-cancer-treatment 2023-12-13T00:00:00+00:00 0.80 https://healthandpharma.net/1702511994lung-cancer-234.jpg FDA Grants Priority Review to Amgen's Tarlatamab: A New Hope for Small Cell Lung Cancer https://healthandpharma.net/servier-tibsovo-ash-acute-myeloid-leukemia-treatment 2023-12-12T00:00:00+00:00 0.80 https://healthandpharma.net/1702394211Servier-Tibsovo-Logo-4.jpg Servier Unveils Tibsovo Data at ASH Meeting: Acute Myeloid Leukemia Treatment https://healthandpharma.net/idecabtagene-multiple-myeloma-abecma 2023-12-12T00:00:00+00:00 0.80 https://healthandpharma.net/1702405598BMS-Abecma-2.jpg New Hope in the Fight Against Multiple Myeloma: Abecma Shows Promising Results https://healthandpharma.net/ai-artificial-intelligence-skin-scanning-diabetes-diagnosis 2023-12-12T00:00:00+00:00 0.80 https://healthandpharma.net/1702433464diabetes-ai-scine-scan.jpg AI-Supported Skin Scanning Revolutionizes Diabetes Diagnosis and Monitoring https://healthandpharma.net/biotech-artificial-cell-life-deliver-drugs 2023-12-11T00:00:00+00:00 0.80 https://healthandpharma.net/1702264301Artificial-Cell-2.jpg New Era in Biotech: Revolutionary Artificial Cells Could Mimic Life and Deliver Drugs https://healthandpharma.net/adcetris-brentuximab-immunotherapy-hodgkin-lymphoma 2023-12-11T00:00:00+00:00 0.80 https://healthandpharma.net/1702315461Seagen-Adcetris-2.jpg Adcetris Plus Immunotherapy Shows Remarkable Results for Hodgkin Lymphoma https://healthandpharma.net/lilly-zepbound-tirzepatide-weight-loss-obesity 2023-12-11T00:00:00+00:00 0.80 https://healthandpharma.net/1702345322lilly-Zepbound-logo-33.jpg Lilly's Zepbound Demonstrates Efficacy in Weight Loss with a 26% Reduction https://healthandpharma.net/als-treatment-nurown-fda-brainstorm 2023-12-10T00:00:00+00:00 0.80 https://healthandpharma.net/1702244315Nurown-als.jpg A New Phase in ALS Treatment: NurOwn Enters a Crucial Stage Following FDA Meeting https://healthandpharma.net/fda-medical-imaging-ai-driven-xray-chest-screening 2023-12-09T00:00:00+00:00 0.80 https://healthandpharma.net/1702137372bravecx-ai-xray-1.jpg A New Frontier in Medical Imaging: FDA Approves AI-Driven X-Ray for Chest Screening https://healthandpharma.net/zanidatamab-trial-metastatic-breast-cancer-treatment 2023-12-09T00:00:00+00:00 0.80 https://healthandpharma.net/1702149659Zanidatamab-cancer.jpg Zanidatamab Trial Marks Major Advance in Treatment of Metastatic Breast Cancer https://healthandpharma.net/astrazeneca-abelzeta-developcart-cancer-therapy-china 2023-12-09T00:00:00+00:00 0.80 https://healthandpharma.net/1702178559astra-abel-cart-2.jpg AstraZeneca and AbelZeta Jointly Co-Develop CAR-T Cancer Therapy in China https://healthandpharma.net/menarini-orserdu-elacestrant-breast-cancer-treatment 2023-12-08T00:00:00+00:00 0.80 https://healthandpharma.net/1702061430Menarini-Stemline-3.jpg Emerald Study: Menarini's Orserdu Offers Hope for ER+ Breast Cancer Patients https://healthandpharma.net/fda-approve-casgevy-crispr-gene-therapy-sickle-cell-disease 2023-12-08T00:00:00+00:00 0.80 https://healthandpharma.net/1702081483dna-genetic-crispr-2.jpg FDA Approves, First CRISPR Gene Therapy, Casgevy, for Sickle Cell Disease https://healthandpharma.net/merck-acceleration-scientific-discovery-open-source-ai 2023-12-07T00:00:00+00:00 0.80 https://healthandpharma.net/1702000284ai-artificial-intelligence-merck.jpg Merck and Acceleration Collaborate to Revolutionize Scientific Discovery with AI https://healthandpharma.net/fda-breakthrough-designation-johnson-tar-bladder-cancer 2023-12-06T00:00:00+00:00 0.80 https://healthandpharma.net/1701885545FDA-logo-Johnson.jpg FDA Grants Breakthrough Designation to J&J's TAR-200 for Bladder Cancer https://healthandpharma.net/fda-approval-fabhalta-pnh-treatment-blood-disorder 2023-12-06T00:00:00+00:00 0.80 https://healthandpharma.net/1701906393novartis-Fabhalta-4.jpg FDA Approval to Fabhalta: A New Era in Treatment of the Rare Blood Disorder PNH https://healthandpharma.net/abbvie-acquisition-cerevel-therapeutics-neuroscience 2023-12-06T00:00:00+00:00 0.80 https://healthandpharma.net/1701915321AbbVie-cerevel-logo-3.jpg AbbVie's Giant Move in Neuroscience: $8.7 Billion Acquisition of Cerevel https://healthandpharma.net/zepbound-tirzepatide-available-us-pharmacies-obesity 2023-12-05T00:00:00+00:00 0.80 https://healthandpharma.net/1701783777eli-lilly-Zepbound-loog.jpg After FDA Approval, Zepbound Available in US Pharmacies for Battling Obesity https://healthandpharma.net/pfizer-positive-outcomes-obesity-drug-danuglipron 2023-12-05T00:00:00+00:00 0.80 https://healthandpharma.net/1701813492Pfizer-drug.jpg Pfizer Announces Positive Phase 2b Outcomes for Obesity Drug Candidate, Danuglipron https://healthandpharma.net/roche-reports-inavolisib-combo-breast-cancer-treatment 2023-12-05T00:00:00+00:00 0.80 https://healthandpharma.net/1697754406roche-logo-headquarter-3.jpg Roche Reports Remarkable Advancement for Inavolisib Combo in Breast Cancer https://healthandpharma.net/everest-nmpa-zetomipzomib-lupus-nephritis-treatment 2023-12-04T00:00:00+00:00 0.80 https://healthandpharma.net/1701701762Everest-Zetomipzomib.jpg China's NMPA Accepts Everest's Zetomipzomib for Treatment of Lupus Nephritis https://healthandpharma.net/biohaven-epilepsy-drug-bhv-aes-meeting 2023-12-04T00:00:00+00:00 0.80 https://healthandpharma.net/1701730860biohaven-bvh-logo-4.jpg Biohaven Presents Promising Data for new epilepsy drug BHV-7000 at AES 2023 https://healthandpharma.net/roche-obesity-drug-market-acquisition-carmot-therapeutics 2023-12-04T00:00:00+00:00 0.80 https://healthandpharma.net/1701217771Roche-flag-logo-1.jpg Roche's Strong Entry into Obesity Market Through $2.7 B Acquisition of Carmot https://healthandpharma.net/astellas-fezolinetant-menopause-vms-hormones-veozah 2023-12-02T00:00:00+00:00 0.80 https://healthandpharma.net/1701610567vms-menopause-32.jpg Astellas' Fezolinetant Offers New Hope for Menopause VMS Without Hormones https://healthandpharma.net/psychogenics-roche-agreement-neuropsychiatric-treatment 2023-12-02T00:00:00+00:00 0.80 https://healthandpharma.net/1701966447Roche-Psych-Gen-2.jpg PsychoGenics and Roche Agreement Advances Neuropsychiatric Treatments https://healthandpharma.net/fda-priority-merck-keytruda-padcev-urothelial-cancer 2023-12-01T00:00:00+00:00 0.80 https://healthandpharma.net/1701443386Merck-Keytruda-Padcev-astellas-3.jpg FDA Grants Priority Review to Keytruda & Padcev Combination for Urothelial Cancer https://healthandpharma.net/everest-medicine-etrasimod-ulcerative-colitis 2023-12-01T00:00:00+00:00 0.80 https://healthandpharma.net/1701452491Everest-Etrasimod-velsipity.jpg Everest's Etrasimod Shows Promising Results in P3 Trial for Ulcerative Colitis https://healthandpharma.net/dravet-syndrome-treatment-stoke-therapeutics-stk 2023-12-01T00:00:00+00:00 0.80 https://healthandpharma.net/1701474259Stoke-Therapeutics-Dravet-Syndrome.jpg Promising Treatment for Dravet Syndrome: Stoke's STK-001 Shows Potential https://healthandpharma.net/fda-approves-jaypirca-chronic-leukemias-treatment 2023-12-01T00:00:00+00:00 0.80 https://healthandpharma.net/1701483399Lilly-Jaypirca-pirtobrutinib-logo.jpg FDA Approves Jaypirca: A Game Changer in Treating Chronic Leukemias and SLL https://healthandpharma.net/abbvie-cancer-therapy-immunogen-acquisition 2023-11-30T00:00:00+00:00 0.80 https://healthandpharma.net/1701351557abbvie-immunogen-elahere-logo.jpg AbbVie's Bold Leap into Cancer Therapy with $10 Billion ImmunoGen Acquisition https://healthandpharma.net/eli-lilly-prism-biolab-alliance-drug-discovery 2023-11-30T00:00:00+00:00 0.80 https://healthandpharma.net/1701367692eli-lilly-Prism-logo.jpg Eli Lilly and PRISM BioLab Forge a $660 Million Strategic Alliance in Drug Discovery https://healthandpharma.net/bd-siterite-vascular-ultrasound-system 2023-11-30T00:00:00+00:00 0.80 https://healthandpharma.net/1701387622BD-SiteRite-9.jpg BD Launches Vascular Access Ultrasound System to Enhance Clinician Efficiency https://healthandpharma.net/acoustic-ai-model-detecting-depression 2023-11-29T00:00:00+00:00 0.80 https://healthandpharma.net/1701286148Ai-Depression-Detection-1.jpg New Acoustic AI Model Achieves 83% Accuracy in Detecting Depression https://healthandpharma.net/fda-ogsiveo-treatment-desmoid-tumors 2023-11-29T00:00:00+00:00 0.80 https://healthandpharma.net/1701303562Ogsiveo-nirogacestat-logo.jpg FDA Approves Ogsiveo as the First and Only Treatment for Rare Desmoid Tumors https://healthandpharma.net/amgen-amazon-aws-drug-manufacturing-ai 2023-11-29T00:00:00+00:00 0.80 https://healthandpharma.net/1701306644amgen-amazon-logo-1.jpg Amgen and Amazon Collaborate to Transform Drug Manufacturing with Power of AI https://healthandpharma.net/ozempic-diabetes-semaglutide-alcohol-use-disorder 2023-11-28T00:00:00+00:00 0.80 https://healthandpharma.net/1701134096ozempic-Semaglutide-2.jpg Novel Study Suggests Wegovy May Reduce Alcohol Use Disorder Symptoms https://healthandpharma.net/merck-pneumococcal-vaccine-pneumonia-v116-stride-trail 2023-11-28T00:00:00+00:00 0.80 https://healthandpharma.net/1701388813Pneumonia-vaccine-V116-Merck-3.jpg A New Frontier in Pneumococcal Vaccination: Merck's V116 Shows Promising Results https://healthandpharma.net/fda-brainspec-ai-mrs-brain-tumor-diagnosis 2023-11-28T00:00:00+00:00 0.80 https://healthandpharma.net/1701202453BrainSpec-logo-32.jpg FDA Clears BrainSpec's AI-Powered MRS Platform for Brain Disease Diagnosis https://healthandpharma.net/roche-hepatitis-b-elecsys-test-diagnosis 2023-11-28T00:00:00+00:00 0.80 https://healthandpharma.net/1701217994roche-logo-32.jpg Roche's Breakthrough Hepatitis B Test Revolutionizes Diagnosis and Monitoring https://healthandpharma.net/china-kras-inhibitor-gfh-review-nmpa-lung-cancer 2023-11-27T00:00:00+00:00 0.80 https://healthandpharma.net/1701093053GenFleet-Therapeutics-cancer.jpg China’s First KRAS Inhibitor GFH925 Receives Priority Review for Lung Cancer https://healthandpharma.net/stem-cells-decide-discovery-cancer-research 2023-11-27T00:00:00+00:00 0.80 https://healthandpharma.net/1701112085stem-cell-cartoon.jpg How do stem cells decide their fate? A Game-Changer Discovery in Cancer Research https://healthandpharma.net/gsk-blenrep-dreamm-trial-multiple-myeloma-treatment 2023-11-27T00:00:00+00:00 0.80 https://healthandpharma.net/1701126931gsk-Blenrep-logo-2.jpg GSK's Blenrep Makes a Comeback with DREAMM-7 Trial for Multiple Myeloma Treatment https://healthandpharma.net/soft-supercapacitors-implantable-medical-devices 2023-11-26T00:00:00+00:00 0.80 https://healthandpharma.net/1701030390implantable-medikal-device-2.jpg How Soft Supercapacitors Could Transform the Future of Implantable Medical Devices? https://healthandpharma.net/engineered-iImmunotherapy-cancer-treatments 2023-11-25T00:00:00+00:00 0.80 https://healthandpharma.net/1700926453immune-cancer-cell-1.jpg Engineered Immunotherapy Shows Promise in Cancer Treatments https://healthandpharma.net/nefecon-approval-china-iga-nephropathy-kidney 2023-11-24T00:00:00+00:00 0.80 https://healthandpharma.net/1700855682kidney-nephropathy-23.jpg Nefecon Receives Approval in China Offering New Hope to IgA Nephropathy Patients https://healthandpharma.net/ai-model-antibiotic-resistance-bacteria 2023-11-24T00:00:00+00:00 0.80 https://healthandpharma.net/1700866845microbes-bacterium-ai-5.jpg New AI Model Detects Antibiotic Resistance with Over 80% Accuracy https://healthandpharma.net/novo-nordisk-drug-supply-expansion-in-france 2023-11-23T00:00:00+00:00 0.80 https://healthandpharma.net/1700844093novo-nordisk-factory-3.jpg Novo Nordisk Boosts Global Drug Supply with $2.3 Billion Expansion in France https://healthandpharma.net/janssen-rybrevant-amivantamab-lung-cancer-fda 2023-11-21T00:00:00+00:00 0.80 https://healthandpharma.net/1700574975Janssen-Rybrevant-logo2.jpg Janssen's Rybrevant Promises Hope for NSC Lung Cancer Patients and Applies to the FDA https://healthandpharma.net/artificial-intelligence-ai-iron-ovarian-cancer-therapy 2023-11-20T00:00:00+00:00 0.80 https://healthandpharma.net/1700491257ovarian-cancer-ai-3.jpg New AI Model Predicts Ovarian Cancer Therapy Success with 80% Accuracy https://healthandpharma.net/alzheimer-research-human-neurons-stem-cells 2023-11-20T00:00:00+00:00 0.80 https://healthandpharma.net/1700520493neurons-brain-cells-3.jpg Milestone in Alzheimer's Research: Human Neurons Generated from Stem Cells https://healthandpharma.net/efineptakin-fda-orphan-drug-approval-acute-radiation 2023-11-20T00:00:00+00:00 0.80 https://healthandpharma.net/1700523439FDA-Approved-orphan.jpg Efineptakin Alfa Gains FDA Orphan Drug Approval for Acute Radiation Syndrome https://healthandpharma.net/eli-lilly-expand-injectable-manufacturing-facility-germany 2023-11-18T00:00:00+00:00 0.80 https://healthandpharma.net/1700307190eli-lilly-logo.jpg Lilly Expands Injectable Manufacturing Capacity with $2.5 Billion Facility in Germany https://healthandpharma.net/truqap-capivasertib-fda-approval-breast-cancer-treatment 2023-11-18T00:00:00+00:00 0.80 https://healthandpharma.net/1700320394FDA-truqap-Astrazeneca-1.jpg AstraZeneca's Truqap Gets FDA Approval for Combined Breast Cancer Treatment https://healthandpharma.net/ai-use-satellite-imaging-cancer-treatment 2023-11-18T00:00:00+00:00 0.80 https://healthandpharma.net/1700345757satalite-ai-world-2.jpg Revolutionary AI Approach Uses Satellite Imaging for Personalized Cancer Treatment https://healthandpharma.net/immune-cell-diversity-flu-battle-vaccine-strategies 2023-11-18T00:00:00+00:00 0.80 https://healthandpharma.net/1700425774immun-cell-flue.jpg Immune Cell Diversity Could Revolutionize Flu Battle and Vaccine Strategies https://healthandpharma.net/casgevy-uk-approves-gene-editing-crispr-treatment-blood-disorders 2023-11-17T00:00:00+00:00 0.80 https://healthandpharma.net/gene-therapy-mrna-1.jpg Casgevy: UK Approves World-First Gene-Editing CRISPR Treatment for Blood Disorders https://healthandpharma.net/fda-approves-xtandi-enzalutamide-prostate-cancer-treatment 2023-11-17T00:00:00+00:00 0.80 https://healthandpharma.net/1700252381Pfizer-Astellas-Xtandi-2.jpg FDA Approves Xtandi (enzalutamide) for Earlier Stage Prostate Cancer Treatment https://healthandpharma.net/bmbs-bristol-myers-augtyro-fda-lung-cancer-treatment 2023-11-17T00:00:00+00:00 0.80 https://healthandpharma.net/1700351005BMS-Augtyro-repotrectini.jpg Bristol Myers Squibb's Augtyro Receives FDA Approval for Targeted Lung Cancer Treatment https://healthandpharma.net/clia-validates-mammogen-gentru-breast-cancer-detection 2023-11-16T00:00:00+00:00 0.80 https://healthandpharma.net/1700093609test-tube-labaratory-dna-2.jpg Mammogen Unveils CLIA-Validated genTRU-breast for Breast Cancer Detection https://healthandpharma.net/sustained-therapeutics-trial-rare-cancer-treatment 2023-11-16T00:00:00+00:00 0.80 https://healthandpharma.net/1700151007Sustained-patient-doctor-2.jpg Sustained Therapeutics Launches Innovative Phase II/III trial for Rare Cancer Treatment https://healthandpharma.net/ai-collaboration-postera-amgen-drug-discovery 2023-11-16T00:00:00+00:00 0.80 https://healthandpharma.net/1700168523amgen-postera-logo-3.jpg AI Collaboration: PostEra and Amgen Team Up for Next-Gen Drug Discovery https://healthandpharma.net/pfizer-biontech-covid-vaccine-wins-prix-galien-award 2023-11-16T00:00:00+00:00 0.80 https://healthandpharma.net/1700170720Pfizer-BioNTech-awarded2023.jpg Pfizer and BioNTech's COVID-19 Vaccine Wins Prestigious Prix Galien Canada Award https://healthandpharma.net/natera-merck-cancer-molecular-signatera-test 2023-11-16T00:00:00+00:00 0.80 https://healthandpharma.net/1704824964Merck-Natera-3.jpg Natera and Merck's Partnership: Revolutionizing Cancer Research with Signatera Test https://healthandpharma.net/lexogen-luthor-hd-single-cell-transcriptomic-analysis 2023-11-15T00:00:00+00:00 0.80 https://healthandpharma.net/1700082904Lexogen-logo2.jpg Lexogen Unveils LUTHOR HD: A New Horizon in Single-Cell Transcriptomic Analysis https://healthandpharma.net/fda-approves-chlamydia-gonorrhea-test-letsget-checked 2023-11-15T00:00:00+00:00 0.80 https://healthandpharma.net/1700087490Lets-Gonorrhea-Test-Kits-2.jpg FDA Approves First At-Home Chlamydia and Gonorrhea Test, Revolutionizing Screening https://healthandpharma.net/university-miami-integrates-aidoc-health-system-patient-care 2023-11-14T00:00:00+00:00 0.80 https://healthandpharma.net/1700001160digital-hospital-ai-health-1.jpg University of Miami Integrates AI into Its Health System to Maximize Patient Care https://healthandpharma.net/anthos-abelacimab-blood-thinner-af-patients 2023-11-14T00:00:00+00:00 0.80 https://healthandpharma.net/1700065886Abelacimab-Anthos-study.jpg Anthos' Blood Thinner Abelacimab Outperforms Rivals in Safety by 67% in AF Patients https://healthandpharma.net/sep-strategies-sepsis-care-cms-reimbursement-policies 2023-11-13T00:00:00+00:00 0.80 https://healthandpharma.net/1699899431hospital-patient-intensive-care-4.jpg Beyond SEP-1: Evolving Strategies in Sepsis Care and CMS Reimbursement Policies https://healthandpharma.net/novartis-legend-biotech-deal-cart-therapy-lung-cancer 2023-11-13T00:00:00+00:00 0.80 https://healthandpharma.net/1699991735novartis-legend-logo-2.jpg Novartis and Legend Biotech Strike $1 Billion Deal on CAR-T Therapy for Lung Cancer https://healthandpharma.net/ai-cancer-treatment-bayer-recursion 2023-11-12T00:00:00+00:00 0.80 https://healthandpharma.net/1699744418Bayer-recursion-Logo-1.jpg Revolutionizing Cancer Treatment with AI: Bayer and Recursion's $1.5B Collaboration https://healthandpharma.net/protein-marker-sdf-gastric-cancer-detection 2023-11-12T00:00:00+00:00 0.80 https://healthandpharma.net/1699827612test-labaratory-tubes-3.jpg New SDF-4 Tumor Marker Revolutionizes Early Cancer Detection with 89% Accuracy https://healthandpharma.net/select-trail-heart-benefit-wegovy-semaglutide-weight-loss 2023-11-12T00:00:00+00:00 0.80 https://healthandpharma.net/1699887056Wegovy-drug-heart-2.jpg Landmark Study Shows Comprehensive Heart Benefits of Wegovy Beyond Weight Loss https://healthandpharma.net/cellular-atlas-personalized-medicine-rheumatoid-arthritis-treatment 2023-11-11T00:00:00+00:00 0.80 https://healthandpharma.net/1699730140RA-Rheumatoid-Arthritis-2.jpg New Cellular Atlas Promises Personalized Medicine in Rheumatoid Arthritis Treatment https://healthandpharma.net/fda-approves-takedas-adzynma-treatment-rare-blood-disorder 2023-11-10T00:00:00+00:00 0.80 https://healthandpharma.net/1699651780takeda-fda-adzynma-1.jpg FDA Approves Takeda's Adzynma as First Treatment for Rare Blood Disorder https://healthandpharma.net/novo-nordiski-biilon-investment-obesity-drug-production 2023-11-10T00:00:00+00:00 0.80 https://healthandpharma.net/1699974470novo-nordisk-flag-3.jpg Novo Nordisk's $6 Billion Investment in Obesity Drug Production Amid Rising Global Demand https://healthandpharma.net/bioelectronic-sensor-implant-organ-rejection-detection 2023-11-09T00:00:00+00:00 0.80 https://healthandpharma.net/1699555466kidney-organ-implant-5.jpg Revolutionary Wireless Bioelectronic Implant Detects Early Signs of Organ Rejection https://healthandpharma.net/fda-approves-takeda-fruzaqla-fruquintinib-metastatic-colorectal-cancer 2023-11-09T00:00:00+00:00 0.80 https://healthandpharma.net/1699715380Metastatic-Colorectal-Cancer-2.jpg FDA Approves Takeda's FRUZAQLA as Novel Therapy for Metastatic Colorectal Cancer https://healthandpharma.net/opinium-martin-sandhu-service-design-digital-hospitals 2023-11-08T00:00:00+00:00 0.80 https://healthandpharma.net/1699567732digital-hospital-6.jpg How a service design approach can make digital hospitals a reality? https://healthandpharma.net/precisedx-ai-digital-test-breast-cancer-recurrence 2023-11-07T00:00:00+00:00 0.80 https://healthandpharma.net/1699369610ai-brest-cancer-1.jpg PreciseDx's New AI-Powered Digital Test Predicts Early Breast Cancer Recurrence https://healthandpharma.net/bergenbio-trial-bemcentinib-keytruda-lung-cancer 2023-11-06T00:00:00+00:00 0.80 https://healthandpharma.net/1699259457lung-cancer-54.jpg BerGenBio's Trial Shows Promise for Bemcentinib and KEYTRUDA in Lung Cancer https://healthandpharma.net/recombinant-anthrax-vaccine-gc-biopharma-approval 2023-11-06T00:00:00+00:00 0.80 https://healthandpharma.net/1699266980Anthrax-Vaccine-Biopharma-1.jpg World's First Recombinant Anthrax Vaccine: GC Biopharma Applies for Approval https://healthandpharma.net/boehringer-klinrisk-ai-model-kidney-disease 2023-11-06T00:00:00+00:00 0.80 https://healthandpharma.net/1699280541ai-artifical-kidney-1.jpg Klinrisk: A Breakthrough AI Model Predicting Kidney Disease Progression for Millions https://healthandpharma.net/bms-bristol-myers-oncology-orum-therapeutics 2023-11-06T00:00:00+00:00 0.80 https://healthandpharma.net/1699360762BMS-logo-2.jpg BMS Expands Oncology Portfolio with $180M Orum Therapeutics Deal https://healthandpharma.net/boehringer-ingelheim-trial-drug-chronic-kidney-disease 2023-11-04T00:00:00+00:00 0.80 https://healthandpharma.net/1699115391kidney-drug-2.jpg Boehringer Ingelheim's P-II Trial Sparks Hope for Chronic Kidney Disease Patients https://healthandpharma.net/kyverna-charite-join-forces-treatment-autoimmune-diseases 2023-11-03T00:00:00+00:00 0.80 https://healthandpharma.net/1699047831Kyverna-Therapeutics-chartite.jpg Kyverna and Charité Join Forces to Revolutionize Autoimmune Disease Treatments https://healthandpharma.net/krazati-uk-mhra-approval-lung-cancer-treatment 2023-11-03T00:00:00+00:00 0.80 https://healthandpharma.net/1699052621Krazati-cancer-drug-2.jpg Innovative Cancer Drug Krazati Wins UK Approval for Lung Cancer Treatment https://healthandpharma.net/deep-sleep-protect-against-dementia 2023-11-02T00:00:00+00:00 0.80 https://healthandpharma.net/1699039007sleep-dementia-old-1.jpg Landmark Study Shows Improving Deep Sleep May Protect Against Dementia https://healthandpharma.net/high-insulin-levels-risk-pancreatic-cancer 2023-11-01T00:00:00+00:00 0.80 https://healthandpharma.net/1698854952insulin-pancreatic-cancer-4.jpg High Insulin Levels in Diabetes Increase Risk of Pancreatic Cancer https://healthandpharma.net/lexaria-diabetes-obesity-drug-delivery-technology 2023-10-31T00:00:00+00:00 0.80 https://healthandpharma.net/1698792203lexaria-logo-1.jpg Lexaria Targets Rising Diabetes and Obesity with Innovative Drug Delivery https://healthandpharma.net/innovent-obesity-drug-mazdutide-treatment 2023-10-30T00:00:00+00:00 0.80 https://healthandpharma.net/medicine-pill-tablets-drug-ilac-36.jpg Innovent's Obesity Drug, Mazdutide, Could Be a Game-Changer in Obesity Treatment https://healthandpharma.net/drug-artificial intelligence-gastric-acid-treatment-ai 2023-10-30T00:00:00+00:00 0.80 https://healthandpharma.net/1698668446ai-drug-deep-quartet-1.jpg Scientists Have Developed Next-Generation Drug with AI Collaboration https://healthandpharma.net/ruby-trial-gsk-jemperli-endometrial-cancer-patients 2023-10-30T00:00:00+00:00 0.80 https://healthandpharma.net/1698680631Gsk-jemperli-logo-3.jpg GSK's Jemperli Shows Promise in Extending Life for Endometrial Cancer Patients https://healthandpharma.net/novartis-atrasentan-kidney-disease-trial 2023-10-30T00:00:00+00:00 0.80 https://healthandpharma.net/1698683951novartis-logo-42.jpg Novartis's Atrasentan Achieves Positive Results in Phase 3 Kidney Disease Trial https://healthandpharma.net/cd95-receptor-cancer-cell-self-destruction-solid-tumor 2023-10-29T00:00:00+00:00 0.80 https://healthandpharma.net/1698596776cart-cancer-apoptosis-5.jpg UC Davis Scientists Discover 'Death Switch' to Triggering Cancer Cell Self-Destruction https://healthandpharma.net/dynein-discovery-curb-metastasis-paralyzing-cancer 2023-10-28T00:00:00+00:00 0.80 https://healthandpharma.net/1698615907cancer-dynein.jpg Revolutionary Dynein Discovery Could Curb Metastasis by Paralyzing Cancer Cells https://healthandpharma.net/eli-lilly-omvoh-mirikizumab-fda-approve-ulcerative-colitis-treatment 2023-10-27T00:00:00+00:00 0.80 https://healthandpharma.net/1698362772eli-lilly-omvoh-logo.jpg Eli Lilly's Omvoh Gets FDA Nod: A New Era for Ulcerative Colitis Treatment https://healthandpharma.net/genetic-research-migraine-treatment 2023-10-27T00:00:00+00:00 0.80 https://healthandpharma.net/1698526880Migraine-pain-head-3.jpg Large Genetic Research Promises New Pathways for Migraine Treatment https://healthandpharma.net/pfizer-biontech-report-combined-influenza-covid-vaccine 2023-10-26T00:00:00+00:00 0.80 https://healthandpharma.net/1698352529pfizer-BioNTech-logo-2.jpg Pfizer and BioNTech Report Positive Results for Combined Influenza and COVID-19 Vaccine https://healthandpharma.net/fda-approves-tibsovo-rare-blood-cancers-msd 2023-10-25T00:00:00+00:00 0.80 https://healthandpharma.net/1700591542Servier-Tibsovo-fda-logo.jpg FDA Approves Servier's Tibsovo as First Targeted Therapy for Rare Blood Cancer: MDS https://healthandpharma.net/keytruda-plus-lenvima-long-survival-benefits-kidney-cancer 2023-10-25T00:00:00+00:00 0.80 https://healthandpharma.net/1698239115keytruda-lenvima-logo-3.jpg Keytruda Plus Lenvima Shows Long Term Survival Benefits for Kidney Cancer https://healthandpharma.net/abvac40-results-araclon-alzheimer-disease-vaccine 2023-10-25T00:00:00+00:00 0.80 https://healthandpharma.net/1698271414alzheimers-neuron-4.jpg Promising ABvac40 P2 Results: Araclon's Alzheimer's Vaccine Slows Disease Progression https://healthandpharma.net/innocan-pharma-cannabidiol-fda-approval-liposomal-cbd 2023-10-24T00:00:00+00:00 0.80 https://healthandpharma.net/1698101425Innocan-Pharma-Logo.jpg Innocan Pharma's New Discovery Bolsters cannabidiol Research https://healthandpharma.net/european-cervical-cancer-screening-market 2023-10-24T00:00:00+00:00 0.80 https://healthandpharma.net/1698143192cervical-cancer-screening.jpg EU Cervical Cancer Screening Market is projected to reach US$ 11.4 Billion by 2028 https://healthandpharma.net/eu-approve-enhertu-lung-cancer-treatment 2023-10-24T00:00:00+00:00 0.80 https://healthandpharma.net/1698165188AstraZ-DaiichiS-Enhertu-2.jpg EU Commission Approves Enhertu: A New Hope for Lung Cancer treatment https://healthandpharma.net/braincheck-device-alzheimer-cognitive-screening 2023-10-24T00:00:00+00:00 0.80 https://healthandpharma.net/1698173716Brain-Check-Logo.jpg BrainCheck Aims to Revolutionize Alzheimer's Cognitive Screening https://healthandpharma.net/biontech-carvac-rna-vaccine-results-solid-tumor-treatment 2023-10-23T00:00:00+00:00 0.80 https://healthandpharma.net/1698095003esmo-2023-Biontech-1.jpg ESMO 2023: BioNTech Unveils Groundbreaking Results for Solid Tumor Treatment https://healthandpharma.net/esmo-gsk-jemperli-merck-keytruda-lung-cancer-treatment 2023-10-23T00:00:00+00:00 0.80 https://healthandpharma.net/esmo-2023-jemperli.jpg ESMO 2023 Highlights: GSK's Jemperli Challenges Merck's Keytruda's in Lung Cancer https://healthandpharma.net/novartis-pluvicto-prostate-cancer-trials-questions 2023-10-23T00:00:00+00:00 0.80 https://healthandpharma.net/1698089499esmo-novartis-Pluvicto-1.jpg ESMO 2023: Novartis' Pluvicto Shows Promising Results in Prostate Ca. Trials https://healthandpharma.net/ketamine-vs-placebo-expectations-depression-treatment 2023-10-22T00:00:00+00:00 0.80 https://healthandpharma.net/1697930837Ketamine-Placebo-Depression-2.jpg Stanford Study Underline the Power of Expectations in Depression Treatment https://healthandpharma.net/fda-pfizer-penbraya-vaccine-prevent-meningitis 2023-10-22T00:00:00+00:00 0.80 https://healthandpharma.net/1697976033Pfizer-Penbraya-vaccine-2.jpg FDA approves Pfizer’s Penbraya: The first vaccine to prevent all types of meningitis https://healthandpharma.net/agenus-sarcoma-treatment-botensilimab-balstilimab-esmo-congress 2023 2023-10-22T00:00:00+00:00 0.80 https://healthandpharma.net/1698011187esmo-2023-logo-2.jpg Agenus' New Sarcoma Treatment Presents Promising Results at ESMO Congress 2023 https://healthandpharma.net/oncolytic-virus-gene-therapy-survival-brain-cancer-glioblastoma 2023-10-20T00:00:00+00:00 0.80 https://healthandpharma.net/1697816133gen-oncolytic-Virus-32.jpg Oncolytic Virus-Based Gene Therapy Enhances Survival in Brain Cancer https://healthandpharma.net/ai-artificial-intelligence-malaria-drug-osteoporosis 2023-10-20T00:00:00+00:00 0.80 https://healthandpharma.net/1697833494ai-artifical-robot-labratory-1.jpg New AI-Driven Discovery: Malaria Drug Reverses Bone Loss in Osteoporosis https://healthandpharma.net/bms-subcutaneous-opdivo-nivolumab-kidney-cancer-treatment 2023-10-20T00:00:00+00:00 0.80 https://healthandpharma.net/1697838153opdivo-nivolumab-bms-logo-4.jpg BMS's Subcutaneous Opdivo Shows Promise in Kidney Cancer Treatment https://healthandpharma.net/midbody-cell-remnants-cancer-spread 2023-10-19T00:00:00+00:00 0.80 https://healthandpharma.net/1697701650division-cell-tumor.jpg New Discovery: Are Cell Division Remnants the Hidden Facilitators of Cancer Spread? https://healthandpharma.net/stanford-discover-anti-aging-enzyme-muscle-weakness 2023-10-19T00:00:00+00:00 0.80 https://healthandpharma.net/1697731038experiment-mice-mouse-2.jpg Stanford Researchers Discover Anti-Aging Enzyme and Drug Candidate https://healthandpharma.net/ultimovacs-cancer-vaccine-survival-bms-combo-trial 2023-10-19T00:00:00+00:00 0.80 https://healthandpharma.net/1697749130Cancer-Vaccine-injection-2.jpg Ultimovacs' Cancer Vaccine Demonstrates Survival Benefits in BMS Combo Trial https://healthandpharma.net/roche-alecensa-lung-cancer-treatment-alina-study 2023-10-19T00:00:00+00:00 0.80 https://healthandpharma.net/1697754406roche-logo-headquarter-3.jpg Unprecedented Results for Alecensa: A Paradigm Shift in Lung Cancer https://healthandpharma.net/ai-medical-imaging-increase-over 2023-10-18T00:00:00+00:00 0.80 https://healthandpharma.net/1697651346ai-imaging-radiology-2.jpg AI Medical Imaging Products Estimated to Increase Over Five-fold by 2035 https://healthandpharma.net/genome-editing-programmable-dna-snails 2023-10-17T00:00:00+00:00 0.80 https://healthandpharma.net/snails-genetic-dna-4.jpg MIT Researchers Discover Programmable DNA-Cutters in Snails https://healthandpharma.net/fda-approves-expanded-use-keytruda-lung-cancer 2023-10-17T00:00:00+00:00 0.80 https://healthandpharma.net/1697041217Merck-Keytruda-2.jpg FDA Approves Expanded Use of Merck's Keytruda for Lung Cancer Treatment https://healthandpharma.net/nanocapsule-drug-boosts-cancer-immunotherapy 2023-10-16T00:00:00+00:00 0.80 https://healthandpharma.net/1697405765drug-nanoparticles-nanocapsules-cancer-2.jpg Nanocapsule Drug Delivery Boosts Efficacy of Cancer Immunotherapy https://healthandpharma.net/fda-approves-pfizer-velsipity-etrasimod-ulcerative-colitis 2023-10-15T00:00:00+00:00 0.80 https://healthandpharma.net/1697324129FDA-Logo-21.jpg FDA Approves Pfizer's Velsipity for Treatment of Ulcerative Colitis https://healthandpharma.net/drug-resistance-cancer-patients-dedection-parithera 2023-10-15T00:00:00+00:00 0.80 https://healthandpharma.net/1697037182dna-genetic-laboratory-53.jpg Early Detection of Drug Resistance in Cancer Patients Possible with Parithera https://healthandpharma.net/google-cloud-empowering-doctors-with-ai-search 2023-10-14T00:00:00+00:00 0.80 https://healthandpharma.net/1697236393google-ai-doctor-asistant-43.jpg Google's Latest Breakthrough: Empowering Doctors With AI Search https://healthandpharma.net/genetic-connection-between-dna-replication-cancer 2023-10-14T00:00:00+00:00 0.80 https://healthandpharma.net/1697289781DNA-genetic-lab-2.jpg Researchers discover key connection between DNA replication and cancer https://healthandpharma.net/oncology-engineered-bacteria-tcells-cancer 2023-10-14T00:00:00+00:00 0.80 https://healthandpharma.net/1697316201engineered-bacteria-paint-targets-tumors-cancer-tcell.jpg Engineered Bacteria Direct T Cells to Combat Cancer for the First Time https://healthandpharma.net/damaged-mitochondrial-dna-parkinsons-disease 2023-10-13T00:00:00+00:00 0.80 https://healthandpharma.net/1697152280brain-dna-parkinson-2.jpg Discovery of Damaged DNA in the Brain Could Be the Key to Solving Parkinson's Disease https://healthandpharma.net/protecting-good-bacteria-antibiotic-doses 2023-10-12T00:00:00+00:00 0.80 https://healthandpharma.net/1697124083medicine-drug-pill-43.jpg Protecting Good Bacteria with Adjusted Antibiotic Doses During Treatment https://healthandpharma.net/ai-algorithm-tool-diagnoses-heart-diseases 2023-10-12T00:00:00+00:00 0.80 https://healthandpharma.net/1697138543ai-patient-hospital-robot-3.jpg New AI Tool Diagnoses Heart Diseases with Remarkable 97% Accuracy https://healthandpharma.net/novo-nordisk-semaglutide-kidney-trial-ozempic 2023-10-12T00:00:00+00:00 0.80 https://healthandpharma.net/1697144618novo-nordisk-3.jpg Novo Nordisk Halts Ozempic Kidney Trial Early Due to Positive Efficacy https://healthandpharma.net/insulin-nanoclusters-diabetes-treatment-karolinska 2023-10-11T00:00:00+00:00 0.80 https://healthandpharma.net/1697033933dna-genetic-laboratory-48.jpg Newly Discovered Insulin Nanoclusters Could Transform Diabetes Treatment https://healthandpharma.net/merck-keytruda-lung-cancer-treatment-nsclc 2023-10-11T00:00:00+00:00 0.80 https://healthandpharma.net/1697042632merck-headquarter-2.jpg Merck's Keytruda Achieves Key Milestone in Early-Stage Lung Cancer Treatment https://healthandpharma.net/ai-screening-app-early-autism-detection 2023-10-10T00:00:00+00:00 0.80 https://healthandpharma.net/autism-detection-46.jpg AI-Supported Screening Tool Revolutionizing Early Autism Detection https://healthandpharma.net/who-endorses-matrixm-malaria-vaccine 2023-10-10T00:00:00+00:00 0.80 https://healthandpharma.net/malaria-vaccine-africa-2.jpg WHO Endorses Second Malaria Vaccine: Matrix-M is Cheaper and Efficient https://healthandpharma.net/digital-healthcare-agency-nuom-wins-disruptor 2023-10-08T00:00:00+00:00 0.80 https://healthandpharma.net/1699547953nuom-team-photo.jpg Digital healthcare agency, nuom, wins as Disruptor of the Year https://healthandpharma.net/wearable-sensor-monitor-vital-health-data 2023-10-06T00:00:00+00:00 0.80 https://healthandpharma.net/digital-sensor-patch-3.jpg Revolutionary Wearable Sensor Can Monitor Vital Health Data in Real-Time https://healthandpharma.net/mits-device-injection-free-diabetes-treatment 2023-09-26T00:00:00+00:00 0.80 https://healthandpharma.net/1695233940MIT-diabete-device-2.jpg MIT's Implantable Device Offers Hope for Injection-Free Diabetes Treatment https://healthandpharma.net/stem-cell-therapy-alzheimers-treatment 2023-09-26T00:00:00+00:00 0.80 https://healthandpharma.net/Alzheimer-nueron-stem-cell.jpg Stanford Study: Stem Cell Therapy Shows Promise in Alzheimer’s Treatment https://healthandpharma.net/astrazeneca-daiichi-sankyo-breast-cancer-drug 2023-09-23T00:00:00+00:00 0.80 https://healthandpharma.net/Astrazenaca-Daiichi-Sankyo-2.jpg Positive Results for AstraZeneca and Daiichi Sankyo's Breast Cancer Drug https://healthandpharma.net/ai-deep-brain-stimulation-depression-recovery 2023-09-23T00:00:00+00:00 0.80 https://healthandpharma.net/brain-neuro-ai-waves-7.jpg AI + Deep Brain Stimulation Could Unlock Paths to Depression Recovery https://healthandpharma.net/alzheimers-drug-candidate-a11-curbs-inflammation 2023-09-22T00:00:00+00:00 0.80 https://healthandpharma.net/alzheimers-neuron-drug-4.jpg New Alzheimer’s Drug Candidate, Curbs Inflammation and Enhances Cognition https://healthandpharma.net/engineered-bacteria-cancer-detection 2023-09-21T00:00:00+00:00 0.80 https://healthandpharma.net/bakterium-dna-genetic-1.jpg Engineered Bacteria: A Revolutionary New Tool in Cancer Detection https://healthandpharma.net/elon-musk-neuralink-receives-fda-approval-for-human-trials 2023-09-20T00:00:00+00:00 0.80 https://healthandpharma.net/1695238608Elon-Musks-Neuralink-1.jpg Elon Musk's Brain Implant, Neuralink, Receives FDA Approval for Human Trials https://healthandpharma.net/regard-gpt-4-clinical-documentation-and-operations 2023-09-17T00:00:00+00:00 0.80 https://healthandpharma.net/patient-doctor-ai-gpt-2.jpg Regard's GPT-4 Enhanced Features Transform Clinical Documentation https://healthandpharma.net/digital-diagnostics-ai-tool-parkinsons-symptoms 2023-09-16T00:00:00+00:00 0.80 https://healthandpharma.net/parkinsons-disease-test-3.jpg AI Tool Shows Promising Results in Assessing Parkinson's Severity https://healthandpharma.net/rna-liquid-biopsy-test-cancer-detection 2023-09-15T00:00:00+00:00 0.80 https://healthandpharma.net/biotech-laboratory-test-8.jpg RNA Liquid Biopsy Could Transform the Future of Cancer Detection https://healthandpharma.net/modified-mrna-therapy-repair-heart-damage 2023-09-14T00:00:00+00:00 0.80 https://healthandpharma.net/heart-dna-virus-5.jpg Modified mRNA Therapy Promises to Repair Heart Damage After Attack https://healthandpharma.net/inverse-vaccine-treat-ms-autoimmune-diseases 2023-09-13T00:00:00+00:00 0.80 https://healthandpharma.net/autoimmune-cell-nureon-3.jpg Inverse Vaccine Could Treat Multiple Sclerosis and Autoimmune Diseases https://healthandpharma.net/ai-boosts-breast-cancer-detection 2023-09-12T00:00:00+00:00 0.80 https://healthandpharma.net/mammography-ai-radiology-digital-3.jpg Faster and More Accurate: AI Boosts Success in Breast Cancer Detection https://healthandpharma.net/new-als-treatment-velcro-like-protein-molecule 2023-09-09T00:00:00+00:00 0.80 https://healthandpharma.net/velcro-likecellular-proteins-3.jpg New ALS Treatment on the Horizon: 'Velcro-like' Protein Molecule Identified https://healthandpharma.net/moderna-updated-covid-19-vaccine 2023-09-07T00:00:00+00:00 0.80 https://healthandpharma.net/moderna-covid-vaccine-7.jpg Moderna: Updated COVID-19 Vaccine is Effective Against Newer Variants https://healthandpharma.net/eye-tracking-device-earlipoint-promises-autism-detection 2023-09-07T00:00:00+00:00 0.80 https://healthandpharma.net/autism-children-4.jpg New Eye-Tracking Device, Promises Rapid and Accurate Autism Detection https://healthandpharma.net/gamma-delta-t-cells-can-recognize-and-destroy-cancer 2023-09-06T00:00:00+00:00 0.80 https://healthandpharma.net/immunotherapy-cancer-tumor-1.jpg New Discovery Shows How Gamma Delta T Cells Can Destroy Cancer https://healthandpharma.net/ai-accuracy-as-radiologists-in-breast-cancer-screening 2023-09-05T00:00:00+00:00 0.80 https://healthandpharma.net/ai-radiology-digital-7.jpg AI Shows Equal Accuracy as Radiologists in Breast Cancer Screening https://healthandpharma.net/biohaven-epilepsy-treatment-results-phase-1-studies 2023-09-05T00:00:00+00:00 0.80 https://healthandpharma.net/biohaven-pharmaceutical-logo-3.jpg Biohaven's Epilepsy Treatment Shows Promising Results in P1 Study https://healthandpharma.net/aromatherapy-boosts-memory-in-elderly 2023-09-04T00:00:00+00:00 0.80 https://healthandpharma.net/aromatherapy-memory-aging-2.jpg Nightly Aromatherapy Boosts Cognitive Capacity by 226% in the Elderly https://healthandpharma.net/approved-ms-drug-promise-as-new-alzheimers-therapy 2023-09-04T00:00:00+00:00 0.80 https://healthandpharma.net/ilac-drug-medicine-pill-16.jpg Approved MS Drug Shows Promise as New Alzheimer’s Therapy https://healthandpharma.net/biomarin-gene-therapy-roctavian-europe-haemophilia-a 2023-09-04T00:00:00+00:00 0.80 https://healthandpharma.net/biomarin-headquarter-1.jpg BioMarin's Revolutionary Gene Therapy, Roctavian, Launches in Europe https://healthandpharma.net/bird-flu-mutation-sparks-global-pandemic-fear 2023-09-04T00:00:00+00:00 0.80 https://healthandpharma.net/biotech-laboratory-test-4.jpg Newly Discovered Bird Flu Mutation Sparks Global Pandemic Fear https://healthandpharma.net/microdevice-personalized-treatment-brain-cancer 2023-09-04T00:00:00+00:00 0.80 https://healthandpharma.net/brain-cancer-surgery-1.jpg New Microdevice Offers Innovative Personalized Treatment for Brain Cancer https://healthandpharma.net/fda-issued-report-on-risks-of-arvr-medical-devices 2023-09-03T00:00:00+00:00 0.80 https://healthandpharma.net/fda-logo-43.jpg FDA has issued a report on risks of virtual reality AR/VR medical devices https://healthandpharma.net/roches-alecensa-lung-cancer-treatment 2023-09-02T00:00:00+00:00 0.80 https://healthandpharma.net/roche-centre-2.jpg Roche’s Alecensa Shows Promise in Early-Stage Lung Cancer Treatment https://healthandpharma.net/stanford-study-predictable-genetic-changes-leading-cancer 2023-09-02T00:00:00+00:00 0.80 https://healthandpharma.net/genetic-dna-14.jpg Stanford's Study Uncovers Predictable Genetic Changes Leading to Cancer https://healthandpharma.net/dr4-allele-gene-factor-alzheimers-and-parkinsons 2023-09-02T00:00:00+00:00 0.80 https://healthandpharma.net/genetic-dna-12.jpg DR4 Allele Gene: A New Beacon of Hope Against Alzheimer’s and Parkinson’s https://healthandpharma.net/non-surgical-skin-cancer-treatment-achieves-99-cure-rate 2023-09-01T00:00:00+00:00 0.80 https://healthandpharma.net/skin-cancer-ultras-15.jpg Non-Surgical Skin Cancer Treatment Achieves 99% Cure Rate https://healthandpharma.net/muvalaplin-drug-targeting-genetic-cholesterol 2023-09-01T00:00:00+00:00 0.80 https://healthandpharma.net/medicine-pill-tablets-drug-ilac-36.jpg Muvalaplin: First Oral Drug Targeting Genetic 'Bad' Cholesterol https://healthandpharma.net/tcell-location-success-of-immunotherapy-in-lung-cancer 2023-09-01T00:00:00+00:00 0.80 https://healthandpharma.net/immunotherapy-cancer-tumor-21.jpg Location of T Cells Could Revolutionize Immunotherapy Success in Lung Cancer https://healthandpharma.net/blood-test-detect-parkinsons-in-initial-stages 2023-09-01T00:00:00+00:00 0.80 https://healthandpharma.net/blood-test-kan-labaratuvar-14.jpg Innovative Blood Test Can Detect Parkinson’s in Its Very Initial Stages https://healthandpharma.net/software-sparkmaster-calciums-role-in-heart-diseases 2023-09-01T00:00:00+00:00 0.80 https://healthandpharma.net/sparkmaster-research-team-wb.jpg New Software Offers Insight into Calcium's Role in Heart Diseases and Aids Research https://healthandpharma.net/gut-bacteria-role-preventing-diabetes-obesity 2023-08-31T00:00:00+00:00 0.80 https://healthandpharma.net/gut-bacteria-stomach-3.jpg Gut Bacteria May Play a Key Role in Preventing Diabetes and Obesity https://healthandpharma.net/fda-orphan-drug-designation-to-bexmarilimab-aml 2023-08-31T00:00:00+00:00 0.80 https://healthandpharma.net/fda-centre-231.jpg FDA Grants Orphan Drug Designation to Bexmarilimab for AML https://healthandpharma.net/new-therapeutic-approach-for-osteoarthritis 2023-08-31T00:00:00+00:00 0.80 https://healthandpharma.net/osteoarthritis-54.jpg Breakthrough Discovery Offers New Therapeutic Approach for Osteoarthritis https://healthandpharma.net/fda-grants-expanded-approval-reblozyl-mds-treatment 2023-08-30T00:00:00+00:00 0.80 https://healthandpharma.net/bms-reblozyl-luspatercept-3.jpg FDA Grants Expanded Approval to Bristol Myers' Reblozyl for MDS Treatment https://healthandpharma.net/uc-irvine-issue-warning-weight-loss-drugs-for-children 2023-08-30T00:00:00+00:00 0.80 https://healthandpharma.net/drug-pil-ilac-3.jpg UC Experts Issue Warning About Weight Loss Drugs for Children https://healthandpharma.net/opioid-vaccines-human-trials-targeting-fentanyl-and-heroin 2023-08-30T00:00:00+00:00 0.80 https://healthandpharma.net/opioid-vaccines.jpg Opioid Vaccines Near Human Trials: Targeting Fentanyl and Heroin https://healthandpharma.net/alzheimers-mysteries-3d-model-offers-new-treatment 2023-08-29T00:00:00+00:00 0.80 https://healthandpharma.net/alzheimers-tcells-neuroen-2.jpg 3D Model Research Offers New Treatment Options for Alzheimer's Disease https://healthandpharma.net/bemdaneprocel-stem-cell-therapy-for-parkinson 2023-08-29T00:00:00+00:00 0.80 https://healthandpharma.net/bayer-parkinson-23.jpg Bemdaneprocel: Stem Cell Therapy for Parkinson's Shows Promising Results https://healthandpharma.net/ec-approval-to-merck-keytruda-for-gastric-cancer 2023-08-29T00:00:00+00:00 0.80 https://healthandpharma.net/merck-keytruda-24.jpg EU Commission grants approval to Merck’s Keytruda for gastric cancer https://healthandpharma.net/abbvie-approval-risankizumab-from-fda-and-ema 2023-08-29T00:00:00+00:00 0.80 https://healthandpharma.net/abbvie-headquarter-.jpg AbbVie Seeks New Approval for Risankizumab from FDA and EMA https://healthandpharma.net/clovibactin-new-antibiotic-discovery-superbugs 2023-08-28T00:00:00+00:00 0.80 https://healthandpharma.net/australian-sepsis-study-to-power-new-antibiotic-discoveries.jpg Clovibactin: New Antibiotic Discovery Offers Hope Against Superbugs https://healthandpharma.net/decoding-cancer-dna-repair-mechanisms-for-treatment 2023-08-28T00:00:00+00:00 0.80 https://healthandpharma.net/gene-therapy-mrna-1.jpg Could Utilizing DNA Repair Mechanisms Be an Option in Cancer Treatment? https://healthandpharma.net/fda-approves-tyruko-novartis-biogen-tysabri 2023-08-27T00:00:00+00:00 0.80 https://healthandpharma.net/fda-drug-23.jpg FDA Approves Tyruko, Novartis' Biosimilar to Blockbuster Tysabri https://healthandpharma.net/obesity-drug-wegovy-results-for-heart-failure-patients 2023-08-27T00:00:00+00:00 0.80 https://healthandpharma.net/obesity-drug-wegovy-3.jpg Obesity Drug, Wegovy Shows Positive Results for Heart Failure https://healthandpharma.net/chatgpts-impressive-accuracy-in-clinical-practice 2023-08-26T00:00:00+00:00 0.80 https://healthandpharma.net/ai-chatgptartificial-intelligence.jpg Study Reveals ChatGPT's Impressive Accuracy in Transforming Clinical Practice https://healthandpharma.net/gene-therapy-micrornas-liver-cancer 2023-08-26T00:00:00+00:00 0.80 https://healthandpharma.net/biotech-laboratory-test-9.jpg MicroRNA-Based Gene Therapy, Holds Promise in Battle Against Liver Cancer https://healthandpharma.net/beme-healths-pivotal-role-in-teen-mental-health 2023-08-17T00:00:00+00:00 0.80 https://healthandpharma.net/beme-app-1.jpg Stanford Study Reveals BeMe Health's Pivotal Role in Teen Mental Support https://healthandpharma.net/epkinly-epcoritamab-treatment-follicular-lymphoma 2023-08-05T00:00:00+00:00 0.80 https://healthandpharma.net/biotech-laboratory-test-8.jpg Epkinly, promise new treatment option for follicular lymphoma https://healthandpharma.net/fda-approves-elevidys-gene-therapy-pediatric-dmd 2023-08-04T00:00:00+00:00 0.80 https://healthandpharma.net/fda-logo-aproved-3.jpg First Gene Therapy for Pediatric DMD Patients Approved by the FDA https://healthandpharma.net/smartwatches-ai-detection-parkinson-symptoms 2023-07-06T00:00:00+00:00 0.80 https://healthandpharma.net/akilli-saat-smart-watch.jpg Smartwatches and AI enable detection of Parkinson's 7 years before symptoms https://healthandpharma.net/fda-approves-biomarins-roctavian-first-gene-therapy-hemophilia-a-2 2023-07-05T00:00:00+00:00 0.80 https://healthandpharma.net/dna-repair-gen.jpg FDA Approves Roctavian, the First Gene Therapy for Severe Hemophilia A https://healthandpharma.net/celltrans-lantidra-cell-therapy-type-1-diabetes-fda-approval 2023-07-03T00:00:00+00:00 0.80 https://healthandpharma.net/1697324129FDA-Logo-21.jpg Lantidra: Revolutionary cell therapy for Type 1 diabetes earns FDA approval